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Abstract
Plants exhibit multitudes of defense mechanisms against diﬀerent kinds of stress. Jas-
monic acid (JA) is one of the identiﬁed signaling compounds mediating plant’s response
to wounding, attack by herbivores or necrotrophic pathogens. Central parts of the
JA signaling pathway have recently been unraveled by demonstrating that (+)-7-iso-
JA-L-Ile is the most bioactive form of JA and that the SCFCOI1-complex functions
as its receptor. However, many other components of the JA signaling pathway re-
main unknown. This includes how and where protein kinases may be involved in JA
signaling. Likewise, the mechanistic details of cross-talk between diﬀerent hormone
signaling pathways are unknown. Using a chemical biology approach, screening for
selective compounds that can be used as tools in applications complementing genetic
approaches, I aimed at identifying some of these unknown components. The advantage
of this method is that it has the potential to circumvent redundancy of gene function,
lethality of mutants and pleiotropic eﬀects, problems generally encountered in genetic
approaches.
I developed a screening procedure for bioactive compounds that uses a transgenic
Arabidopsis thaliana line, harboring the JA-responsive reporter gene LOX2p::LUC.
This procedure allowed bidirectional screening for activators or inhibitors of reporter
expression. Sifting through approx. 1,700 natural compounds, I identiﬁed one activator
of reporter gene expression and 16 inhibitors of methyl jasmonate induced reporter
expression. Critical validation of these primary hits revealed that the putative activator
in fact interfered with the activity of the luciferase reporter. It presumably binds and
stabilizes luciferase, thereby enhancing its apparent activity, whereas reporter gene
expression was not aﬀected. After validation and characterization of the inhibitors, one
compound (12) was identiﬁed as selective inhibitor of JA signaling. Structure-activity
relationship studies, using derivatives of the compound, deﬁned parts of the molecule
that where indispensable for its bioactivity. Based on this analysis, a derivatized probe
was designed that harbors a ‘photoreactive’ benzophenone for establishing covalent
binding and an alkyne residue to attach a detectable ﬂuorophore using ‘click chemistry’.
Importantly, this probe retained activity and was used in ﬁrst aﬃnity-based target
identiﬁcation experiments.
In a second screen using a small, targeted library of 84 known protein kinase in-
hibitors, I identiﬁed three compounds that impaired JA signaling. This ﬁnding suggests
the involvement of protein kinases in the JA signaling pathway that has been previ-
ously reported. Among the identiﬁed inhibitors was 5-iodotubercidin, a nucleoside
antibiotic. A derivative of this compound, toyocamycin, was previously described to
selectively impair auxin signaling, which is mechanistically related to JA signaling. Sev-
eral structural analogs were investigated with respect to their eﬀect on JA-dependent
reporter expression or JA-independent readouts. Toyocamycin was considered to be
the most speciﬁc derivative. To elucidate the role of toyocamycin in the Arabidopsis
hormonal signaling network, I performed a microarray analysis after treatment with
toyocamycin. The expression data showed that this compound modulates expression
of JAZ genes, which are repressors of JA induced gene expression. Toyocamycin also
modulated genes, which may be involved in hormonal crosstalk between e.g. auxin
or salicylic acid signaling. The fact that toyocamycin caused a root growth pheno-
type, which is dependent on allene oxide synthase (AOS) and jasmonoyl-isoleucine
synthetase (JAR1), indicated that multiple targets may exist, because inhibition of
the LOX2 marker was independent of JAR1.
Identiﬁcation of the protein targets of toyocamycin and compound 12 may even-
tually lead to identiﬁcation of yet unknown components in JA signaling or hormonal
crosstalk.
Zusammenfassung
Pﬂanzen weisen eine Reihe an Verteidigungsmechanismen gegen verschiedene Arten
von Stress auf. Jasmonsäure (JA) ist eine der bekannten Signalkomponenten in der
Pﬂanzenreaktion auf Verwundung, Herbivorenangriﬀ oder auf necrotrophe Pathogene.
Wesentliche Teile des JA Signalwegs sind bereits aufgedeckt. (+)-7-iso-JA-L-Ile ist die
bioaktivste Form von JA und der SCFCOI1-Komplex ist der Rezeptor. Andere Kom-
ponenten des JA Signalwegs sind noch unbekannt. Diese schließen ein, ob und wie
Proteinkinasen involviert sind. Ebenso sind mechanistische Details des „Crosstalks“
zwischen verschiedenen Hormonsignalwegen unbekannt. Über einen „chemisch biolo-
gischen“ Ansatz – Durchmustern von Chemikalienbibliotheken nach selektiven chemi-
schen Verbindungen, die in genetisch komplementierenden Versuchen als Werkzeug
eingesetzt werden können – habe ich versucht, solche unbekannten Komponenten zu
identiﬁzieren. Der Vorteil dieses Ansatzes ist die Möglichkeit, Genredundanz, Lethalität
von Mutanten und pleiotrope Eﬀekte zu umgehen, welche häuﬁg auftretende Probleme
in genetischen Ansätzen sind.
Ich habe eine Screeningmethode entwickelt, die eine transgene Arabidopsis thalia-
na-Linie verwendet, welche den JA-induzierbaren Reporter LOX2p::LUC trägt. Dieser
Ansatz erlaubte bidirektionales Durchmustern nach Aktivatoren oder Inhibitoren der
Reporterexpression. Aus ca. 1700 Naturstoﬀverbindungen habe ich einen Aktivator
von Reporterexpression und 16 Inhibitoren von Methyljasmonat-induzierter Reporter-
expression identiﬁziert. Durch kritische Validierung dieser primären Kandidaten stell-
te sich heraus, dass der vermeintliche Aktivator die Aktivität des Luziferasereporters
beeinﬂusste. Vermutlich bindet und stabilisiert die Verbindung Luziferase, wodurch
scheinbar die Aktivität gesteigert wird, ohne jedoch Genexpression zu beeinﬂussen.
Nach Validierung und Charakterisierung der Inhibitoren, habe ich Verbindung 12
als selektiven Inhibitor des JA Signalwegs bestätigt. Die Anwendung von Derivaten
dieser Verbindung ergab deﬁnierte Struktur-Aktivitätsbeziehungen und zeigte für die
Aktivität notwendige Strukturen auf. Darauf aufbauend wurde eine modiﬁzierte Son-
de entwickelt, die einen „photoaktivierbaren“ Benzophenonrest – zum Herstellen von
kovalenten Bindungen mit Proteinen – und einen Alkinrest, zum Anfügen eines de-
tektierbaren Fluorophores über „Klick-Chemie“, enthält. Diese Sonde wies weiterhin
Bioaktivität auf und wurde in ersten aﬃnitätsbasierten Experimenten angewandt, um
mögliche Zielproteine zu identiﬁzieren.
In einem zweiten Screen mit einer kleinen zielgerichteten Chemikalienbibliothek, die
aus 84 beschriebenen Proteinkinaseinhibitoren besteht, habe ich drei Proteinkinasein-
hibitoren identiﬁziert, welche den JA Signalweg beeinﬂussten. Dies deutet auf eine
Rolle von Proteinkinasen im JA Signalweg hin. Unter den identiﬁzierten Inhibitoren
war 5-Iodotubercidin, ein Nukleosidantibiotikum. Ein Derivat der Verbindung, Toyo-
camycin, wurde bereits als selektiver Inhibitor des Auxin Signalwegs beschrieben, wel-
cher dem JA Signalweg mechanistisch sehr ähnelt. Mehrere Strukturanaloga wurden
auf ihren Eﬀekt auf jasmonatabhängige Reporterexpression oder jasmonatunabhängige
Reaktionen untersucht. Toyocamycin schien diesbezüglich die speziﬁschste Verbindung
zu sein. Um die Rolle von Toyocamycin im Arabidopsis Hormonnetzwerk zu erklären,
habe ich den Eﬀekt der Verbindung in einer Microarray-Analyse untersucht. Die Ex-
pressionsdaten zeigten, dass Toyocamycin die Expression von JAZ -Genen, Repressoren
von JA-induzierter Genexpression, veränderte. Außerdem wurde Expression von Genen
beeinﬂusst, die im „Hormoncrosstalk“ zwischen z. B. Auxin- oder Salicylsäure Signal-
wegen eine Rolle spielen könnten. Toyocamycin hemmt des Weiteren Wurzelwachstum,
was abhängig von der Allenoxidsynthase (AOS) und von der Jasmonoylisoleucinsyn-
thetase (JAR1) ist. Dies deutet auf die Existenz von mehreren Zielproteinen hin, denn
die Hemmung des LOX2 -Markers war unabhängig von JAR1.
Die Identiﬁzierung von Zielproteinen von Toyocamycin und Verbindung 12 wird
möglicherweise zur Identiﬁzierung von bisher unbekannten Komponenten des JA Si-
gnalwegs oder „Hormoncrosstalk“ führen.
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1 Introduction
1.1 The past, present and future of jasmonic acid signaling
Jasmonic acid (JA) and its derivatives, collectively referred to as jasmonates, comprise
a group of oxylipin signaling molecules in plants that share a high degree of structural
and functional similarity to prostaglandins found in animals. Both types of compound
are derived from fatty acid oxidation pathways that are activated in response to stress.
Correspondingly, jasmonate levels increase drastically and rapidly upon wounding, UV
irradiation, ozone treatment and other abiotic stresses (Wasternack, 2007). In ad-
dition, responses to biotic stress, such as herbivore attack or infection by microbial
pathogens also depend on jasmonates. In healthy, non-stressed plants jasmonates me-
diate developmental processes, such as root growth seed germination, tuber formation,
tendril coiling, trichome initiation, ﬂower development and senescence (Wasternack,
2007; Browse and Howe, 2008). Jasmonates operate via changing genome wide gene
expression, which is in part mediated by the transcription factor MYC2 (Lorenzo et al.,
2004; Dombrecht et al., 2007; Fonseca et al., 2009a). Elucidation of their mode of ac-
tion has long been hampered by the fact that plants contain many JA derivatives,
biosynthetic precursors and JA metabolites, which diﬀer considerably in their biolog-
ical activities (Krumm et al., 1995; Kramell et al., 1997; Stintzi et al., 2001; Staswick
and Tiryaki, 2004; Taki et al., 2005; Miersch et al., 2008).
Most of our current knowledge about synthesis and function of jasmonates has been
derived from mutants that are defective in JA biosynthesis or the physiological response
to JA treatment (Berger et al., 2002; Wasternack, 2006; Browse, 2009b). However in
addition to such biological approaches, chemical strategies have also always been inte-
gral part of jasmonate research. During the ﬁrst years after discovery of jasmonates
as plant constituents that are important for plant growth and development (Ueda and
Kato, 1980; Dathe et al., 1981), extensive studies on structure-activity relationships
were carried out. These included the synthesis of numerous JA derivatives and de-
termining their impact on various plant responses (Wasternack, 2007; Wasternack and
Kombrink, 2010). This type of work provided ﬁrst insights into structural requirements
for jasmonate bioactivity and aimed at development of tools for target identiﬁcation.
This approach led to the synthesis of the highly active jasmonate analog coronalon,
which was inspired by the extremely high bioactivity of the bacterial phytotoxin coro-
natine (COR) (Mithöfer et al., 2004).
Because of its exceptional structure and bioactivity, COR has been essential for two
important discoveries in jasmonate research: (1) Application of COR in a genetic screen
yielded the A. thaliana mutant coronatine insensitive 1 (coi1 ), which is defective in a
central regulatory unit of jasmonate signaling (Feys et al., 1994), and (2) its deﬁned
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stereochemical structure provided the blueprint for identiﬁcation and synthesis of the
plant endogenous most bioactive jasmonate, (+)-7-iso-jasmonoyl-L-isoleucine (Fonseca
et al., 2009b).
1.1.1 The jasmonate biosynthesis pathway
The plant-speciﬁc pathway of JA biosynthesis has been unraveled. It comprises at
least ten mostly well-characterized enzymatic reactions that are outlined in Figure 1.1
(Wasternack, 2007; Schaller and Stintzi, 2009). After the initial release of α-linolenic
acid (C18:3) from plastidial galactolipids by phospholipases such as DAD1 or GDL
(Ishiguro et al., 2001; Hyun et al., 2008), it is oxidized by a 13-lipoxygenase (LOX).
The product 13(S )-hydroperoxy-octadecatrienoic acid [13(S )-HPOT] is converted to
12,13(S )-epoxy-octadecatrienoic acid [12,13(S )-EOT] by allene oxide synthase (AOS),
which represents the ﬁrst committed step of JA biosynthesis. In Arabidopsis AOS is a
single copy gene and the loss-of-function mutant is deﬁcient in JA (Park et al., 2002; von
Malek et al., 2002). Allene oxide cyclase (AOC) converts the allylic epoxide product
of AOS into optically pure (9S,13S )-12-oxo-phytodienoic acid [cis-(+)-OPDA], which
is the endproduct of the plastid-localized part of the JA biosynthesis pathway and
represents the ﬁrst cyclic compound with pronounced bioactivity (Stenzel et al., 2003;
Wasternack, 2007). Note that the same set of enzymes acting on hexadecatrienoic acid
(C16:3) generate dinor-OPDA (Weber, 1997). Interestingly, in Arabidopsis chloro-
plasts OPDA and dnOPDA have also been identiﬁed as constituents of membrane
galactolipids and upon selective release by lipases may act as signals or contribute to
JA biosynthesis (Stelmach et al., 2001; Andersson et al., 2006).
For further conversion OPDA is translocated from chloroplasts to peroxisomes,
which in part is mediated by the ATP-binding cassette transporter CTS1 (identical
to PXA1/PED3) (Theodoulou et al., 2005). OPDA reductase (OPR3) catalyzes the
reduction of OPDA to OPC-8 (Fig. 1.1). In Arabidopsis and tomato only this iso-
form is found in the peroxisome and the JA-deﬁcient phenotype of the opr3 mutant
indicates that other isoforms do not contribute to JA biosynthesis (Sanders et al.,
2000; Stintzi and Browse, 2000). The following β-oxidation is initiated by activation
of the carboxylic acid moiety to the corresponding CoA ester by OPC-8:CoA ligase 1
(OPCL1), one member of a large superfamily of acyl-coenzyme A synthetase in Ara-
bidopsis (Schneider et al., 2005; Koo et al., 2006; Kienow et al., 2008). After three
rounds of β-oxidation, jasmonoyl-CoA is cleaved by a yet unknown thioesterase (TE)
giving rise to (+)-7-iso-JA that equilibrates to the more stable (-)-JA. An overview
of all steps of JA biosynthesis is shown in Figure 1.1. Arabidopsis mutants that have
been important for understanding JA biosynthesis are highlighted in blue.
1.1.2 Metabolic conversion and structure-activity relationship (SAR) of
jasmonates
JA is subject to enzymatic modiﬁcations as evident from numerous JA metabolites
that were shown to be constituents in various plant species and tissues or to accumu-
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Figure 1.1: Pathway of jasmonic acid biosynthesis. Upon release of α-linolenic acid (C18:3)
from galactolipids by phospholipases (PL) in the chloroplast, the hydroperoxy compound 13(S)-HPOT
is formed by 13-lipoxygenase (LOX). The unstable allene oxide 12,13(S)-EOT is generated by allene
oxide synthase (AOS) and further converted to (9S,13S)-OPDA by allene oxide cyclase (AOC). In the
peroxisome OPDA is reduced to OPC-8 by OPDA reductase 3 (OPR3). Subsequent activation to the
corresponding CoA ester by OPC-8:CoA ligase (OPCL1) allows shortening of the carboxylic acid side
chain via the fatty acid β-oxidation machinery, comprising acyl-CoA oxidase (ACX), multifunctional
protein (MFP) and L-3-ketoacyl CoA thiolase (KAT). The endproduct, jasmonoyl-CoA, is cleaved by
a putative thioesterase (TE) yielding (+)-7-iso-JA, which equilibrates with the more stable (-)-JA.
Arabidopsis mutants that have been important for understanding JA biosynthesis are indicated in
blue. Reaction scheme modified after Wasternack and Kombrink (2010).
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late in response to stress (Wasternack, 2007; Göbel and Feussner, 2009). Among these
metabolites are the methyl ester (MeJA), amino acid conjugates of JA, e.g. JA-Ile,
JA-Leu, JA-Val or the hydroxylation products 12-OH-JA (Fig. 1.2 includes more JA
metabolites). The abundance and bioactivity of diﬀerent metabolites may vary consid-
erably (Miersch et al., 2008), which immediately raises two important questions: (1)
What is the biological signiﬁcance of such large number of JA derivatives? (2) What
are the structural requirements for bioactivity in diﬀerent bioassays?
After the ﬁrst reported JA-induced plant responses, e.g. growth inhibition (Ueda
and Kato, 1980; Dathe et al., 1981), the increasing structural and functional diversity
of identiﬁed, natural jasmonates stimulated a strong interest in structure-activity re-
lationships (SAR) and extensive synthesis of novel JA derivates, standard approaches
executed in drug research that precede target identiﬁcation steps. From early chemical-
biological exercises, distinct structural requirements for JA-activity were deﬁned based
on various biological responses, such as tuber formatin, root growth inhibition, tendril
coiling, alkaloid formation or expression of JA responsive genes (Koda et al., 1992;
Staswick et al., 1992; Blechert et al., 1995, 1999; Miersch et al., 1999). These require-
ments include that a cyclopentanone ring carrying a keto group at C-6 is essential,
that an intact pentenyl side chain is required for activity, that formation of amino
acid conjugates generally increases bioactivity or that hydroxylation at C-11 or C-12
impairs biological activity.
Data about SAR provided only ﬁrst hints about the functional signiﬁcance of par-
ticular derivatives or distinct structural units. Some of the JA metabolites, such as
12-OH-JA, 12-HSO4-JA, 12-O-Glc-JA, may even occur in distinct tissues or organs of
some plants (e.g. Zea mays, Glycine max ) at concentrations that are orders of mag-
nitude higher than those of JA, suggesting a function as inactivated storage form of
JA (Miersch et al., 2008). Indeed, formation of 12-OH-JA and 12-HSO4-JA is accom-
panied with a partial suppression of JA signaling (Gidda et al., 2003; Miersch et al.,
2008). Likewise, accumulation of several glucosides of JA and JA derivatives has been
observed upon wound-induced JA biosynthesis, and collectively, these data indicate a
role of JA metabolism in turning oﬀ JA signaling by conversion of active jasmonates
into metabolites that are at least partially inactive (Glauser et al., 2008; Miersch et al.,
2008; Glauser et al., 2010).
Still, the question about what is the most bioactive jasmonate in planta remained
unsolved. The presence of two chiral centers in jasmonic acid (see Fig. 1.2) allows
four possible stereo isomers of jasmonates; however, only the (3R,7S ) and (3R,7R)
conﬁgurations occur in natural compounds, e.g. JA or JA-Ile, since isomerization at
C-3 apparently does not occur (Koda et al., 1992; Holbrook et al., 1997). Based on
the facts that the ratio of the stereo isomers, (+)-7-iso-JA vs. (-)-JA, in plant tis-
sues increases drastically in response to wounding (Schulze et al., 2006) and that the
jasmonate mimic COR, in which epimerization is not possible, shows extremely high
bioactivity, a search for stereo speciﬁc compounds among 40 diﬀerent JA derivatives
was performed. This uncovered only (+)-7-iso-JA-L-Ile to be exceptionally active (as
well as the non-natural (+)-JA-L-Ile), whereas all other tested compounds showed only
weak or no activity. Those included JA, MeJA, OPDA and other JA amino acid conju-
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Figure 1.2: Metabolism of jasmonic acid. Conjugation of (+)-7-isoJA to isoleucine by jasmonoyl-
isoleucine synthetase (JAR1) generates the natural bioactive jasmonate (+)-7-iso-JA-L-Ile, which is
converted to inactive 12-OH-(+)-7-iso-JA-L-Ile by JA-Ile hydroxylase (CYP94B3). JAR1 presumably
also catalyzes the conjugation of JA to other amino acids such as valine, leucine, phenylalanine, tryp-
tophan or the ethylene precursor aminocyclopropane carboxylic acid (not shown). Other common JA
transformations include hydroxylation to 12-OH-JA, which can be sulfated by a sulfotransferase (ST2a)
to 12-HSO4-JA or glucosylated to 12-O-glucosyl-JA or conjugated with isoleucine to 12-OH-(+)-7-
iso-JA-L-Ile (presumably by JAR1), hydroxylation to 11-OH-JA and methylation at the carboxyl
group by JA methyltransferase (JMT) to MeJA. Enzymes catalyzing formation of JA-1-glucoside or
reduction to 9,10-dehydro-JA, cis-jasmone or cucurbic acid are not yet known. Note that only a
selection of JA metabolites is shown and their absolute stereoconfiguration is mostly not established
or represented by racemic mixtures. Chiral centers in (+)-7-iso-JA are highlighted in red.
gates (Fonseca et al., 2009b). The previously reported activity of (-)-JA-L-Ile (Thines
et al., 2007; Katsir et al., 2008) could be attributed to low, residual contamination by
(+)-7-iso-JA-L-Ile resulting from epimerization (Fonseca et al., 2009b).
For the biosynthetic enzyme jasmonoyl-isoleucine synthetase (JAR1) from tomato a
strong preference for (+)-7-iso-JA over (-)-JA and isoleucine over other amino acids has
recently been demonstrated (Suza and Staswick, 2008; Suza et al., 2010), suggesting
that JAR1 activity is tightly coupled to (+)-7-iso-JA formation before its epimeriza-
tion can occur. Inactivation of jasmonate signaling originating from (+)-7-iso-JA-L-Ile
was recently shown to involve hydroxylation of the jasmonate residue by a cytochrome
P450 monooxygenase (CYP94B3) leading to 12-hydroxy-JA-Ile and attenuation of jas-
monate responses (Koo et al., 2011; Kitaoka et al., 2011). In addition, jasmonate
signaling may also be turned oﬀ by other mechanisms, such as epimerization at C7
converting active (+)-7-iso-JA-L-Ile to inactive (-)-JA-L-Ile or methyl esteriﬁcation to
(+)-7-iso-JA-L-Ile-Me, which was also shown to be inactive (Fonseca et al., 2009b).
The natural occurrence of JA-L-Ile methyl esters indicates that this mechanism of
hormone inactivation may indeed operate in planta (Hause et al., 2000).
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1.1.3 Searching for signaling components - dissecting the JA signaling
pathway
Genetic and molecular analyses have been pivotal for the current understanding of
JA biosynthesis and function in signaling processes. In contrast to many other alter-
native approaches, mutant analysis oﬀers the potential to provide clear, unequivocal
information about how gene products aﬀect plant function. Some JA-related mutants
were initially identiﬁed based on recognizable phenotypic characteristics, such as defec-
tive ﬂower development in the mutants delayed dehiscence 1 (dde1/opr3 ) and delayed
dehiscence 2 (dde2/aos), defective in anther dehiscence 1 (dad1 ), or deﬁciency in un-
saturated fatty acids in the fatty acid desaturase triple mutant fad3 fad7 fad8, but
subsequently turned out to be aﬀected in JA biosynthesis (McConn and Browse, 1996;
McConn et al., 1997; Sanders et al., 2000; Ishiguro et al., 2001; von Malek et al., 2002).
Other JA-related mutants were identiﬁed in screens by applying jasmonates (MeJA,
COR, etc.) to chemically enforce a phenotype and by selecting resistant plants (Berger
et al., 2002; Wasternack, 2006; Browse, 2009b). Among the large number of these
mutants, three have turned out to be of particular importance: jasmonate resistant 1
(jar1 ), coronatine insensitive 1 (coi1 ), and jasmonate insensitive 1 (jai1/jin1/myc2 ).
MeJA and other jasmonates strongly impair root growth and the jar1 mutant of
Arabidopsis was found to be insensitive to this inhibition (Staswick et al., 1992). Sub-
sequent biochemical analyses showed that the enzyme encoded by JAR1 catalyzes
the conjugation of JA with isoleucine to JA-Ile (Staswick et al., 2002; Staswick and
Tiryaki, 2004; Suza and Staswick, 2008). In the jar1 mutant JA-Ile levels are drasti-
cally reduced and most, but not all, JA responses impaired (e.g. fertility is retained),
indicating the important and central signaling function of JA-Ile, as outlined above
(Staswick and Tiryaki, 2004; Staswick, 2008; Browse, 2009a).
The coi1 mutant of Arabidopsis was isolated in a screen for plants that were resistant
to root growth inhibition by COR (Feys et al., 1994). Subsequent work showed that
coi1 is also insensitive to MeJA, male sterile and impaired in almost all jasmonate
responses (Wasternack, 2007; Browse, 2009b). The identiﬁcation of COI1 as F-box
protein was seminal for subsequent work on JA signaling (Xie et al., 1998), but the
suggested function of COI1 acting as an E3 ubiquitin ligase in a Skp/Cullin/F-box
complex (SCFCOI1) and as such being involved in marking other regulators for degra-
dation was only recently conﬁrmed by discovery of the so-called jasmonate-ZIM-domain
(JAZ) proteins (Chini et al., 2007; Thines et al., 2007; Yan et al., 2007). Although ex-
tensive genetic screens provided numerous mutants aﬀected in JA signaling, the genetic
approach failed to identify SCFCOI1 targets (Browse, 2009b).
Another informative mutant originating from a screen for jasmonate insensitive root
growth is the Arabidopsis mutant jai1/jin1, which is defective in the basic helix-loop-
helix leucine zipper (bHLHzip)-type transcription factor MYC2 (Lorenzo et al., 2004).
Importantly, MYC2 is involved in diﬀerential regulation of two branches of the JA
signaling pathway. One of these branches, positively regulated by MYC2, activates
expression of genes involved in the wound response, e.g. VSP2, LOX3, TAT, the other
branch, negatively regulated by MYC2, is required for expression of pathogen defense
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genes, e.g. PDF1.2, PR1, PR4. In comparison to coi1, the jai1/jin1/myc2 mutant is
defective in fewer JA responses and shows a weaker phenotype, suggesting that MYC2
acts downstream of COI1 and may be involved in mediating crosstalk between diﬀerent
signaling pathways (Lorenzo et al., 2004; Dombrecht et al., 2007).
Since genetic screens did not provide additional signaling candidate components act-
ing downstream of COI1 or targets of SCFCOI1, alternative experimental approaches
were exploited, including yeast-two-hybrid screening, transcriptional proﬁling, and bio-
chemical puriﬁcation. An important step towards understanding JA signaling was the
discovery of the JAZ proteins, which function in repression of JA responsive genes and
are encoded by a gene family of 12 members in Arabidopsis (Chung et al., 2009). They
were identiﬁed by three diﬀerent experimental approaches: (1) Their rapid JA-induced
expression in stamens of Arabidopsis ﬂowers (Thines et al., 2007), (2) by cloning of the
dominant JA-resistant Arabidopsis mutant jai3-1 (Chini et al., 2007), (3) identiﬁcation
and cloning of a gene acting as repressor of JA-inhibited root growth in Arabidopsis,
which turned out to represent a splice variant of JAZ10 (Yan et al., 2007). All JAZ
proteins contain a ZIM domain of 27 amino acids in their central part and a Jas domain
near the C-terminus. They are translocated into the nucleus via a nuclear localization
signal present in the Jas domain (Browse, 2009a; Chung et al., 2009; Grunewald et al.,
2009). Beside the sheer number of diﬀerent JAZ proteins, their functional diversity may
be further increased by the occurrence of diﬀerent splice variants, e.g. as demonstrated
for JAZ10, which may contribute to the sensitivity and speciﬁcity of JA signaling (Yan
et al., 2007; Chung et al., 2009). Another regulatory role seems to be provided by
homo- and heterodimerization of particular JAZ proteins, and the demonstration of 38
combinatorial interactions among the 66 possible heterodimeric combinations clearly
emphasizes the potential regulatory ﬂexibility in JA signaling (Chini et al., 2009b;
Chung et al., 2009). The output of JAZ protein action is dependent on the speciﬁc
transcription factors aﬀected by JAZ proteins (Lorenzo et al., 2004; Fernández-Calvo
et al., 2011; Qi et al., 2011; Song et al., 2011).
Recently, new pieces for understanding the JA signaling puzzle were supplied by
biochemical analysis (Pauwels et al., 2010). Tandem aﬃnity puriﬁcation (TAP) was
applied in order to identify new JAZ interactors and to monitor the dynamics of JAZ
complex assembly. First, the half-life of a JAZ1-ﬁreﬂy luciferase fusion protein upon
treatment of cultured cells with JA was determined, and subsequently this time-frame
(1 min after JA treatment) was used for purifying proteins interacting with the JAZ-
TAP-tagged bait. In addition to several known JAZ-interactors, such as JAZ12 re-
ﬂecting the reported dimerization of JAZ proteins, MYC3 as close relative to MYC2,
and COI1, a novel protein called NINJA (Novel Interactor of JAZ) was identiﬁed as
an adaptor protein that interacts with the ZIM domain of most JAZ proteins, with ex-
ception of JAZ7 and JAZ8 (Pauwels et al., 2010). In addition, NINJA interacts via its
EAR motif with the co-repressor TOPLESS (TPL), which was previously identiﬁed to
mediate auxin-dependent transcriptional repression in Arabidopsis (Szemenyei et al.,
2008; Pauwels et al., 2010). This exciting ﬁnding highlights the mechanistic similar-
ity between auxin and jasmonate signaling beyond the common SCF-ubiquitin-ligase-
catalyzed degradation of repressor proteins Aux/IAA and JAZ, respectively (Chini
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et al., 2009a; Santner and Estelle, 2009; Wasternack and Kombrink, 2010; Pauwels and
Goossens, 2011).
With all the identiﬁed components, the scenario of JA signaling via the SCFCOI1
complex can be summarized as shown in Figure 1.3. In cells containing low levels of the
bioactive jasmonate, (+)-7-iso-JA-L-Ile, JAZ proteins bind to the positive regulators
of JA signaling, MYC2 and related transcription factors, which reside on promot-
ers of JA-responsive genes (Chini et al., 2007; Thines et al., 2007; Yan et al., 2007).
By additional interaction with the adaptor protein NINJA, the general co-repressor
TPL is recruited to the MYC2–JAZ–NINJA complex, which is thought to eﬀectively
prevent downstream signaling (Pauwels et al., 2010). This repression is relieved un-
der conditions that activate JA biosynthesis and leads to an increase of endogenous
(+)-7-iso-JA-L-Ile via JAR1 activity, which may occur very rapidly, e.g. 5 min after
wounding (Chung et al., 2008; Glauser et al., 2008; Koo et al., 2009; Koo and Howe,
2009). (+)-7-iso-JA-L-Ile levels will promote physical interaction between COI1 and
JAZ proteins, which allows ubiquitination of JAZ by the SCFCOI1 complex (Chini
et al., 2007; Thines et al., 2007; Katsir et al., 2008). JAZ repressor(s) are then de-
graded via the 26S proteasome, which leads to de-repression of MYC2 and thereby
allowing expression of JA-responsive genes, and release of NINJA and TPL, which
may get engaged in interactions with other proteins (Causier et al., 2012).
This model is supported by a wealth of experimental evidence that was generated by
yeast-two-hybrid protein interaction studies, expression analyses, binding assays, pull-
down experiments, analyses employing mutants and overexpression lines for various
signaling components presented (for reviews see Kazan and Manners (2008); Staswick
(2008); Browse (2009a); Chini et al. (2009a); Chung et al. (2009); Fonseca et al. (2009b);
Wasternack and Kombrink (2010); Pauwels and Goossens (2011)). The mechanism of
JA signaling via SCF complex-dependent proteasomal degradation exhibits striking
similarities to the signaling mechanisms by auxin, ethylene and gibberellin, where
similar components participate (Chini et al., 2009a; Santner and Estelle, 2009; Pauwels
and Goossens, 2011).
1.1.4 Target identification of the bioactive jasmonates, JA-Ile and COR
The results obtained so far demonstrate that the COI1–JAZ–JA-Ile complex is an
essential unit in jasmonate perception and signaling, but the participation of addi-
tional components could not be excluded because bioassays were performed with crude
extracts or partially puriﬁed COI1 and JAZ proteins. It also remained unknown in
which order the COI1–JAZ–JA-Ile complex assembled. Unraveling these molecular
details required puriﬁed components and structural information of the complex, which
was established by in silico homology modeling of COI1 and crystal structure analysis
of the COI1–JAZ co-receptor (Yan et al., 2009; Sheard et al., 2010).
Experimental evidence for direct binding of JA-Ile or COR by COI1 was provided
by three independent approaches (Yan et al., 2009). (1) Retention of COI1 from crude
plant extracts was achieved by aﬃnity chromatography, using a matrix with JA cou-
pled to the amino group of a 1,6-diaminohexane spacer on sepharose beads, generating
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Figure 1.3: Model of jasmonate action in regulation of gene expression. In the resting state,
at low level of JA-Ile, transcription factors (e.g. MYC2) are bound to their target sequence at the
promoter of jasmonate-responsive gene (e.g. G-box), but their activity is repressed by interaction with
JAZ proteins, the adaptor protein NINJA and the co-repressor TOPLESS (TPL). Upon stimulation
by stress (e.g. wounding or infection by necrotrophic pathogens) or developmental cues, (+)-7-iso-JA-
L-Ile rapidly accumulates and binds to the jasmonate receptor COI1 (F-box protein), which is part of
the SCFCOI1 complex, comprising the protein components ASK1, Cullin, Rbx and the E2 ubiquitin-
conjugating enzyme. JAZ proteins are recruited from their initial binding site to the SCFCOI1 complex,
which acts as an E3 ubiquitin ligase transferring ubiquitin (Ub) from the E2 ubiquitin-conjugating
enzyme to the COI1-interacting JAZ proteins. Upon poly ubiquitination, JAZ proteins are degraded
by the 26S proteasome thereby releasing MYC2 and activating expression of JA responsive genes,
including those encoding JAZ proteins, while NINJA and TPL could engage in other interactions.
Synthesis of new JAZ repressors results in termination of JA gene expression. Modified after Pauwels
et al. (2010).
a jasmonoylamide (Fig. 1.4). Although COI1 was selectively eluted from the column by
JA-Ile (and not JA), this approach does not exclude the possibility that other proteins
contribute to this interaction. (2) Surface plasmon resonance (SPR) measurements
revealed that the three puriﬁed components, COI1, JA-Ile and JAZ1, are suﬃcient to
form a complex, thereby ruling out the possibility that other COI1 co-puriﬁed proteins
are involved in JA-Ile perception. The SPR technology records changes in light refrac-
tion on sensor chip surfaces that occur upon interaction between two (or more) binding
partners, one of which is covalently linked to the sensor chip surface. This approach
also veriﬁed that JAZ1 alone (immobilized on the sensor chip) could neither bind JA-
Ile/COR nor COI1. Unfortunately, the inverse experimental set-up, COI1 immobilized
on the chip surface, could not be realized. (3) To gain direct evidence for COI1 bind-
ing JA-Ile/COR, a photoaﬃnity probe, PACOR, was designed and synthesized that
contained three functional groups, COR, biotin, and the photoreactive phenyldiazirine
group (Fig. 1.4). Upon incubation with aﬃnity-puriﬁed His-tagged COI1 and exposure
to UV irradiation, the PACOR probe was covalently linked to the protein through pho-
tolysis, which allowed simultaneous detection of the probe-labeled receptor/COI1 after
SDS-PAGE separation by immuno-blotting using anti-His and anti-biotin antibodies.
Importantly, PACOR retained reasonable biological activity and binding to COI1 was
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competed out by COR, suggesting that COI1 directly binds JA-Ile/COR and functions
as a receptor for JA-Ile/COR (Yan et al., 2009).
Further insight into the mechanism of jasmonate perception was eventually provided
by the crystal structure of COI1 in complex with JA-Ile and a JAZ peptide (Sheard
et al., 2010). First, binding assays using 3H-labeled COR and puriﬁed proteins con-
ﬁrmed that the jasmonate receptor is a co-receptor consisting of COI1 and JAZ proteins
(Sheard et al., 2010). High-aﬃnity, saturable binding of 3H-COR to COI1 occurred
only in the presence of full-length JAZ protein and active (+)-7-iso-JA-L-Ile eﬀectively
competed for binding, whereas the inactive stereoisomer (-)-JA-L-Ile was less eﬀective.
By contrast, 3H-COR showed no binding to JAZ proteins and only marginal binding
to COI1, accounting for less than 2 % in comparison to the COI1–JAZ complex. Map-
ping of the COI1-binding region in the JAZ proteins revealed that a minimal sequence
of 21 amino acids (Glu200-Val220 deﬁning the JAZ degron peptide) is suﬃcient for
establishing the COI1–JAZ–JA-Ile complex (Sheard et al., 2010). The crystal struc-
ture of COI1 in complex with the JAZ1 degron and JA-Ile/COR revealed that the
ligand is buried deeply in the binding site and only the keto and the carboxyl groups of
COR/JA-Ile remain exposed. This provides the surface for interaction with the JAZ
degron peptide and upon its binding the COR/JA-Ile ligand is completely covered by
the two components, explaining high-aﬃnity binding of the hormone to the COI1–JAZ
co-receptor (Sheard et al., 2010). Inositol pentakisphosphate (InsP5) was identiﬁed as
third critical component of the jasmonate co-receptor complex COI1–JAZ, extending
the similarity to the auxin receptor complex TIR–Aux/IAA, which contains an inosi-
tol hexakisphosphate (InsP6) molecule bound underneath the auxin-binding site (Tan
et al., 2007). For the COI1–JAZ1 co-receptor it was demonstrated that InsP5 is crucial
for high aﬃnity ligand binding, suggesting that interaction of its phosphate residues
with basic amino acids of COI1 is involved in shaping the ligand-binding pocket prop-
erly (Sheard et al., 2010).
Although the observed binding mode of COR/JA-Ile by the COI1–JAZ1 co-receptor
is markedly diﬀered from that predicted by computational modeling, it does not pre-
clude the previously proposed sequential order for assembling the receptor complex
(Yan et al., 2009). Eventually, the bioactive jasmonate is in direct contact with both
COI1 and JAZ1 supporting the molecular glue mechanism previously proposed for
the auxin system (Tan et al., 2007). Despite diﬀerences in structural and mechanistic
details, jasmonate perception follows the same common theme as previously estab-
lished for other plant hormones, including auxin, gibberellin, ethylene and abscisic
acid (Santner and Estelle, 2009).
1.1.5 The hunt is not yet over: Open questions and searching for
additional JA signaling pathways and components
Despite the enormous progress in understanding JA perception and signaling, many
important questions remain to be answered. Perhaps the most captivating is to ex-
plain the multitude of biological jasmonate responses and the pronounced diﬀerential
bioactivity of jasmonate derivatives, which are diﬃcult to reconcile with only one com-
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Figure 1.4: Structures of synthetic probes used for jasmonate target identification. Jas-
monic acid immobilized on sepharose beads served as affinity matrix for purification of JA interacting
proteins. The photoaffinity- and biotin-tagged coronatine (PACOR), a bioactive jasmonate mimic, was
used to demonstrate that COI1 has the capacity to bind COR and functions as jasmonate receptor.
Similarly, photoaffinity- and biotin-tagged 12-O-β-D-glucopyranosyl-(-)-jasmonic acid (12-O-Glc-JA)
labeled the (-)-LCF-binding membrane protein. The bioactive jasmonate residues are labeled in blue
and the photoreactive trifluoromethyldiazirine and benzophenone residues in dark red.
mon perception and signaling mechanism as outlined above for the COI1–JAZ–JA-Ile
module. Thus, the search for missing signaling components is not yet over.
For example, OPDA, the bioactive precursor of JA biosynthesis, has signaling prop-
erties that are markedly diﬀerent from JA, MeJA or JA-Ile (Weiler et al., 1994; Stintzi
et al., 2001; Taki et al., 2005; Wasternack, 2007; Böttcher and Pollmann, 2009). In
Eschscholtzia californica OPDA induced alkaloid biosynthesis. In Bryonia dioica as
well as in Phaseolus vulgaris it was identiﬁed as endogenous signaling molecule medi-
ating tendril coiling (Weiler et al., 1994; Blechert et al., 1995; Stelmach et al., 1998).
In cultured tobacco cells OPDA, as well as JA, induced a transient increase in cy-
toplasmic Ca2+ concentrations, whereas JA-Ile did not (Walter et al., 2007), and in
the conditional flu mutant of Arabidopsis OPDA was suggested to antagonize JA-
promoted cell death (Danon et al., 2005; Reinbothe et al., 2009). In the Arabidopsis
opr3 mutant, which is defective in JA biosynthesis, the activation of the complete
set of wound-inducible gene required the application of both OPDA and JA suggest-
ing that two independent signaling pathways exist, which is further supported by the
observation that opr3, in comparison to coi1, showed increased resistance to fungal
and insect attack and concomitant activation of COI1-dependent genes that are also
regulated by JA, and COI1-independent genes that are not induced by JA (Stintzi
et al., 2001). Likewise, global expression proﬁling experiments using Arabidopsis and
diﬀerent jasmonates revealed that OPDA triggers expression of distinct set of genes
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that are related to the wound response (Taki et al., 2005). Many plant species con-
tain high levels of OPDA, both as free acid and bound in chloroplast membranes as
galactolipids that further increase upon wounding or infection. The mechanisms that
initiate distinct signaling cascades from the SCFCOI1 complex depending on either
OPDA or JA/JA-Ile are currently unknown (Miersch et al., 2008; Ribot et al., 2008).
Similarly, COI1-independent defense responses (to wounding or infection) are only
poorly characterized. Distinct and informative mutants have not yet emerged from
genetic analyses (Reymond, 2000; Reymond et al., 2004; Devoto et al., 2005; Ribot
et al., 2008; Stotz et al., 2011).
Other examples of JA derivatives with distinct bioactivities are cis-jasmone, which
induced expression of a set of genes in Arabidopsis that is diﬀerent from MeJA treat-
ment (Bruce et al., 2008), and 12-O-β-D-glucopyranosyljasmonic acid (12-O-Glc-JA),
which has been identiﬁed as speciﬁc regulator of nycnastic leaf movement, leaf-closing
factor (LCF), in the Leguminosae Samanea saman and Albizzia julibrissin (Ueda et al.,
2000; Ueda and Nakamura, 2007; Nakamura et al., 2008a).
For the latter, chemical synthesis and studies of structure-function relationships
revealed that only the (3R,7R) epimer of 12-O-Glc-JA, (-)-LCF, displayed high leaf-
closing activity. The corresponding aglycon, (-)-12-OH-JA (also known as tuberonic
acid), showed low activity, whereas all other compounds tested were inactive, including
(+)-ent-LCF, JA, JA-Ile, and COR. This suggested that the mechanism of leaf closing
operates independent of the COI1–JAZ module (Nakamura et al., 2008a, 2011b).
To unravel this signaling pathway, the direct target of (-)-LCF was identiﬁed as
plasma membrane resident protein using a biotin-tagged aﬃnity probe containing a
photoreactive benzophenone residue (Nakamura et al., 2008b, 2011a). Although the
identity of the protein target has not yet been uncovered, its successful and eﬃcient la-
beling has been made possible by ﬁrst establishing structure-function relationships and
subsequent design and optimization of the aﬃnity probe for photoaﬃnity cross-linking.
This highlights the importance of alternative experimental strategies for dissecting sig-
naling pathways in systems that are not tractable by genetic approaches.
Jasmonate action is integrated into a network with other signaling processes, includ-
ing biotic and abiotic responses as well as the action of other hormones (Glazebrook,
2005; Lorenzo and Solano, 2005; Pieterse et al., 2009; Santner and Estelle, 2009). While
a synergistic and antagonistic interaction between jasmonate, salicylic acid, abscisic
acid and auxin is well documented, the molecular mechanisms and components partic-
ipating in these processes are not yet identiﬁed. However, the recent identiﬁcation of
the general repressor TPL, which also acts in auxin signaling, may provide a possible
link (Szemenyei et al., 2008; Pauwels et al., 2010; Causier et al., 2012). Likewise, the
participation of mitogen-activated protein kinases (MAPK), as well as other protein
kinases and phosphatases in jasmonate signaling has been established, some of which
operate in a COI1-independent manner (Jensen et al., 2002; Brodersen et al., 2006;
Ortiz-Masia et al., 2007; Takahashi et al., 2007). However, how these regulatory steps
are integrated into the current model of JA signaling remains unclear.
The identiﬁcation of signaling components or their molecular characterization of-
ten involves the application of biochemical or other combined chemical and biological
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methods. This approach is used, when genetic approaches fail and mutants cannot be
isolated because of redundant or indispensable gene functions. Identiﬁcation of selec-
tive chemicals, acting as agonist or antagonists of a response, and their application
in genetic screens has recently found broader application in plant biology (Blackwell
and Zhao, 2003; Walsh, 2007; Hicks and Raikhel, 2009; McCourt and Desveaux, 2010).
However, in contrast to other plant hormone responses (Armstrong et al., 2004; Gen-
dron et al., 2008; De Rybel et al., 2009; Park et al., 2009; Lin et al., 2010), jasmonate
signaling has not been subject to such alternative chemical genetic interrogation in
search for additional signaling components.
The only exception documented so far is bestatin, an inhibitor of aminopeptidases
and leukotriene A4 hydrolase in plants and animals (Zheng et al., 2006; Harbut et al.,
2011). Bestatin was shown to speciﬁcally activate expression of JA-responsive genes in
tomato and Arabidopsis in a COI1-dependent manner, but without strict requirement
for JA biosynthesis. This lead to the hypothesis that bestatin exerts its function
through modulation of key regulators in JA signaling (Zheng et al., 2006). To identify
these (novel) regulators, bestatin was applied in a genetic screen for mutants resistant
to root growth inhibition, which bestatin exerted as eﬃciently as MeJA. Although
numerous bestatin resistant (ber) mutants were isolated by this approach, novel JA
signaling components have not been uncovered (Zheng et al., 2006). However, the
rational for such screen and its feasibility is documented by the ﬁnding that one of the
ber mutants turned out to be a new jin1/myc2 allele (Zheng et al., 2006).
1.2 Chemical genetics and screening strategies
Traditional forward genetic approaches have been widely used to identify genes or sets
of genes that are responsible for a particular phenotype. In model organisms this
strategy often involves random or directed mutagenesis and gene mapping by breed-
ing. Major limitations of such mutational approaches are lethal mutations because
of essential gene functions, pleiotropic eﬀects caused by multi-functionality of a gene
product, and redundant gene functions.
Small cell-permeable molecules with activating or inhibitory bioactivity have the po-
tential to complement mutational approaches for dissection of biological processes be-
cause chemical interference can be performed in a conditional, dose-dependent and re-
versible manner (Smukste and Stockwell, 2005). Chemical genetic techniques have long
been applied in animal systems in areas such as cancer research, cell death and drug
development (Schreiber, 1998; Stockwell, 2000; Mayer, 2003; Gangadhar and Stockwell,
2007).
More recently these approaches have also found application in plant biology (Black-
well and Zhao, 2003; Armstrong et al., 2004; Walsh, 2007; Serrano et al., 2007; Hicks
and Raikhel, 2009; Tóth and van der Hoorn, 2010; McCourt and Desveaux, 2010). In
particular, the model plant A. thaliana provides excellent prerequisites for scanning
small molecule libraries for compounds acting on cellular targets that are inaccessi-
ble or recalcitrant to conventional mutational analysis. It is suitable for cultivation
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in microplates and thus allows high-throughput screening (HTS) using miniaturized
bioassays (Walsh, 2007; Armstrong et al., 2004; Tóth and van der Hoorn, 2010; Lin
et al., 2010). Studies that have systematically explored the potential of small molecules
to interfere with plant-speciﬁc processes include the gravitropic response, auxin-, ab-
scisic acid- or brassinosteroid-mediated signaling, plant cell morphogenesis, and innate
immunity (Zhao et al., 2003; Armstrong et al., 2004; Zouhar et al., 2004; Surpin et al.,
2005; Serrano et al., 2007; Yoneda et al., 2007; DeBolt et al., 2007; Gendron et al.,
2008; Robert et al., 2008; Schreiber et al., 2008; Knoth et al., 2009; Lin et al., 2010;
Serrano et al., 2010; He et al., 2011). The methods applied to screen for bioactivity of
small molecules diﬀer greatly, ranging from visual evaluation of phenotypic alterations
such as seed germination or hypocotyl length (Zhao et al., 2007; Robert et al., 2008;
Savaldi-Goldstein et al., 2008; Bassel et al., 2008; De Rybel et al., 2009; Serrano et al.,
2010; He et al., 2011) to quantifying biometric traits such as enzyme activities or re-
porter gene expression (Zhao et al., 2003; Armstrong et al., 2004; Serrano et al., 2007;
Kim et al., 2011). All these screens use miniaturized assay formats in microplates.
For such chemical screening procedures a large number of chemical libraries is com-
mercially available. Combinatorial libraries contain simple compounds with a limited
variety of building blocks (Smukste and Stockwell, 2005). Natural compound libraries
on the contrary typically comprise compounds of high chemical diversity, biochemical
speciﬁcity and other molecular properties that make them favorable as lead structures
for drug discovery (Koehn and Carter, 2005). However, natural products are limited by
the building blocks of living organisms, which can be increased by designing libraries
with compounds of semi-synthetic origin. One challenge in chemical biological research
is to choose a library that ﬁts best the own interest. Suppliers often oﬀer preselected
collections of pharmacophore libraries, which comprise ‘drug-like molecules’ (Muegge,
2002). Typically, compounds in chemical libraries fulﬁll the following criteria: they are
able to cross the cell membrane, they contain substructures similar to known bioactive
molecules and they do not contain high reactive functional groups that are likely to
cause cytotoxic eﬀects (Mayer, 2003).
It is important to note that identiﬁcation of candidate compounds in a chemical
screen is only the ﬁrst step of a successful chemical genetic strategy. Bioactive com-
pounds originating from the primary screen need to be critically validated. This in-
cludes veriﬁcation of their activity in secondary screens (e.g. using a biological readout
that is related but not identical to the primary screen), determination of IC50 values,
and evaluation of their selectivity by comparing their eﬀects on a variety of biological
responses. The latter assays should include dedicated counter screens to identify false
positive hits, leaving only biological relevant chemicals.
Ultimately, the identiﬁcation of the protein target of a bioactive small molecule is
of fundamental importance for understanding its mode of action. To this end, various
experimental strategies can be applied. For instance following traceable derivates, such
as radioactive labeled or otherwise tagged molecules, can lead to successful identiﬁca-
tion of the target via fractionation in chromatography- or aﬃnity-based puriﬁcation.
Such techniques have contributed fundamentally to our recent understanding of the
COI1–JAZ co-receptor (compare section 1.1.4). Other methods for target identiﬁca-
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tion are the yeast-three-hybrid technology (Kley, 2004; Cottier et al., 2011), phage dis-
play (Crameri et al., 1994) quartz crystal microbalances (Cooper and Singleton, 2007)
or protein microarrays (Huang et al., 2004). Techniques requiring modiﬁed derivatives
reach their limits, because the modiﬁed derivatives may lose their bioactivity. The clas-
sical approach without ligand derivatization is application of a selective compound in
a genetic screen to identify mutants with a discriminative eﬀect to chemical treatment.
Recent achievements in elucidating hormone-resistant Arabidopsis mutants exemplify
the power of this chemical genetic strategy (Chini et al., 2007; Thines et al., 2007;
Murase et al., 2008; Shimada et al., 2008; Park et al., 2009; Santner and Estelle, 2009).
However, the step from initial mutant identiﬁcation to target identiﬁcation is labor
intensive and time consuming. In combination with the described biochemical meth-
ods, genome wide microarray studies can also basically contribute to understanding
the mode of action of a compound (Bassel et al., 2008; Park et al., 2009; Lin et al.,
2010). A general strategy for chemical biological research is depicted in Figure 1.5.
Figure 1.5: From high-throughput screening to target identification. A robust biological
readout can be applied in a primary screen for chemical compounds with bioactivity on the desired
pathway. Such primary hits are verified in secondary screens and evaluated for their biological relevance
in counter screens. Confirmed hits can be used as tool in genetic screening procedures or more generally
in chemical biological or bioinformatic approaches to identify their cellular target and mode of action.
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1.3 Aims of this thesis
Over the past few years the ﬁeld of jasmonate research has seen exciting developments
and many details of JA biosynthesis, metabolism, perception and signal transduction
have been unraveled. And yet, many questions remain open. They include, but are
not restricted to the following: (1) How is selectivity of diverse biological JA responses
established? (2) What is the mode of action and perception mechanism for diﬀerent
bioactive jasmonates? (3) What are the molecular mechanisms of cross-talk between
diﬀerent hormonal signaling pathways and what are the missing components?
The aim of this thesis is to answer these questions, which will likely provide an
increased mechanistic understanding of plant hormone perception and signaling beyond
the speciﬁc action of jasmonates. Since chemical biological approaches in jasmonate
signaling remain unused, I aim at identiﬁcation of compounds that speciﬁcally impair
or modulate jasmonate signaling.
Screening a natural compound library may lead to identiﬁcation of compounds that
modulate jasmonate signaling via unknown mechanisms, while application of a kinase
inhibitor library may uncover if kinases are involved in jasmonate signaling and how
they exert their function in the signaling pathway.
To identify compounds with such a speciﬁc eﬀect on JA signaling, a robust chemical
screening procedure will be developed. As such, a reporter-based chemical screen
in A. thaliana will aﬀord at least semi-quantitative data that allow discrimination
between compounds with high and low bioactivity. After establishment of screening
conditions and identiﬁcation of compounds that aﬀect the reporter readout, secondary
and counter screens will be applied. These will verify, if the identiﬁed compounds
aﬀect JA signaling in a selective and unique way. Selective compounds can be applied
in subsequent genetic screens and/or other chemical biological approaches to uncover
new components in the JA signaling network.
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2 Screening of a natural compound
library uncovers one putative
activator and several putative
inhibitors
For the challenge to identify new bioactive molecules that selectively impair JA signal-
ing in Arabidopsis, I designed a chemical screening procedure in Arabidopsis seedlings
harboring an inducible ﬁreﬂy luciferase (LUC ) reporter construct under the control of
the jasmonate-inducible promoter of the LIPOXYGENASE 2 (LOX2 ) gene (Jensen
et al., 2002). Such a reporter provides excellent prerequisites for scanning small
molecule libraries for compounds acting on cellular targets that are inaccessible or
intractable to conventional genetic screening (McCourt and Desveaux, 2010). Treat-
ment of Arabidopsis seedlings, which were directly grown in 96-well microplates, with
100 µM MeJA lead to accumulation of LUC. MeJA induces the LOX2 promoter al-
ready one hour after application. The over 24 hours accumulated LUC reporter can
be detected as ﬂash LUC activity after triggering the LUC reaction with D-luciferin
(Fig. 2.1). Initial luciferase activity is proportional to the amount of protein expressed
from the activated reporter gene (and the turnover of the protein). However, since
luciferase is inhibited by its product oxyluciferin, maximum enzyme activity declines
over time and reaches a steady state after a certain time. For data analysis in the
chemical screen, I decided to use the average of the initial triggered phase (Fig. 2.1),
because averaging the luminescence of the ‘triggered phase’ would increase diﬀerences
in LUC activity between control and compound treatment that modulates reporter
expression.
Sifting through a library comprising about 1,700 small molecules of natural and
semi-synthetic origin (AnalytiCon Discovery), I identiﬁed a single compound, 1-propyl-
2-carboxy-3,8-dihydroxy-anthraquinone (766), that apparently activated expression of
the reporter gene (see section 2.1, Fig. 2.3). Conversely, screening the same library
for inhibitors uncovered several small molecules that strongly impaired MeJA-induced
expression of the LOX2p::LUC reporter gene. Three of the identiﬁed compounds,
cycloheximide 8, and the two trichothecene mycotoxins diacetoxyscirpenol 15 and
neosolaniol 16, inhibit protein synthesis (Serrano et al., 2010). An example of one
microplate in a screen for inhibitors including the translational inhibitors is shown in
Figure 2.2. The whole screen for inhibitors is shown in section 2.2 (Fig. 2.8).
Note that the MeJA-stimulated LOX2p::LUC expression varies considerably across
all samples of this primary screen. This is largely attributed to variable seedling size
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Figure 2.1: Time course of LUC activity. 12-day-old Arabidopsis LOX2p::LUC seedlings were
treated with 100 µM methyl jasmonate (MeJA) to induce reporter gene expression. After 24 h in
vivo LUC activity measurement was initiated by addition of luciferin (t = 0 h) and recorded for
the indicated time. Values represent average activity (± standard deviation, n = 33) in counts per
second (cps). The red line represents activities of induced samples. The blue line represents activities
of samples treated with the DMSO control. Activities in the chemical screen and subsequent LUC
assays are based on the average of each value in the triggered/flash phase (green shaded area). Values
of the steady state phase (blue shaded area) were not considered for comparisons.
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Figure 2.2: Chemical screen for inhibitors of reporter gene expression. 12-day-old
LOX2p::LUC seedlings were preincubated for 1 h with the indicated compounds (each at 25 µM)
and expression of the reporter gene was induced by 100 µM methyl jasmonate. LUC activity was
determined after 24 h in duplicate samples, values (± standard deviation) are normalized to the av-
erage activity of the whole plate (96 samples). The shaded area shows a two-fold upper and lower
threshold of the plate average. Three candidate compounds (8, 15, 16; dark red diamonds) were
confirmed in a secondary screen (Fig. 2.9 A) and identified as translational inhibitors, cycloheximide
(8), diacetoxyscirpenol (15), and neosolaniol (16). Other candidates outside the indicated thresholds
have not been confirmed (gray diamonds).
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and orientation within individual microplate wells, thus leading to variable lumines-
cence detection, which eﬀectively renders the assay only semi-quantitative. However,
stringent selection criteria for primary hits and their conﬁrmation with increased sam-
ples numbers reduces the false discovery rate.
2.1 Screen for activators
The screening procedure of the chemical library of natural and semi-synthetic origin
uncovered only one chemical compound that apparently activated expression of the
reporter gene (Fig. 2.3, structure see Fig. 2.5). I conﬁrmed the higher LUC activity in
an independent experiment using the same reporter (Fig. 2.4 A). To verify the eﬀect
on jasmonate signaling, I used a second MeJA inducible marker, VSP1p::LUC (VSP1 :
VEGETATIVE STORAGE PROTEIN 1 ) as secondary readout. The induction by 766
alone was much weaker than the induction by MeJA (Fig. 2.4 B). However, application
of 766 together with MeJA caused an almost six-fold hyperactivation in VSP1p::LUC
(Fig. 2.4 C).
Figure 2.3: Chemical screen for activators of reporter gene expression. 12-day-old Ara-
bidopsis seedlings harboring the LOX2p::LUC reporter gene were treated for 24 h with 1,728 different
compounds (each at 25 µM). One of these compounds (766) caused an increase in LUC activity, which
is presented as average ± standard deviation from duplicate samples. cps: counts per second.
2.1.1 Derivatives of 766 modulate LOX2:LUC
Compound 766 (1-propyl-2-carboxy-3,8-dihydroxy-anthraquinone) is a derivative of
9,10-anthracenedione (anthraquinone) (see table 2.1) and derivatives are commercially
available. To investigate if other anthraquinones were able to modulate the expression
of the reporter, I tested the structure-function relationship (SAR) by application of 31
other anthraquinone derivatives to the LOX2 reporter line (For structures see Table 2.1
and supplemental Fig. S.2).
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Figure 2.4: Activation of reporter expression upon chemical treatment.
A: 12-day-old Arabidopsis seedlings harboring the LOX2p::LUC reporter gene were treated for 24 h
with 766 or MeJA (25 µM). 766 induces LOX2 similar to MeJA. B: 12-day-old Arabidopsis seedlings
harboring the VSP1p::LUC reporter gene were treated with 766 or MeJA (25 µM) for 24 h. DMSO
served as negative control. 766 causes weak induction of VSP1 compared to MeJA. C: 12-day-old
Arabidopsis seedlings harboring the VSP1p::LUC reporter gene were pretreated with 766 or MeJA
(25 µM) for one hour. Then reporter expression was induced with MeJA (100 µM) for 24 h. DMSO
served as negative control. Double application of 766 and MeJA causes strong hyperactivation. LUC
activity is presented as average (± standard deviation, n = 2-4 ) from one representative experiment
out of two. Asterisks indicate significant differences compared to the respective control (Student’s
t-test **p<0.05, *p<0.1). cps: counts per second.
Of all derivatives tested, only 47 and 48 showed inducing activity similar to 766
(Fig. 2.5 A, green bars). However, strong hyperactivation compared to MeJA alone,
as in the VSPp::LUC reporter, could only be observed for 766 together with MeJA
(Fig. 2.5 A, blue bars). Interestingly, two compounds, 18 and 39, inhibited the MeJA-
induced expression of the reporter (Fig. 2.5 A & B, blue bars).
The derivatives 47, 48 and 766 share the carboxylic acid at carbon atom 2 and dif-
ferently substituted carbon chains at carbon atom 1 (see Fig. 2.5). The derivatives 18
and 39 only share the carboxylic acid at carbon atom 2. Together, all bioactive deriva-
tives contain a carboxylic acid group at C-2, whereas only the activating compounds
contain a substituted carbon chain at C-1. This indicates that a structure-activity
relationship at carbon atoms 1 and 2 exists, which may have diﬀerent impact on their
activity.
2.1.2 766 modulates LUC activity, rather than JA signaling
The use of reporter lines in chemical screenings provides an indirect readout for mon-
itoring gene expression and depends (1) on the size of the promoter fragment and its
insertion site and (2) on the activity of the reporter gene product. To verify the eﬀect
of 766 on the LOX2p::LUC line, I tested its eﬀect by monitoring the activity of the
β-glucuronidase (GUS) under the control of the LOX2 promoter instead of LUC in a
secondary assay. Neither 766 nor 18 had an eﬀect on the expression of the GUS re-
porter line (Fig. 2.6 A, green bars). After application of MeJA compound 18 prevented
the induction of LOX2p::GUS eﬃciently (Fig. 2.6 A, blue bars). Interestingly, 766 did
also inhibit the induction of LOX2p::GUS by MeJA in contrast to hyperactivating the
LUC reporter.
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Figure 2.5: Activation of LOX2p::LUC after application of anthraquinones.
12-day-old seedlings harboring LOX2p::LUC were pretreated for one hour with anthraquinones as
indicated (25 µM). JA-specific expression was induced with MeJA (100 µM) for 24 h. DMSO served
as negative control. A: Effect of 23-48. 47, 48 and 766 activate the reporter. 766 and MeJA
together cause strong hyperactivation. 39 inhibits MeJA-induced reporter expression. B: Effect of
18-22. MeJA or 766 activate the reporter. 766 and MeJA together cause hyperactivation. 18
inhibits MeJA-induced reporter expression. LUC activity is presented as average of two independent
experiments with at least four replicates± standard deviation. Asterisks indicate significant differences
compared to the respective control (Student’s t-test **p<0.02, *p<0.05). cps: counts per second.
Monitoring an alternative reporter is still an indirect method of testing gene ex-
pression. Therefore I tested the eﬀect of 766 on endogenous mRNA accumulation at
diﬀerent time points after chemical application to the LOX2p::LUC reporter line. 766
did neither induce the expression of LUC nor of the endogenous JA-signaling markers
LOX2 or VSP1. It rather inhibited the expression of LOX2 (Fig. 2.6 B).
This result indicated that 766 may rather modulate LUC activity than gene expres-
sion. For veriﬁcation of this hypothesis I applied 766 to Arabidopsis seedlings harbor-
ing a construct, which expresses LUC under the control of the CaMV35S promoter.
The monitored activities after application of 766 were almost three-fold higher com-
pared to the DMSO control (Fig. 2.7 A). The derivative 18 caused a two-fold reduction
in LUC activity. To verify the eﬀect on LUC activity I also performed an in vitro LUC
assay using recombinant luciferase (Roche). DMSO, 766 or 18 were incubated in reac-
tion buﬀer containing ATP. Upon application of a mixture with luciferin and LUC the
luminescence was repeatedly measured at ﬁve diﬀerent time points. Intriguingly, 766
inhibited the reaction at time point zero (Fig. 2.7 B) and even stronger at later time
points (Fig. 2.7 C). Compound 18 did not cause any signiﬁcant eﬀects although the
activity was constantly lower than the control with higher variation between samples.
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Figure 2.6: Effect of selected anthraquinones on LOX2p::GUS activity and gene expres-
sion.
12-day-old seedlings harboring different reporters were pretreated for one hour with anthraquinones as
indicated (25 µM). JA-specific expression was induced with MeJA (100 µM) for 24 h. DMSO served as
control. A: Chemical intervention on LOX2p::GUS activity. 18 and 766 both inhibit MeJA-induced
LOX2p::GUS and do not induce the reporter itself. GUS activity was quantified in plant extracts
using 4-methylumbelliferyl-β-D-glucuronide as substrate in a fluorimetric assay and is related to the
protein concentration. Activities are normalized to the control. The data represent the average of four
biological replicates ± standard deviation. Asterisks indicate significant differences compared to the
respective control (Student’s t-test **p<0.02, *p<0.05). B: Chemical intervention on gene expression.
LUC expression is induced, LOX2 expression is inhibited and VSP1 expression is unchanged after
application of 766. The picture depicts RT-PCR on RNA of Arabidopsis LOX2p::LUC. Plants were
treated as indicated and RNA harvested at the indicated time points.
Figure 2.7: Effect of selected anthraquinones on LUC in vivo and in vitro.
A: 12-day-old seedlings harboring CaMV35Sp::LUC were treated for 24 h with anthraquinones as
indicated (25 µM). 766 enhances LUC activity, whereas 18 inhibits. LUC activity is presented as
average of six replicates ± standard deviation. cps: counts per second.
B,C: 766 inhibits in vitro LUC activity. Compounds were mixed with ATP. One second after injection
of a mixture of luciferin and luciferase luminescence was detected over 10 s with a luminometer
(B). Measurement was repeated at different time points (C). LUC activity is presented as absolute
luminescence or is normalized to the control. One sample without ATP served as negative control.
The data represent the average of five replicates ± standard deviation. Asterisks indicate significant
differences compared to the DMSO control (Student’s t-test **p<0.02, *p<0.05). RLU: relative light
units.
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These results suggest that probably 766 binds to LUC. In vivo 766 enhances activity,
since it may stabilize the protein by binding and preventing it from degradation. In
vitro the compound impairs enzyme activity, because it may bind to the enzyme.
Proving the hypothesis of stabilizing function may be done via immunodetection of
LUC in extracts but was not of further interest for the overall project.
Table 2.1: Anthraquinone derivatives of 766.
The structures of 766 and anthraquinone are shown. The numbering of the carbon atoms is depicted
next to anthraquinone. The table names the functional groups of each derivative at its respective
carbon atom. For full structures see supplemental Fig. S.2.
766 21 Anthraquinone
Number Position Group Number Position Group
18 2 -carboxylic acid 34 2 chloromethyl-
19 2 ethyl- 35 1 chloro-
20 1,4 dihydroxy- 36 1,5 dichloro-
21 Anthraquinone 37 2 chloro-
22 1,3,8 / 6 trihydroxy- / methyl- 38 3,6 diamino-
23 1 amino- 39 1 / 4 / 2 amino- / bromo- / -carboxylic acid
24 1,2 diamino- 40 1 / 2 aminomethyl- / -carboxylic acid
25 1,8 dichloro- 41 1 / 2 nitro- / -carboxylic acid
26 1 methylamino- 42 1 / 2 amino- / -methyl ester
27 2 -sulfonic acid 43 1,4 -carboxylic acid
28 2 amino- 44 1 / 2 aminoethyl- / -carboxylic acid
29 2 hydroxymethyl- 45 1 / 2 aminophenyl- / -carboxylic acid
30 1,4 diamino- 46 1 / 2 amino- / -carboxylic acid
31 1,8 dinitro- 47 1 / 2 (aminopropyl-3-methyl ester)- /
32 1,5 dinitro- -carboxylic acid
33 1,5 diamino- 48 1 / 2 (aminopropyl-3-hydroxy)- /
-carboxylic acid
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2.2 Screen for inhibitors
The chemical screen for inhibitors of MeJA-induced LOX2p::LUC expression showed
big variations in LUC activity. Each plate consisting of 96 diﬀerent chemicals was
analyzed for itself and candidates were obtained by comparing activities of the chemical
plate to one separate control plate. Screening the natural compound library yielded 16
candidates that apparently prevented the induction of LOX2p::LUC gene expression
(Fig. 2.8).
Figure 2.8: Chemical screen for inhibitors of reporter gene expression. 12-day-old Ara-
bidopsis seedlings harboring the LOX2p::LUC reporter gene were pretreated for one hour with 1,728
different compounds (each at 25 µM) before addition of MeJA (100 µM). The overall screen was
performed in 13 separate steps with each containing one separate control plate. Due to their relative
activity compared to the respective control plate, 16 compounds were chosen for further analysis (red
diamonds). The plot presents relative average LUC activities (normalized to the respective control
plate) after treatment with the chemical library (n = 2).
In a secondary assay for conﬁrmation of the 16 candidates, only 10 of those inhibited
the LOX2p::LUC expression signiﬁcantly (Fig. 2.9 A). One candidate is cycloheximide
(8), a compound which is known to inhibit protein synthesis. Two other candidates,
the mycotoxins diacetoxyscirpenol (15) and neosolaniol (16), are also translational in-
hibitors (Serrano et al., 2010). Candidate 17, piericidin, is a potent inhibitor of the
mitochondrial type I NADH-ubiquinone oxidoreductase in the respiratory chain and
is considered to bind to the ubiquinone binding site of the enzyme (Darrouzet et al.,
1998). Because 17 generally may interfere with energy dependent metabolism or sig-
nal transduction pathways it was excluded from further studies. The translational
inhibitors 8, 15 and 16 were also not considered for secondary and counter screens.
For the other candidate compounds (2, 3, 4, 5, 6, 7, 9, 10, 11, 12, 13, 14) no addi-
tional information was available in the suppliers database (For structures of conﬁrmed
candidates see Fig. 2.11).
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Figure 2.9: Activity of selected compounds on various LUC and GUS reporters. 12-
day-old Arabidopsis seedlings harboring the indicated reporter gene were pretreated with compounds
(25 µM). Reporter expression was induced by MeJA (100 µM) or flg22 (1 µM). A: Confirmation
of the candidate-modulated LOX2p::LUC activity is shown as average of two replicates ± standard
deviation. B: Only confirmed and selected candidates were tested for their effect on VSP1p::LUC
activity. LUC activity is shown as average of two independent experiments with two replicates each
± standard deviation.
Asterisks indicate significant differences compared to the control (Student’s t-test **p<0.02, *p<0.05).
C: LOX2p::GUS and VSP1p::GUS reporter activities were induced by MeJA (blue staining). Pre-
treatment with selected compounds interferes with reporter activation (reduced staining). D:
WRKY29p::GUS reporter activity was induced by flg22 (blue staining). Only 10 and 12 do not
interfere with reporter activation. Histochemical GUS staining shows one representative out of at
least two independent experiments.
2.2.1 Compound 12 is the most selective compound
To ensure that the inhibition of gene expression is speciﬁc for JA signaling, I performed
an analysis of the candidate’s eﬀect using diﬀerent Arabidopsis reporter lines and dif-
ferent readouts. In a secondary screen I tested expression of VSP1 by in vivo detection
of luminescence in Arabidopsis VSP1p::LUC seedlings after application of MeJA and
the respective candidate compounds (Fig. 2.9 B). The reporter expression was not af-
fected by compound 4. MeJA-induced LUC expression was completely suppressed by
6, 7 and 12. Compounds 5 and 10 were less eﬀective but still provoked signiﬁcantly
reduced reporter expression.
To conﬁrm the results obtained with the Arabidopsis lines expressing the LUC re-
porters I repeated the experiment with two lines harboring the β-Glucuronidase (GUS)
fused to the LOX2 and VSP1 promoter, respectively (Fig. 2.9 C). Compared to the
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Figure 2.10: Chemical intervention of flg22-dependent production of reactive oxygen
species and gene expression after chemical application. A: Arabidopsis leaf discs were in-
cubated in a solution containing 0.25% DMSO and the indicated compound for 30 min, supplied
with luminol and peroxidase and elicited with 1 µM flg22. Luminescence is given as relative light
units (RLU) and monitored over the indicated time course. The graph depicts averages of two inde-
pendent experiments with 6 replicates each. B: Arabidopsis LOX2p::LUC seedlings were incubated
with the chemicals as indicated for different time and gene expression was analyzed by semi quanti-
tative RT-PCR. Expression is shown for the genes LUC, LOX2, VSP1 and Actin, where the latter
served as expression control. The picture shows results of one representative out of two independent
experiments.
LOX2p::LUC reporter 4 and 10 did behave diﬀerent. Both compounds did not or only
slightly inhibit the GUS reporter in both GUS reporter lines. 5, 6, 7 and 12 inhibited
GUS accumulation completely.
As counter screen for veriﬁcation of the compound’s selectivity the eﬀect on the
JA independent Arabidopsis line WRKY29p::GUS was tested. This line harbors the
WRKY29 promoter fused to GUS. WRKY29 expression is inducible by the elicitor
epitope ﬂg22, which originates from bacterial ﬂagellin (Asai et al., 2002). JA-speciﬁc
candidate compounds should not aﬀect this readout. Compounds 6 and 7 showed
strong inhibition of the reporter (Fig. 2.9 D). 4 and 5 where just slightly able to
inhibit the reporter expression whereas 10 and 12 did not have any eﬀect.
Since the observed eﬀect of the chemicals on the reporter lines is only indirect
and dependent on a functional transcription and translation machinery, a reporter-
independent readout was applied as other counter screen. The oxidative burst reac-
tion in Arabidopsis is a very fast generated signal as response to stress or pathogen-
associated molecular patterns such as ﬂg22 (Rentel et al., 2004; Zipfel et al., 2004;
Nühse et al., 2007; Galletti et al., 2008; Mersmann et al., 2010). This production
of reactive oxygen species (ROS) is independent of JA. Arabidopsis leaf discs were
incubated with the respective candidate compounds and then elicited with ﬂg22. In-
creasing ROS levels were monitored by their reaction with luminol and a peroxidase,
which results in luminescence emission.
The only compounds without any eﬀect on ROS production are 10 and 12 (Fig. 2.10
A). Whereas 4 slightly and 6 almost completely inhibited the oxidative burst, 5 pro-
moted ROS production. After treatment with 7, ROS accumulated slower and to
a lesser extent and after 15 minutes ROS levels stayed at the same level instead of
decreasing.
In conclusion 10 and 12 modulate JA-dependent responses but do not interfere
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Figure 2.11: Structure of selected candidate compounds. The picture depicts structures of
candidate compounds that were selected after the secondary screen for analysis in counter screens. No
further information was available in the suppliers database. For structures of all confirmed candidates
see supplemental Fig. S.1.
with ﬂg22-mediated responses. To verify the eﬀect on the LOX2 and VSP1 reporters
I monitored endogenous mRNA accumulation of LOX2 and VSP1. Compounds 10
and 12 did both cause inhibition of endogenous LUC expression in the LOX2p::LUC
reporter line as well as inhibition of endogenous LOX2 at least 3 and 6 hours after
MeJA induction. Consistent with the results using LOX2p::GUS, only 12 inhibited
endogenous VSP1 expression 3, 6 and 24 hours after MeJA induction. Due to the
selective eﬀect of 12 on all JA speciﬁc readouts, this compound was considered most
interesting to continue with for further analysis (see Table 2.2 for an overview of the
eﬀects). For structures of the tested compounds see Fig. 2.11.
Table 2.2: Overview of effects caused by different compounds. The table summarizes the
effects of the selected candidate compounds on different readouts. Asterisks indicate significant inhi-
bition compared to the control (Student’s t-test **p<0.02 [red], *p<0.05 [light red]). Minus or plus
signs indicate the strength of inhibiting or enhancing effects, estimated from the qualitative readout;
red: strong inhibition; light red: weaker inhibition; green: activation. Note that 7 initially causes
inhibition of ROS, but causes higher ROS levels at later stages [orange]. Note as well, that 12 is the
only compound with an effect on all JA specific readouts and does not affect flg22 dependent readouts.
Compound LOX2:LUC VSP1:LUC LOX2:GUS VSP1:GUS WRKY29:GUS ROS
4 ** - -
5 * ** - - - +
6 ** ** - - - - - - - -
7 ** ** - - - - - -/+
10 ** **
12 * ** - - - -
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2.2.2 IC50 of compound 12 and gene expression
To see whether the previously used concentration is appropriate for further experi-
ments, I tested the response of Arabidopsis LOX2p::GUS seedlings to diﬀerent concen-
trations of 12. This experiment conﬁrmed the strong inhibition at 25 µM and indi-
cates that the half maximum inhibitory concentration (IC50) of 12 is around 10 µM
(Fig. 2.12 A).
The concentration of 10 µM was then used to analyze expression of LOX2 at diﬀer-
ent time points. Seedlings were pretreated with 12 and subsequently LOX2 expression
was induced by addition of MeJA. LOX2 is induced already one hour after induc-
tion and reaches a peak after eight hours (Fig. 2.12 B). In plants pretreated with 12,
LOX2 expression is not prevented but reduced at every time point. Although this
indicates a rather weak eﬀect, I decided to analyze genome wide gene expression using
the AGRONOMICS1 microarray (Rehrauer et al., 2010). Samples were collected eight
hours after treatment and before hybridization with the microarray, LOX2 expression
was tested via quantitative real-time PCR. Despite the signiﬁcant diﬀerences between
the diﬀerent treatments (Fig. 2.12 C), the microarray data did only yield a few sig-
niﬁcant diﬀerentially expressed genes, which even did not include the JA-downstream
markers LOX2 and VSP1 (data not shown).
Figure 2.12: Dose response of 12 and LOX2 expression.
A: 12-day-old Arabidopsis seedlings harboring the LOX2p::GUS reporter gene were pretreated with
12 for one hour at the indicated concentrations. MeJA (100 µM) was added and incubated for
24 h. GUS activity was quantified in plant extracts using 4-methylumbelliferyl-β-D-glucuronide as
substrate in a fluorimetric assay and related to the protein concentration. Activities are normalized to
the control and are shown as average of 4 replicates ± standard deviation. B: 14-day-old Arabidopsis
seedlings (Col-0) were pretreated with DMSO or 12 (10 µM) and LOX2 expression was induced by
application of MeJA (100 µM). Plants were harvested at the indicated time points and expression
was monitored by qRT-PCR. C: 14-day-old Arabidopsis seedlings (Col-0) were treated as in B and
harvested after 8 hours. After confirming the inhibitory effect of 12, these RNA samples were taken
for microarray hybridization. Expression was normalized to the untreated control and is shown as
average of 3 biological replicates ± standard error. Asterisks indicate significant differences compared
to the MeJA control (Student’s t-test **p<0.02, *p<0.05).
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2.2.3 12 inhibits root growth and degradation of JAZ
Since 12 interferes with JA-speciﬁc gene expression, an obvious question is, whether
the compound also aﬀects other JA-related phenotypes or not. If grown on plates
containing solid medium supplemented with diﬀerent concentrations of 12, Arabidopsis
root growth elongation was impaired with increasing concentrations, whereas the aerial
part of the plant was not impaired (Fig. 2.13 A & B). The IC50 for the root growth
phenotype is between 10 and 30 µM, which is higher than for the LOX2p::GUS reporter.
If subsequently transferred to soil all plants did recover and developed normally as did
untreated plants (data not shown).
JA biosynthesis or signaling mutants do not respond to JA induced inhibition of
primary root growth. To see whether such mutants would be resistant to 12 as well,
I tested Arabidopsis mutants for their response to 12. Neither the JA-biosynthesis
mutant aos nor jar1-1, which cannot produce the bioactive jasmonate (+)-7-iso-JA-
L-Ile, were resistant to inhibition of root growth elongation (Fig. 2.13 A).
One central component in JA signaling is the proteosomal degradation of JAZ pro-
teins. To investigate if this part of JA signaling is inhibited by 12 I tested the JAZ
degradation in an Arabidopsis line (CaMV35Sp::JAZ-GUS, Thines et al. (2007)), that
constantly overproduces a JAZ1-GUS fusion protein. The degradation of JAZ pro-
tein can be detected 30 minutes after application of MeJA in roots. After incubation
with 12 the JAZ1 fusion protein was not degraded, while it was fully degraded after
treatment with the DMSO control (Fig. 2.14). This eﬀect was already visible at con-
centrations of 3 µM. The proteasome inhibitor MG132 served as positive control for
inhibition of this degradation.
Thus 12 may interfere with proteasome activity or exert its function via other ways
to interfere with JA signaling.
Figure 2.13: Root growth phenotype after treatment with compound 12. A: Arabidopsis
seeds were germinated on solid medium containing 12 and grown vertically under day/night conditions.
After 9 days pictures were taken and root length was measured using ImageJ software. Root length
is shown as average of at least 19 plants ± standard deviation. B: The picture depicts representative
Arabidopsis Col-0 plants. Two independent experiments gave the same results.
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Figure 2.14: MeJA-dependent degradation of the JAZ protein after chemical treatment.
Seven-day-old Arabidopsis CaMV35Sp::JAZ1-GUS seedlings were incubated for one hour with the
indicated chemical. The seedlings were then treated with MeJA (10 µM) to induce degradation of
the fusion protein. The presence of JAZ1-GUS was visualized by histochemical GUS staining. 12
prevents the degradation of the fusion protein at all tested concentrations. The proteasome inhibitor
MG132 was included as control for prevention of JAZ1-GUS degradation.
2.2.4 Structure-activity relationship of 12
Analysis of the structure of 12 revealed that the core structure consisted out of
aminocytisine. Cytisine is a plant alkaloid from Faboidae (Izaddoost et al., 1976). This
core structure is connected to two diﬀerent functional groups (biphenyl-carboxylic acid
and 3-methoxy-propionic acid) via two amide bonds. The commercial availability of
numerous derivatives of aminocytisine opened the opportunity to study the SAR of
12. I tested cytisine derivatives carrying diﬀerent substituents for their ability to mod-
ulate reporter expression of Arabidopsis LOX2p::LUC in response to MeJA. Some of
the derivatives are depicted in Figure 2.15; for all structures tested see supplemental
Figure S.3.
Only 49 and 52 prevented expression of LOX2p::LUC to the same extent as 12
(Fig. 2.15 A). Both compounds share with 12 the core structure of aminocytisine
and the biphenyl-carboxylic acid as substituents at the same position. All other tested
derivatives did not cause any eﬀect. Concluding from this, the position of the biphenyl-
carboxylic acid, as well as the connection to aminocytisine is important for the ability to
inhibit MeJA-induced LOX2p::LUC reporter expression. The alternative position can
be varied with diﬀerent substituents, deﬁning the site for modiﬁcation of 12 without
impairing its activity.
The ultimate goal in chemical biology is to identify a compound’s direct target and
its mode of action. For target identiﬁcation I used a photoaﬃnity cross-linking and
protein puriﬁcation approach with a modiﬁed version of the original compound. Since it
appears to be possible to modify 12 at one position of the molecule, I went for targeted
modiﬁcations including a photoreactive benzophenone group and an alkyne. Modiﬁed
derivatives were synthesized and provided by a collaborating group (Prof. Markus
Kaiser, ZMB, Universiät Duisburg Essen). Benzophenones are chemically very stable,
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Figure 2.15: Structure-activity relationship of 12.
A: 12-day-old Arabidopsis LOX2p::LUC were pretreated with derivatives of 12 (25 µM) and induced
with MeJA (100 µM). 12, 49 and 52 inhibit MeJA-induced LOX2p::LUC activation. LUC activity is
presented as average of two independent experiments ± standard deviation with 6 replicates each.
B: A modified derivative (65) inhibits MeJA-induced LOX2p::LUC activation. LUC activity is pre-
sented as average of six replicates ± standard deviation. At least two independent experiments gave
similar results. Asterisks indicate significant differences compared to the control (Student’s t-test
**p<0.02, *p<0.05). Structures of selected compounds are depicted including the core structure
cytisine (56) and biphenyl-carboxylic acid (57).
can be manipulated in ambient light and establish covalent binding with unreactive
C-H bonds, even in the presence of solvent water and bulk nucleophiles (Kauer et al.,
1986; O’Neil et al., 1989; Dormán and Prestwich, 1994; Nakamura et al., 2011a). This
photoreactive group allows establishing of covalent binding to the putative protein
target using UV irradiation. The alkyne enables subsequent labeling of the protein-
compound complex via so called ‘click-chemistry’ (Speers et al., 2003). As expected, the
activation of MeJA-induced LOX2p::LUC is reduced after application of the modiﬁed
probe 65 (Fig. 2.15 B). However, the probe was less eﬃcient than the original compound
12 at same concentrations.
2.2.5 First steps towards target identification
Since 65 was able to modulate the JA response in the LOX2p::LUC reporter line, I
initiated protein labeling experiments to identify its direct protein target. The labeling
was performed on Arabidopsis cell cultures to ﬁrst establish experimental conditions.
The advantage of in dark conditions grown cell culture is that it contains less light
absorbing pigments than seedlings, which would complicate photoaﬃnity cross-linking
with UV light.
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Arabidopsis cell cultures were treated for one hour with 65 and irradiated at the same
time with UV-light to establish covalent cross-linking with C-H bonds of the protein
target. Since the probe does not contain a group, which can be puriﬁed with aﬃnity-
based chromatography or detected on a gel, it was necessary to label the probe after
cross-linking. This was performed using copper-catalyzed 1,3-dipolar cycloaddition
(‘click’ reaction) between the alkyne of the probe and an ﬂuorescent probe containing
an azide.
After separation of the labeled protein extracts on a polyacrylamide gel, it could be
observed, that 65 binds several diﬀerent proteins (Fig. 2.16 A, lane 3). This binding
was competed out by addition of 12 (Fig. 2.16 A, lane 4), which indicated speciﬁc
binding of 65 to a similar protein target of 12.
Since the band pattern of proteins reﬂects the whole-protein-stain of the gel (Fig. 2.16
B), an obvious question was, if the UV-cross-link just established general unspeciﬁc
bonds to several proteins and that the observed competition may in fact be competition
for uptake. Thus I performed the UV-cross-linking on protein extracts, in which no
competition for uptake would occur. Intriguintly, the result reﬂects completely the re-
sult of the previous experiment (Fig. 2.16 C and D). Consequently, the labeled proteins
are bound by 65 in a speciﬁc manner. A control for unspeciﬁc UV-cross-linking (66),
which contained a benzylamine fused to a benzophenone and an alkyne (see supple-
mental Fig. S.3), did not label any proteins. This indicates as well the speciﬁc labeling
by 65. If one target would exist, that is bound at lower concentrations of the ligand
than the other proteins, lower concentrations of the probe would maybe result in a
more speciﬁc band pattern. Unfortunately lowering the concentrations of 65 resulted
just in a decrease in overall signal instead of appearance of more speciﬁc protein bands
(data not shown).
However, these ﬁndings encourage to continue the eﬀorts to pull down the protein
target. Modifying the experimental conditions in a targeted approach and increasing
the spatial resolution by 2D-SDS-PAGE may eventually lead to identiﬁcation of speciﬁc
protein target(s). Unfortunately these additional experiments could not be performed
under the time constraints of this PhD thesis.
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Figure 2.16: Photoaffinity labeling of Arabidopsis proteins with a photoreactive deriva-
tive of 12. Arabidopsis cell cultures or Arabidopsis cell culture protein extracts were treated for one
hour with 100 µM of 65. This high concentration was used, since the compound was less efficient
at inhibiting reporter activity compared to 12. UV-cross-linking was performed using a hand-held
UV lamp at 254 and 366 nm wavelength. Protein extracts were labeled with a fluorophore (Alexa
FluorR©555) and labeled proteins were visualized on a fluorescence scanner. Subsequently the gel was
stained with coomassie blue to reveal unlabeled and labeled proteins. A: Fluorescence of gel after
pulldown on cell culture. B: Coomassie stain of gel after pulldown on cell culture. C: Fluorescence of
gel after pulldown on cell culture extracts. D: Coomassie stain of gel after pulldown on cell culture
extracts. (1): DMSO, (2): UV-cross-link control (66, 100 µM, Fig. S.3), (3): 65 (100 µM), (4): 65
(100 µM) + 12 (400 µM)
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3 Screening of a kinase inhibitor library
identifies toyocamycin as modulator
of JA signaling
In addition to the screen of a natural compound library, I performed a second screen
using the MeJA inducible LUC reporter construct LOX2p::LUC in A. thaliana. The
second chemical library contained 84 known kinase inhibitors (Biomol GmbH). Phos-
phorylation and dephosphorylation of proteins via speciﬁc or non-speciﬁc kinases are
common modiﬁcations in metabolism and signaling pathways. One advantage of this
rather small library is that it contains a variety of speciﬁc and non-speciﬁc kinase in-
hibitors with already described target(s). The probability to cause any eﬀects in planta
is rather high compared to libraries selected for chemical diversity.
3.1 Three kinase inhibitors disturb JA signaling
The screen for kinase inhibitors, which modulate the expression of LOX2 did not un-
cover any activator of LOX2p::LUC. Out of 84 kinase inhibitors only three compounds
caused robust inhibition of MeJA-induced LOX2p::LUC expression (Fig. 3.1). Com-
pound 6, staurosporine, is a general kinase inhibitor, which was shown to inhibit more
than 80 percent out of 290 tested human kinases (Karaman et al., 2008). In contrast
to 6 compound 16, tyrphostin AG-879, is more speciﬁc. It is an inhibitor of protein
tyrosine kinases and mitogen-activated protein kinases, which are involved in human
breast or prostate cancer (Meng et al., 2000; Larsson, 2004; Rende et al., 2006). The
third compound, 5-iodotubercidin 25, is a nucleoside analog and also a general kinase
inhibitor. As adenosine analog it was shown to inhibit human adenosine kinase (Massil-
lon et al., 1994; Ugarkar et al., 2000). Several structural derivatives of 5-iodotubercidin
are described to speciﬁcally inhibit auxin signaling, which is mediated via SCFTIR1,
which is mechanistically related to JA signaling (Hayashi et al., 2009). Because of the
functional similarity between auxin and JA signaling pathways, 5-iodotubercidin was
selected for further studies. As inhibitor of both pathways it could enhance the under-
standing of how hormonal crosstalk between auxin and JA may be mediated. Thus,
diﬀerent derivatives of 5-iodotubercidin were compared for their ability to interfere with
MeJA-induced reporter expression (for structures see supplemental Fig. S.4). Sangi-
vamycin is the strongest inhibitor of LOX2p::GUS expression with an IC50 between
0.3 and 1 µM (Fig. 3.2 A). Toyocamycin is less eﬀective and inhibits half maximum
at 1 µM. The weakest eﬀect is caused by tubercidin and 5-iodotubercidin, which both
exhibit an IC50 of 3 µM. For IC50 values see Table 3.1.
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Figure 3.1: Chemical screen for inhibitors of reporter gene expression. 12-day-old Arabidop-
sis seedlings harboring the LOX2p::LUC reporter gene were pretreated for one hour with 84 different
kinase inhibitors (each at 10 µM). The reporter was induced with MeJA (100 µM) for 24 h. In two
independent experiments only three compounds were able to inhibit expression of the LOX2p::LUC
reporter (red). Activities were normalized to the control. The plot presents relative average LUC
activities of two independent experiments.
3.1.1 Toyocamycin is the most selective derivative
For all nucleosides I did a secondary assay with two MeJA-inducible reporter con-
structs, VSP1p::GUS and OPCL1p::GUS. The expression of VSP1p::GUS was most
eﬃciently inhibited by sangivamycin, although the IC50 (1 µM) is lower than in the
LOX2 reporter line (Fig. 3.2 B, Table 3.1). The IC50 of toyocamycin on VSP1p::GUS
expression is between 1 and 3 µM and thus close to the IC50 on the LOX2 reporter
line. Tubercidin and 5-iodotubercidin have IC50 values around 30 µM. All together,
the tendency to inhibit LOX2 and VSP1 is the same. OPCL1 is as well inducible by
MeJA, but its gene product acts in the biosynthesis of JA downstream of LOX2. In-
triguingly, the eﬀect of the nucleosides on OPCL1p::GUS expression is very diﬀerent to
expression of LOX2p::GUS (Fig. 3.2 C). Sangivamycin and 5-iodotubercidin are caus-
ing an inhibitory eﬀect at concentrations higher than 10 µM, whereas tubercidin and
toyocamycin inhibit OPCL1p::GUS expression only at 30 µM. Overall, toyocamycin is
the least eﬀective at 30 µM, where the other analogs cause already complete inhibition.
As counter assay for testing JA independent readouts I analyzed expression of the
Arabidopsis WRKY29p::GUS line, which is inducible by ﬂg22. All nucleoside analogs
inhibited the expression of WRKY29p::GUS to the same extent (IC50 1 µM), although
tubercidin appeared to be less eﬀective than the other analogs at 10 µM (Fig. 3.2 D).
To sort out, if kinases are more generally aﬀected or if there may be inhibition of
speciﬁc kinases, I tested, whether the compounds are able to inhibit the activation of
the ﬂg22-induced MAPK cascade. Arabidopsis seedlings treated with the respective
nucleoside were triggered with ﬂg22 to induce activation of the MAPK cascade. The
36
Figure 3.2: Inhibition of various Arabidopsis promoter GUS lines by nucleoside analogs.
Arabidopsis plants harboring the respective promoter fused to GUS were grown in liquid culture for
2 weeks and subsequently treated with the indicated compounds for 24 h (LOX2, VSP, OPCL1)
or 5 h (WRKY29). Control treatment was MeJA (LOX2, VSP, OPCL1) or flg22 (WRKY29) only.
GUS activity was quantified in plant extracts using 4-methylumbelliferyl-β-D-glucuronide as substrate
in a fluorimetric assay and related to the protein concentration. Activities are normalized to the
control. The data represent the average of at least three biological replicates ± standard deviation.
A: LOX2p::GUS activity is inhibited by all nucleosides. B: VSP1p::GUS activity is inhibited by all
nucleosides. C: OPCL1p::GUS activity is less inhibited than the other reporters and least affected by
toyocamycin. D: WRKY29p::GUS activity is inhibited by all nucleosides.
active, phosphorylated form of three MAPKs (MPK3, MPK4 and MPK6) was detected
via a commercial antibody (Fig. 3.3). Sangivamycin and 5-iodotubercidin prevented
the activation of MPK3 and MPK4 almost completely and prevented the activation
of MPK6 slightly at 10 µM. The general kinase inhibitor staurosporine inhibited the
activation of all three MAP kinases. Even at 1 µM sangivamycin and 5-iodotubercidin
prevented the phosphorylation (data not shown), whereas toyocamycin and tubercidin
did not inhibit at even 10 µM (Fig. 3.3). Since the MPK6 is also activated by JA
(Takahashi et al., 2007), it would be interesting to see, whether the same eﬀect of
the kinase inhibitors could be observed. Unfortunately, the activation could not be
detected by the commercial antibody (data not shown).
Table 3.1: IC50 values of nucleoside analogs on various Arabidopsis GUS reporter. The
table shows IC50 values of the nucleoside analogs on the activity of the depicted GUS reporter. IC50
values have been estimated from the GUS activities shown in Fig.3.2.
IC50 on reporter activity of:
LOX2p::GUS VSP1p::GUS OPCL1p::GUS WRKY29p::GUS
5-Iodotubercidin (µM) 3 30 3 - 10 1 - 3
Tubercidin (µM) 3 30 10 - 30 1 - 3
Toyocamycin (µM) 1 1 - 3 30 1 - 3
Sangivamycin (µM) 0.3 - 1 1 3 - 10 1 - 3
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Figure 3.3: Chemical intervention with activation of mitogen-activated protein kinases.
14-day-old Arabidopsis Col-0 seedlings were pretreated with nucleoside analogs (10 µM). Activation
of MAPK upon application of flg22 was analyzed by α-phospho-p44/42-MAPK immunoblot. This
commercial antibody (Cell Signaling Technology) binds to the active, phosphorylated form of MPK3,
MPK4 and MPK6. Staurosporine was included as control for a general kinase inhibitor. At least two
independent experiments revealed comparable results. Ponceau staining confirmed loading of equal
amounts of protein.
Due to the described eﬀect on mechanistically related SCFTIR1 mediated auxin sig-
naling (Hayashi et al., 2009) and the less general eﬀect of toyocamycin (no inhibition of
MAPKs, less inhibition of OPCL1p::GUS), I focused on toyocamycin for the remainder
of this study.
3.1.2 Toyocamycin inhibits root growth in a JAR1 and AOS dependent
manner
To investigate if application of toyocamycin in addition to impairing LOX2 reporter
expression also caused other phenotype in Arabidopsis, I grew plants in the presence
of this compound. Arabidopsis plants grown on solid MS medium supplemented with
diﬀerent concentrations of toyocamycin showed severe inhibition of primary root elon-
gation (Fig. 3.4 A). To see whether JA signaling is involved in this root phenotype, I
tested Arabidopsis mutants impaired in JA biosynthesis or signaling for their response
to toyocamycin. Since root growth was eﬃciently inhibited at 0.3 µM, I chose this
concentration for further analysis. Root growth elongation in coi1-16 and jin1-1 was
as eﬃciently inhibited as in wild type (Fig. 3.4 B), indicating a COI1 independent
regulation of root growth inhibition. However the JA-biosynthesis mutant aos and
the JA-Ile-synthesis mutant jar1-1 were less susceptible to root growth inhibition by
toyocamycin (Fig. 3.4 B). It has been shown that kinases are involved in root growth
elongation, since several kinase inhibitors can prevent root growth elongation in Ara-
bidopsis seedlings (Baskin and Wilson, 1997). To see if the eﬀect of toyocamycin on
root growth elongation and the resistant phenotype of jar1-1 is based on inhibition of
kinase activity, I tested the response of Arabidopsis wild type and jar1-1 to the general
kinase inhibitor staurosporine. This compound also inhibits root growth and jar1-1 is
fully responsive as the wild type (Fig. 3.4 C).
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Figure 3.4: Effect of Toyocamycin on Arabidopsis root growth and gene expression in
Arabidopsis mutants. Arabidopsis seeds were germinated on solid medium containing chemicals
as indicated and grown vertically under day/night conditions. After seven to nine days pictures were
taken and root length was measured using ImageJ software. Root length is shown as average of at
least 15 plants ± standard deviation and normalized to the untreated control if not stated otherwise.
A: Arabidopsis wild type roots are strongly affected by 0.3 µM toyocamycin. Absolute root length is
shown in cm. B: Root growth is less inhibited by toyocamycin in jar1-1 (blue bars) and aos (yellow
bars). C: The general kinase inhibitor staurosporine inhibits root growth in jar1-1 as strong as in
Arabidopsis wild type. D: MeJA has an additive effect to root growth inhibition by toyocamycin
(0.3 µM), since root growth is even stronger impaired by the double treatment. jar1-1 roots are
not inhibited by MeJA. E: COR has an additive effect to root growth inhibition by toyocamycin
(0.3 µM), since root growth is even stronger impaired by the double treatment. aos and jar1-1
root growth is as strong inhibited by COR as in Arabidopsis wild type. F: 14-day-old Arabidopsis
seedlings were pretreated with DMSO or toyocamycin (10 µM) and LOX2 expression was induced
by application of MeJA (100 µM). Plants were harvested at the indicated time points and LOX2
expression was monitored by semiquantitative RT-PCR. Actin served as control for equal amounts of
RNA. Experiments with comparable results were repeated at least two times.
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To verify that this phenotype is independent of the root phenotype induced by JA,
solid MS medium was supplemented with MeJA or the JA-Ile analog COR together
with toyocamycin. Root growth of wild type and aos was inhibited by MeJA, whereas
roots of jar1-1 were resistant (Fig. 3.4, D), since jar1-1 cannot convert JA to bioactive
JA-Ile. The eﬀects of MeJA and toyocamycin together were additive, since roots were
shorter after double treatment compared to treatment with the single compounds.
After application of COR, wild type, aos and jar1-1 are inhibited in their root growth
(Fig. 3.4 E), as they are all able to perceive COR. The eﬀect caused by COR was
slightly stronger than the one caused by MeJA at the respective concentrations, but
root growth was still stronger impaired, if toyocamycin and COR were applied together.
Roots of aos and jar1-1 are still slightly longer than in wild type after COR and
toyocamycin treatment. Together these data show that toyocamycin induces a root
phenotype diﬀerent from JA, which may not be mediated via COI1 and MYC2.
Whereas the root phenotype caused by toyocamycin depends on JAR1, LOX2 gene
expression surprisingly does not. Expression of endogenous LOX2 was inducible by
COR in wild type and jar1-1 (Fig. 3.4 F). Simultaneous application of toyocamycin
prevents this induction in wild type. This inhibitory eﬀect could also be observed in
jar1-1, suggesting that two independent eﬀects of toyocamycin on root growth and
gene expression exist.
3.1.3 Toyocamycin does not inhibit SCF-complex mediated processes
Toyocamycin was described to prevent auxin-dependent degradation of Aux/IAA re-
pressors without impairing proteasome activity, suggesting a general role in the SCF-
ubiquitination pathway (Hayashi et al., 2009). To conﬁrm a potential role in SCF-
mediated processes I conducted similar experiments by monitoring JA dependent degra-
dation of JAZ1-GUS fusion protein in Arabidopsis seedlings expressing JAZ1-GUS.
MeJA initiates the degradation of the JAZ1-GUS fusion protein via the SCFCOI1-
proteasome pathway. The presence of the fusion protein can be detected via histochem-
ical GUS staining. After 30 minutes incubation with MeJA degradation of JAZ1-GUS
could be observed in comparison to mock treated plants (Fig. 3.5, A). This degrada-
tion was prevented in the presence of the potent proteasome inhibitor MG132. Even
at high concentrations of 50 µM, toyocamycin was not able to prevent the degradation
of the fusion protein and toyocamycin treatment itself did not induce degradation of
the protein. This indicates that toyocamycin does not have any eﬀect on the SCFCOI1
mediated degradation of JAZ repressors.
Another SCF-mediated process in Arabidopsis is early petal development, which
depends on UNUSUAL FLORAL ORGANS (UFO), which encodes a F-box protein
and was shown to be a transcriptional co-factor to regulate ﬂower development (Durfee
et al., 2003; Chae et al., 2008). Arabidopsis plants impaired in diﬀerent components
of the SCFUFO complex exhibit severe ﬂoral morphological defects (Ni et al., 2004). If
toyocamycin generally would interfere with SCF-mediated processes, application of the
compound during ﬂower development could probably reduce fertility of such plants.
Thus, I sprayed Arabidopsis ﬂowers on ﬁve consecutive days with toyocamycin and
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Figure 3.5: MeJA-dependent degradation of the JAZ protein and flower development
after toyocamycin treatment. A: Seven-day-old Arabidopsis CaMV35Sp::JAZ1-GUS seedlings
were incubated for one hour with the indicated chemical. The seedlings were then treated with or
without MeJA (10 µM) to induce degradation of the fusion protein. The presence of JAZ1-GUS was
visualized by histochemical GUS staining. Toyocamycin does not prevent MeJA-induced degradation
of the fusion protein. The proteasome inhibitor MG132 was included as control for prevention of
JAZ1-GUS degradation. Three independent experiments showed comparable results. B: Shoots of
flowering Arabidopsis wild type plants were sprayed with DMSO (0.05%) or Toyocamycin (50 µM)
in Silwet L-77 (0.05%) on five consecutive days. Toyocamycin does not have any effect on flower
development, since siliques developed normally. Pictures were taken after flowers developed siliques.
Three independent experiments showed comparable results.
waited for the plants to produce siliques. Flowers developed normally and produced
normal siliques (Fig. 3.5 B).
Toyocamycin inhibits jasmonate downstream markers in a JAR1 independent man-
ner while inhibition of the elongation of the primary root is dependent on functional
JAR1 and AOS. Although JA signaling seems to be modulated by toyocamycin the
SCF-complex mediated degradation of JAZ proteins, one central part in the JA sig-
naling pathway, is unaﬀected.
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Figure 3.6: Expression of LOX2 after MeJA and toyocamycin stimulus. 14-day-old Ara-
bidopsis seedlings (Col-0) were pretreated with DMSO or toyocamycin (10 µM) and LOX2 expression
was induced by application of MeJA (100 µM). Plants were harvested at the indicated time points
and expression was monitored by qRT-PCR. Toyocamycin reduced LOX2 expression after MeJA
treatment. B: 14-day-old Arabidopsis seedlings (Col-0) were treated as in A and harvested after 8
hours. Toyocamycin causes reduced LOX2 expression after MeJA treatment, but did not affect the
untreated control. Expression was normalized to the untreated control and is shown as average of
3 biological replicates ± standard error. Asterisks indicate significant differences compared to the
control (Student’s t-test **p<0.02, *p<0.05).
3.1.4 Analysis of global gene expression
To gain a better understanding of the particular phenotype caused by toyocamycin,
I decided to analyze the impact on global gene expression after incubation with the
compound. As ﬁrst step, I tested how expression is changed over time after applica-
tion of toyocamycin and MeJA. Already one hour after MeJA stimulus on Arabidop-
sis seedlings, an increase of LOX2 transcript could be observed (Fig. 3.6 A). Over
time LOX2 expression increased further and reached its maximum between eight and
twelve hours. If seedlings were additionally treated with toyocamycin this increase was
strongly inhibited (Fig. 3.6 A). The biggest diﬀerences between control and toyocamy-
cin treatment were observed eight and twelve hours after the MeJA stimulus.
Based on these observed diﬀerences, an eight hour treatment was chosen for the mi-
croarray setup. Arabidopsis seedlings were incubated with toyocamycin one hour before
the MeJA stimulus was given. After eight hours samples were harvested and LOX2
expression was veriﬁed via quantitative real-time PCR. LOX2 transcript is highly in-
duced by MeJA (40-fold compared to untreated control), whereas toyocamycin and
MeJA together cause only a 12-fold induction (Fig. 3.6 B). The single treatment of
toyocamycin did not cause any eﬀect at this time point. This indicated a success-
ful treatment and therefore the samples were hybridized with the AGRONOMICS1
microarray (Rehrauer et al., 2010).
Comparing the microarray expressions after toyocamycin treatment with the respec-
tive DMSO control showed that toyocamycin alone induced the expression of 1,441
genes (Fig. 3.7 A). In combination with MeJA 1,040 genes were upregulated in com-
parison with MeJA alone. 701 genes were coregulated in both comparisons.
In comparison to the DMSO control, toyocamycin inhibited the expression of 1,373
genes (Fig. 3.7 A). By the double treatment of toyocamycin/MeJA a total of 1,057
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Figure 3.7: Misregulated gene expression and Gene Ontology (GO) of genes affected by
toyocamycin. 14-day-old Arabidopsis plants were pretreated with DMSO or toyocamycin (10 µM)
and then incubated for eight hours with DMSO or MeJA (100 µM). A: Microarray expression values
were compared to the respective control (DMSO or MeJA) and two-fold misexpression was plotted
into a venn diagram. 1,441 (740 + 701) genes were upregulated by toyocamycin and 1,040 (339 +
701) genes were upregulated by toyocamycin and MeJA. 1,373 (653 + 720) genes were downregulated
by toyocamycin and 1,057 (337 + 720) genes were downregulatedy by toyocamycin and MeJA. B:
Genes that were misregulated by toyocamycin alone were subjected to GO analysis. Enrichment of
GO terms for cellular compartment is shown as percentage of total misregulated genes.
was inhibited compared to MeJA alone. 720 genes were coregulated with the sin-
gle treatment. Thus, there are more genes misregulated by toyocamycin alone than
by the combination of toyocamycin with MeJA with an even smaller number being
misregulated speciﬁcally only together with MeJA.
To get an impression about which processes are aﬀected by toyocamycin, I performed
an analysis of Gene Ontology (GO) terms (TAIR, Berardini et al. (2004)) that are
aﬀected by toyocamycin. Interestingly, the GO term for cellular compartment was
enriched in genes, misregulated by toyocamycin, whose gene products are localized
to the chloroplast (Fig. 3.7, B). Genes misregulated by toyocamycin in combination
with MeJA showed the same enrichment and analysis via a diﬀerent tool (AmiGO,
Ashburner et al. (2000)) conﬁrmed this enrichment (data not shown).
To verify that JA downstream signaling is inhibited by toyocamycin, I compared the
expression of previously tested LOX2 and VSP1/2 (Fig. 3.8). Both marker genes were
strongly induced by MeJA, and this was prevented by the pretreatment with toyoca-
mycin. Jasmonate biosynthesis occurs in chloroplast and peroxisome (see introduction
Fig. 1.1). Based on the fact that the GO term chloroplastic localization was enriched
in genes misregulated by toyocamycin, I analyzed microarray expressions of several
Figure 3.8 (following page): Microarray expression levels of selected genes. 14-day-old
Arabidopsis seedlings (Col-0) were pretreated with DMSO or toyocamycin (10 µM) and JA-specific
expression was induced by application of MeJA (100 µM). Plants were harvested eight hours after
MeJA stimulus. Expression of three independent replicates was analyzed on an AGRONOMICS1
microarray (Rehrauer et al., 2010). Absolute expression values are shown as average ± standard
deviation. LOX2, the main lipoxygenase of JA biosynthesis, AOS and AOC2, the major allene oxide
cyclase, are localized to the chloroplast as well as LOX3, LOX4, LOX6, AOC1, AOC3 and AOC4.
The committed step of JA synthesis in the peroxisome is catalyzed by OPR3. OPCL1, which activates
OPC-8 for β-oxidation is also localized to the peroxisome. VSP1 and VSP2 are common downstream
markers for JA signaling.
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Figure 3.9: Microarray expression levels of JAZ, Aux/IAA and DELLA. 14-day-old Ara-
bidopsis seedlings (Col-0) were pretreated with DMSO or toyocamycin (10 µM) and JA-specific ex-
pression was induced by application of MeJA (100 µM). Plants were harvested eight hours after MeJA
stimulus. Expression of three independent replicates was analyzed on an AGRONOMICS1 microarray
(Rehrauer et al., 2010). Expression was normalized to the respective control and is shown as average
± standard deviation. A: Mainly JAZ are upregulated by toyocamycin compared to the DMSO con-
trol. B: JAZ expression was analyzed after treatment with toyocamycin in combination with MeJA
and normalized to expression after MeJA single treatment. Expression of JAZ5, 7 and 8 is strongly
induced, while expression of other JAZ is rather unchanged.
selected genes of JA biosynthesis. Beside LOX2, the major lipoxygenase participating
in JA biosynthesis, the gene family comprises ﬁve additional members, of which only
LOX3, 4 and 6 have the chloroplast target sequence (Stenzel et al., 2003). All of them
exhibit lower expression levels and do not behave as LOX2. The other two chloroplastic
enzymes participating in JA biosynthesis, AOS and AOC2, behave similar to LOX2.
Whereas AOC1 and AOC4 show just a similar trend, expression of AOC3 behaves
diﬀerent and is upregulated after toyocamycin treatment.
Expression of the committing single-copy gene OPR3 and of the OPC-8 activating
acyl-coenzyme A synthethase OPCL1 in the peroxisome shows a complete diﬀerent
pattern. It is not inhibited by toyocamycin but rather induced or unchanged. These
observations coincide with the results of GO term analysis, which was enriched in the
GO term for chloroplastic localization.
Because of the described eﬀect of toyocamycin on auxin signaling, I wanted to see,
which eﬀect it has on the transcriptional regulated repressors of auxin signaling. I
compared the microarray expression of all repressors of the mechanistically related
signaling pathways auxin, gibberellin and jasmonic acid. Interestingly, predominantly
JAZ expression was induced eight hours after toyocamycin stimulus (Fig. 3.9, A),
whereas expression of Aux/IAA and DELLA was not signiﬁcantly changed. Brieﬂy,
expression of JAZ5 was aﬀected strongest with almost eight-fold higher expression
than in the DMSO control. JAZ1, JAZ6, JAZ9 and JAZ10 transcripts were less
aﬀected by toyocamycin but exhibited still a more than two-fold upregulation. This
means that toyocamycin mostly aﬀects JA signaling concerning the transcriptional
regulation of the repressors. Because JAZ expression is known to be induced by MeJA
alone, I wanted to see, if after application of MeJA and toyocamycin any additional
or reducing eﬀects on JAZ expression exist. Indeed, most JAZ were upregulated by
MeJA with the exception of JAZ4, JAZ11 and JAZ12 (See supplemental Fig. S.6).
45
None of the Aux/IAA or DELLA was modulated by MeJA. Intriguingly, JAZ5, JAZ7
and JAZ8 exhibited even higher expression after application of toyocamycin together
with MeJA (Fig. 3.9, B). Since JAZ5 expression is already more than seven-fold higher
with toyocamycin alone, this may explain the higher expression in combination with
MeJA.
3.1.5 Structure-activity relationship of toyocamycin
Toyocamycin is a structural analog of adenosine. Adenosine is phosphorylated into
its nucleotides (mono-, di- or triphosphate), as such providing energy for numerous
biological processes. To rule out the possibility that toyocamycin acts as adenosine
analog, I tested the activity of adenosine and its corresponding nucleotides on the
LOX2p::LUC reporter. None of the derivatives was able to induce reporter expression
itself (data not shown) and all derivatives did not have any eﬀect on MeJA-induced
expression (Fig. 3.10 A, blue bars). If toyocamycin would compete with adenosine
or its nucleotides for a protein target, the inhibitory eﬀect would vanish upon excess
application of the adenosine derivatives. However, the eﬀect of toyocamycin on the
expression of LOX2p::LUC was not signiﬁcantly aﬀected, neither at equimolar con-
centrations nor at concentrations ten-fold higher than toyocamycin (Fig. 3.10 A, rose
bars). This means that the eﬀect on this reporter is not based on replacement of
adenosine by toyocamycin.
Adenosine can be phosphorylated to AMP by the adenosine kinase. Toyocamy-
cin was previously shown to inhibit recombinant human adenosine kinase, but with
only moderate activity (Ugarkar et al., 2000). Thus, binding to Arabidopsis adenosine
Figure 3.10: Competition assay of toyocamycin and adenosine-(nucleotides) and
structure-activity relationship (SAR) of toyocamycin. 14-day-old Arabidopsis seedlings
were pretreated with the indicated chemicals and LOX2p::LUC expression was induced with MeJA
(100 µM). LUC activity is shown as average of two independent experiments ± standard deviation
with four replicates each. A: Adenosine, AMP, ADP and ATP do not inhibit reporter expression,
nor do they compete with toyocamycin at 10-fold excess concentration. LUC activity is normalized
relative to the MeJA control. B: Targeted modifications of toyocamycin at the 5’-OH group lead to
increased or decreased activity. Absolute LUC activity is shown in relative light units (RLU). Two
independent experiments with four replicates each showed comparable results.
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kinase and phosphorylation of toyocamycin in planta could be possible. To see if a
phosphorylated form is the active form, I tested two diﬀerent derivatives for their eﬀect
on LOX2p::LUC. Toyocamycin-BOC cannot be phosphorylated, whereas toyocamycin-
sulfamate (toyocamycin-H3NSO3) mimics the 5’-phosphate and cannot be phosphory-
lated either (Fig. 3.11). Even at higher concentrations of 30 µM, toyocamycin-BOC
was not able to inhibit the reporter expression (Fig. 3.10, B). Toyocamycin-sulfamate
caused even strong inhibition at low concentrations. This means that apparently the
phosphorylated form of toyocamycin is the active form. For identiﬁcation of a direct
protein target, we obtained toyocamycin-sulfamate containing an alkyne as linker for
click chemistry. This derivative showed the same activity as toyocamycin-sulfamate
(data not shown) and may be used in aﬃnity-based target identiﬁcation experiments,
which have been initiated. Unfortunately, further experiments have not been performed
due to time restrictions for this PhD thesis.
Figure 3.11: Structure of toyocamycin and modified derivatives. The structures of toyoca-
mycin and modified derivatives is depicted. Targeted modification of toyocamycin yielded the inactive
toyocamycin-BOC and the highly bioactive toyocamycin-sulfamate (H3SNO3). Toyocamycin-click
was as active as toyocamycin-sulfamate, contains and alkyne and may be used in target identification
experiments using affinity-based labeling methods in combination with click chemistry.
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4 Discussion
Many components of jasmonate biosynthesis or signaling have been unraveled, such
as the perception of the most bioactive jasmonate (+)-7-iso-JA-L-Ile by the COI1–
JAZ co-receptor module. However, some components remain unknown, such as mode
of action and perception of other bioactive jasmonates or the molecular mechanism
of cross-talk between diﬀerent hormonal signaling pathways. Genetic approaches in
jasmonate research have reached their limits and the usage of chemical genetics in
plant sciences is rapidly expanding. Despite the successful achievements by chemical
genetic approaches in plant biology, such as in auxin, ABA or ethylene signaling (Zhao
et al., 2003; Armstrong et al., 2004; Park et al., 2009), this methodology remains
unexploited in jasmonate research.
This was the reason to design a chemical screen in Arabidopsis, which should be
the basis for uncovering chemical compounds, that selectively modulate JA signaling.
Unveiling the cellular target of such compounds may answer open questions in JA
research, which may not have been answered due to redundancy of gene function or
lethality of mutants. The here described chemical screening procedure was developed
to enable simultaneous handling of high numbers of chemicals to allow screening of
bigger chemical libraries comprising molecules of high chemical diversity. This require-
ment was fulﬁlled by using Arabidopsis seedlings, which could be grown directly in
96-well microplates. As readout, the MeJA inducible ﬁreﬂy luciferase (LUC) reporter
LOX2p::LUC was chosen. The advantage of such reporter-based screen is that it af-
fords semi-quantitative data that allow discrimination between compounds with high
and low bioactivity. Additionally, it allows bidirectional screening for either activators
of reporter expression or for compounds that prevent reporter activation after MeJA
stimulus. The LUC activities were based on the average of the ﬁrst four hours af-
ter initiation of LUC measurement, which approximates the integrated activity over
time and yielded most stable and reliable results. Unfortunately the LUC activities
showed considerable variations between diﬀerent samples, which can be attributed to
size (biomass) and orientation of seedlings in the microplates. Because of this ﬁnding,
deep analysis of the data and stringent threshold values, which dictate the selection of
candidate compounds from the analyzed population, were necessary.
The small kinase inhibitor library (chapter 3), containing only 80 compounds, was
screened in one day. Due to the small number of chemicals, controls were included
on the same plate and the whole screen was repeated once completely. This assured
a stringent selection of candidates. Conversely, large scale screening is time consum-
ing and cannot be repeated as a whole. The natural compound library (chapter 2)
comprised over 1,700 diﬀerent compounds, which were supplied in a 96-well microplate
format. The screening procedure was performed in small steps, each including a maxi-
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mum of three diﬀerent chemical plates at the same time. Instead of including controls
on each of the screening plates, a separate control plate was included. This was con-
sidered for practical reasons, because in this case, the 96-well format of the chemical
library could be directly transferred to the 96-well formatted screening plates. Can-
didate compounds were selected by comparison of LUC activities to the average LUC
activity of the control plate.
It could be observed that the average activities during the diﬀerent steps of the
screening procedure diﬀered considerably (compare supplemental Fig. S.5). Averages
of whole plates sometimes diﬀered up to 50 % compared to the average of the control
plate. This plate-to-plate variation indicates that minor changes in growth conditions
may have major eﬀects on LUC activity and that it may not be suﬃcient to rely on
controls on a separate microplate. Such datasets need critical statistic evaluation to
gain conﬁdent selection of candidates. The evaluation using comparison to a control
plate generated a set of candidates, of which one was selected for further characteri-
zation (compound 12). The selectivity of this compound proves the principle of this
selection method but maybe diﬀerent rather statistic based approaches could be useful
for future screenings.
One conﬁdent selection method of candidates in high-throughput-screening (HTS)
is based on using the so called Z-score (Malo et al., 2006). The Z-score is a simple
normalizing method, which considers the variation of the readout, thus adding a higher
degree of conﬁdence to candidate generation. It includes the average of the whole plate
as control, since most compounds are expected to have no eﬀect, thus rendering the
eﬀect of single compounds negligible (‘Z = xi−x¯
sx
where xi is the raw measurement on
the ith compound, x¯ and sx are the mean and the standard deviation, respectively,
of all measurements within the plate’) (Malo et al., 2006). Although candidates of
the natural compound library have been selected already, I applied the Z-score to the
dataset of this library. This analysis revealed that all of the conﬁrmed candidates would
have met the selection criteria, while some of the not conﬁrmed candidates would have
been discarded in the ﬁrst place. Intriguingly, this method would have led to some
other candidate compounds, but their relevance remains to be shown.
Based on these ﬁndings, I performed the same screen on another chemical library
(Prestwick Chemical Library R©, 1,200 compounds). For ﬁrst candidate selection a more
relaxed threshold was used (data not shown) and ﬁnal candidate generation may be
done including the Z-score. The true value of such analysis on this screen remains to be
shown by subsequent analysis of the selectivity of such candidates but in other screens
which used the Z-score it proved to be applicable (Lee et al., 2010; Thorne et al., 2011;
Saydmohammed et al., 2011).
However, the fact that the screen on the natural compound library uncovered one
apparent activator and several inhibitors, including cycloheximide (8) and the two tri-
chothecene mycotoxins diacetoxyscirpenol (15) and neosolaniol (16), proves the con-
cept of the screening procedure. Since 8, 15 and 16 have in common that they inhibit
protein synthesis in general (Serrano et al., 2010), any of these compounds may serve
as suitable positive control in reporter-based screens for inhibitors.
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4.1 766 can be lead structure for designing novel luciferase
ligands
The screen for activators of LOX2p::LUC uncovered compound 766, as apparent acti-
vator. 766 is a derivative of 9,10-anthracenedione (anthraquinone) (see Table 2.1). It
was ﬁrst isolated from Streptomyces griseorubiginosus and showed inhibitory activity
on the binding of the transcription factor AP-1 to its recognition site in rat cell cultures
(Naruse et al., 1998; Goto et al., 1998). The same compound and related derivatives
were shown to have antifungal and cytotoxic activity (Tang et al., 2004; Poumale et al.,
2006; Lee et al., 2007). Other anthraquinones like physcion, rhein and emodin are de-
scribed to have antifungal activity. They can protect plants against phytopathogens
such as Botrytis cineria, Erysiphe graminis, Plasmopara viticola or induce expression of
defense genes (Kim et al., 2004; Godard et al., 2009; Vinale et al., 2008). Additionally,
higher anthraquinone levels were observed in damaged buckthorn (Rhamnus alpinus)
leaves (Bañuelos et al., 2004). This ﬁndings initially emphasized the possibility of 766
to be able to modulate defense response pathways.
SAR studies indicated the importance of the functional groups at carbon atoms 1 and
2 to activate the LUC reporter. Of all anthraquinones tested, the compounds 44, 47
and 48 are the only compounds, which have carbon chains of the same or longer length
at carbon atom one compared to 766. All of these compounds also have a carboxylic
acid group at the second carbon atom (see structures in Fig. 2.5). The chains of 47 and
48 are longer and both compounds cause higher reporter expression than the negative
control. Note in this experiment the low activity of 766, which is based on general
problems with expression of the reporter. This is potentially caused by successive
silencing during propagation of the plants (Nocarova et al., 2010). The activity of 47
and 48 indicates that a carbon chain at the ﬁrst carbon atom may be of importance for
eﬀective binding to a protein target. Unfortunately, compound 44, which also contains
a carbon chain at C-1, did not modulate the reporter response. Based on the missing
activity, no clear conclusion about SAR can be drawn. By contrast, compound 18 and
39 caused inhibition of the reporter (see structures in Fig. 2.5). They contain also a
carboxylic acid group at C-2. Since both compounds also modulated the response in
the same reporter line, this indicated, that the group at C-2 may be involved in binding
to a protein target but that the carbon chain at C-1 may be important for activating
LOX2 reporter expression.
In secondary assays, 766 did not induce endogenous LOX2 expression or expression
of the LOX2p::GUS reporter. This were ﬁrst indications that this compound does
not modulate JA signaling. In a LUC overexpression line I observed higher LUC ac-
tivities caused by 766. Intriguingly, the compound inhibited LUC activity in vitro.
The apparent in vivo activation may in fact reﬂect increased enzyme stability. LUC
is inhibited by its product oxyluciferin and it has been reported that the LUC pro-
tein is sensitive to ligand-based stabilization, leading to accumulation of the enzyme
(Thompson et al., 1991; Chiou and Ueda, 1994; Leitão and Esteves da Silva, 2010). In
luminescence based detection of LUC, an increased enzyme level will be reﬂected in
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higher luminescence emission. Thus ligand-based stabilization of LUC in vivo may ap-
pear as reporter activation, if the ligand binds competitively to LUC, still allowing its
reaction with D-luciferin. Such binding could decrease LUC activity in vitro, because
less enzyme would react with D-luciferin, while some of it is occupied by the other
ligand (Thorne et al., 2010b,a).
By showing the inhibitory activity of 766 in vitro on recombinant LUC, I provide
strong evidence that this compound acts on LUC. Adding an excess of luciferase to the
in vitro assay after LUC inhibition could strengthen the hypothesis that 766 inhibits
the enzyme. This experiment could verify that ATP is still available in the system and
that in fact LUC is inhibited. If the compound binds competitively could be resolved
by enzyme kinetics.
If 766 binds LUC, thus increasing enzyme levels in planta, how does 18 cause
inhibition of the reporter? If this compound would be a non-competitive ligand of
LUC, it would prevent the LUC reaction in planta as well as in vitro. However, 18 it
did not aﬀect in vitro LUC activity, although activity seems to be slightly reduced and
more variable. This may be ascribed to just weak binding to LUC. Thus, 18 is not
a true ligand of LUC and the inhibitory eﬀect in planta could be attributed to other
eﬀects, such as toxicity of the compound. If the functional group at carbon two may
be involved in LUC binding remains to be shown. Stronger evidences for SAR need a
more targeted approach by modifying the molecule at single carbon atoms and testing
their eﬀectiveness on LUC inhibition.
Finally, docking simulations suggest as well that 766 binds to the luciferase. The
crystal structure of ﬁreﬂy luciferase (Photinus pyralis) has been resolved (Conti et al.,
1996). I used this crystal structure as basis for docking simulations of the binding
of D-luciferin and 766 to the enzyme using an online tool (DockingServer, Bikadi
and Hazai 2009). Both molecules were calculated to bind at the same site of the
enzyme although in diﬀerent orientations. The estimated binding energy of luciferin
binding was -6.31 kcal/mol, whereas 766 released -4.42 kcal/mol upon binding. Both
molecules established pi-pi-bonds with His245 but 766 additionally established pi-pi-
bonds with Phe247. Since the original crystal structure established for LUC does not
include the substrate bound to the enzyme, I compared the results with the crystal
structure of luciferase from the japanese ﬁreﬂy (Luciola cruciata), which is very similar
to Photinus pyralis luciferase and includes oxyluciferin and AMP into the structure
(Kajiyama et al., 1992; Nakatsu et al., 2006). Indeed the respective His is bound to
oxyluciferin via pi-pi-bonds, whereas AMP interacts with the respective Phe, supporting
the hypothesis of competitive inhibition of LUC by 766. An example of the binding
pocket with D-luciferin and 766 is shown in Figure 4.1.
Since 766 appears to bind LUC, this raised the question if there are any possible
applications of this ligand. Increased LUC stability via the addition of competitive
inhibitors could improve the sensitivity of weak promoters as already proposed by
Thompson et al. (1991). Although detection limits for LUC are very low (Stanley,
2000) uninduced or weak promoters may not yield enough enzyme for detection. This
problem can be approached by application of competitive LUC inhibitors, which im-
prove protein stability and lead to detectable enzyme concentrations. Thus, 766 could
be a lead structure for such a ligand and extensive SAR studies and more detailed
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Figure 4.1: Docking simulation of ligands to firefly luciferase. Docking simulation was
achieved using the free version of DockingServer (Bikadi and Hazai, 2009) based on the crystal struc-
ture of firefly luciferase (Conti et al., 1996) and the structures of D-luciferin and 766. The model
shows one of several possibilities, how the molecules hypothetically both bind to the same part of the
enzyme. Each possible conformation potentially released energy. A: D-luciferin bound to luciferase,
B: 766 bound to luciferase.
in silico modeling could improve the eﬀectiveness of a ligand. I did not perform any
additional experiments, since proving the mechanism of 766–LUC interaction was not
the main interest of this project.
However, the discovery of 766 as putative ligand of the reporter enzyme demon-
strates the importance of secondary and counter screens for veriﬁcation of a candidate
compound. This is a general problem of using reporters in chemical screens, which
highlights advantages of reporter independent readouts.
4.2 Uncovering selective inhibitors
An alternative way of screening is to look for inhibitors of reporter expression. To
approach this, Arabidopsis seedlings were preincubated for one hour with diﬀerent
chemicals before LOX2p::LUC expression was induced by MeJA. The corresponding
LUC activities were detected 24 hours after induction.
After uncovering the compounds 4, 5, 6, 7, 8, 10, 12, 15, 16, 17 (see structures in
supplemental Fig. S.1) as inhibitors of MeJA-induced LOX2p::LUC reporter expression
in Arabidopsis, I veriﬁed the speciﬁcity for JA signaling only for 12. The translational
inhibitors 8, 15 and 16 were excluded from this study. Candidate 17, piericidin in-
hibits the mitochondrial type I NADH-ubiquinone oxidoreductase in the respiratory
chain (Darrouzet et al., 1998). Because it may generally interfere with energy depen-
dent pathways it was as well excluded. It is worth noting, that piericidine was also
identiﬁed in other chemical screens performed in the lab (ﬂg22-repressed anthocyanin
accumulation, Serrano et al. (2012); ﬂg22-induced Ca2+ spike, Jens Maintz, unpub-
lished results). The compounds 4, 5, 6 and 7 inhibited the JA independent induction
of the reporter WRKY29p::GUS and interfered with ﬂg22 induced ROS production,
whereas 10 and 12 did not. This only left 10 and 12 as JA selective compounds, of
which 12 inhibited all MeJA-induced readouts, whereas 10 did not interfere with the
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GUS reporters and exhibited a less pronounced eﬀect on the VSP1p::LUC reporter.
In parallel, the screen on the kinase inhibitor library yielded three diﬀerent inhibitors
of MeJA-induced LOX2p::LUC expression. Two are non-speciﬁc kinase inhibitors
(staurosporine and 5-iodotubercidin) and one is an inhibitor of protein tyrosine kinases
and mitogen-activated protein kinases (MAPK), tyrphostin AG-879. Thus, tyrphostin
AG-879 has the potential to cause more speciﬁc eﬀects than the other two inhibitors.
Nevertheless, I focused on the analysis of 5-iodotubercidin and three of its derivatives
(tubercidin, sangivamycin and toyocamycin), based on the published eﬀect on SCFTIR1
mediated auxin signaling (Hayashi et al., 2009), which is mechanistically similar to JA
signaling. Tyrphostin AG-879 still will be included in secondary and counter screens,
which aim at conﬁrming candidates from the Prestwick Chemical Library R©, which has
not been included in this study. Likewise, staurosporine will be included into these
veriﬁcations, although its eﬀects on numerous human kinases (Karaman et al., 2008)
may indicate that it is less speciﬁc. This suggests that its inhibition of JA signaling
requires critical evaluation.
Testing the four diﬀerent nucleoside analogs (5-iodotubercidin, tubercidin, toyoca-
mycin and sangivamycin) for their ability to interfere with the expression of diﬀerent
reporters revealed, that all inhibited JA independent expression of WRKY29 to the
same extent, whereas ten-fold diﬀerences in their IC50 for the JA dependent reporters
could be observed. This indicates that all four compounds may have one or more
common targets, that are involved in the ﬂg22 dependent activation of WRKY29, but
that they have a diﬀerent speciﬁcity for JA dependent expressions. Of all nucleosides
tested, sangivamycin exhibited the strongest eﬀect on each reporter and also prevented
the ﬂg22 dependent activation of MAPKs. This indicates that this compound is less
speciﬁc than the others, because it inhibited all responses tested. 5-Iodotubercidin was
less eﬀective on the expression of the LOX2 or VSP1 reporters, but also prevented the
activation of MAPKs. This only left tubercidin and toyocamycin, of which toyocamy-
cin caused stronger eﬀects on the expression of the LOX2 and VSP1 reporter, whereas
it was less eﬀective on the expression of the OPCL1 reporter. Both compounds did
not interfere with ﬂg22-dependent activation of MAPKs.
In conclusion, based on critical evaluation of all biological reporters tested, I decided
to focus on compound 12 and toyocamycin as selective inhibitors of JA signaling.
The main question emerging was, where to put the eﬀect of the compounds into the
Arabidopsis hormonal signaling network, which I tried to answer for each compound
by diﬀerent experimental strategies.
4.3 Analysis of compound 12 and its effect on hormone
signaling
To ﬁgure out the mode of action of compound 12 one important point was to determine
how fast it aﬀects (JA)-responses. The degradation of JAZ proteins is a rapid response
and depends on a JA stimulus (Chini et al., 2007; Thines et al., 2007). The prevention
of JAZ1-GUS degradation mediated by 12 indicates that this compound is taken up
eﬃciently by the seedlings and that it is a potent inhibitor of speciﬁc processes already
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one hour after application.
Compound 12 not only aﬀects rapid responses in Arabidopsis, but it also aﬀects long
term responses. Root growth was inhibited by 12 and this eﬀect appears to be inde-
pendent of JA or JA-Ile synthesis since the biosynthesis mutants aos and jar1 both are
as sensitive as the wild type. This is a strong indication that root growth inhibition is
independent of JA signaling. Further proof of this hypothesis may be delivered after
testing the JA-Ile receptor mutant coi1 and the MYC2 transcription factor deﬁcient
mutant jin1 for their responsiveness to 12. Additionally, testing mutants of auxin,
ethylene or ABA signaling may shed light on the question whether 12 might inhibit
root growth by a diﬀerent mechanism, since some Arabidopsis mutants of these phyto-
hormone signaling pathways are resistant to root growth inhibition by the respective
hormone (Roman et al., 1995; Ghassemian et al., 2000; Lorenzo et al., 2004; Růžička
et al., 2007).
One way to get more insight into the question what is aﬀected by 12 would be
application of the compound in a genome wide microarray expression analysis. This
approach could show, which signaling pathways are involved in the Arabidopsis re-
sponse to 12. I performed such a microarray experiment in parallel to the microarray
with toyocamycin. Because of time and budget constraints, I decided to test only one
time point and only Arabidopsis wild type plants for their response to 12 and toyoca-
mycin. Eight hours treatment appeared to be a suitable time point to observe robust
eﬀects with both compounds. Selected genes may later be analyzed via quantitative
real-time PCR (qRT-PCR) at diﬀerent time points and in selected Arabidopsis mutants
to see the impact on fast responses as well as on deﬁned signaling pathways.
Due to the lower eﬀect of 12 on the LOX2 inhibition (IC50 10 µM) compared to
the more potent inhibitor toyocamycin (IC50 1 µM), I performed careful analysis of
the samples concerning RNA integrity and signiﬁcant LOX2 inhibition in qRT-PCR.
Interestingly, the trend of gene expression of genes such as LOX2 or VSP1/VSP2 in
the microarray dataset was as expected, but unfortunately the diﬀerences between con-
trol and application of 12 were not signiﬁcant. Even with lowered signiﬁcance levels
(p ≤ 0.1) only a total of 129 genes was misregulated by 12 alone and 50 genes in
combination with MeJA. The low diﬀerences in gene expression cannot be attributed
to the new AGRONOMICS1 tilling array, since it was shown that AGRONOMICS1
and the previously commonly used ATH1 (Redman et al., 2004) yield nearly identical
expression fold changes (Rehrauer et al., 2010). The big diﬀerences between expression
fold changes of qRT-PCR and the AGRONOMICS1 tiling array are a commonly ob-
served phenomenon (Annegret Roß, Moritz Schön, MPI for Plant Breeding Research,
personal communication). The resulting low hit rate for the array with 12 makes fast
and easy data analysis practically impossible. However, those data may still be used
to support upcoming experiments, since trends in gene expression are still valid. In
retrospect, a higher concentration of 12 could have improved the microarray but the
desicion for the ﬁnally used, less eﬀective concentration was made, to ensure that at
least one treatment would yield usable data, in the case that the eﬀect of toyocamycin
would be too strong. Ironically, exactly the other way came true.
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4.4 Target identification
Root growth elongation was inhibited by 12 but it was not possible to link this phe-
notype to JA signaling by testing diﬀerent JA biosynthesis/signaling mutants. This
missing link indicates that the compound may be either involved in an unknown JA
signaling pathway or act on another hormone signaling pathway. Beside the approach
to integrate it into the signaling network via analysis of known mutants or via mi-
croarray analysis, identiﬁcation of the direct protein target would be an elegant way to
arrange the compound’s eﬀect into the network with the possibility to unravel its mode
of action. In similar approaches chemical probes have been successfully developed to
label e.g. members of a lectin protein family or to identify a target membrane protein
of the jasmonate glycoside that controls leaf movement in Albizzia saman (Ballell et al.,
2005; Nakamura et al., 2008b).
Prerequisite for this approach is a speciﬁc compound, that is taken up eﬃciently,
exhibits strong binding aﬃnity to its target and is detectable. The ﬁrst steps towards
target identiﬁcation via aﬃnity based labeling usually comprise SAR studies. These
aim at identiﬁcation of indispensable parts of the molecule. Identiﬁcation of sites that
allow modiﬁcations without loosing bioactivity enable linking of ﬂuorophores or biotin.
Such a modiﬁed compound can then be used as probe for puriﬁcation or detection of
bound proteins.
The established SAR for 12 allowed modiﬁcation on the side of the propanoic acid-
methyl ether. The weak eﬀect of 12 (IC50 10 µM) compared to a stronger inhibitor like
toyocamycin (IC50 1 µM) indicates the possibility of weak binding to the target. To
approach this problem, the probe 65, which contains a photoreactive benzophenone
group was synthesized. This probe was provided by Prof. Markus Kaiser (ZMB,
Universiät Duisburg Essen). The photoreactive group can be used to establish covalent
cross-linking to the target protein. A benzophenone was chosen, since it can be worked
with in ambient light, does hardly react with solvents and modiﬁes C-H bonds within
3 Å of the carbonyl oxygen (Dormán and Prestwich, 1994, 2000). Benzophenone-
containing molecules can be synthesized relative easily via peptide chemistry using
p-benzoyl-L-phenylalanine (Kauer et al., 1986). In favor of a small alkyne group,
the direct incorporation of a bulky ﬂuorescent or biotin tag was abandoned, since
the probe may be easier taken up by the cell and may be more likely to distribute
within living cells in an unbiased manner. Using ‘click chemistry’, a copper-catalyzed
1,3-dipolar cycloaddition between azide and alkyne, a commercial ﬂuorophore can be
added after UV-cross-linking (Speers et al., 2003). In the literature several examples
exist in which speciﬁc proteins or protein families have been characterized employing
photoreactive and/or ‘click chemistry’ probes (for reviews see Puri and Bogyo (2009);
Kalesh et al. (2010); Kolodziejek and van der Hoorn (2010); Heal et al. (2011)). Indeed,
the probe was able to prevent activation of the LOX2p::LUC reporter, although the
concentrations were higher than with compound 12. This lower eﬃciency may be
attributed to insolubility (the solutions with 65 appeared more turbid than with 12)
or less eﬃcient uptake of the probe.
The fact that 65 was able to label proteins in a concentration dependent and by 12
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competable manner suggests that the probe indeed targets proteins, but unfortunately
not as speciﬁc as expected. The UV-cross-linking control did not label any proteins,
which indicates that labeling by 65 is not based on unspeciﬁc UV-cross-linking. If
among these labeled proteins a main target may be masked remains unclear. This
question may be answered by increasing the spatial resolution via separation of proteins
on two-dimensional gels. In the case of that no main protein target can be identiﬁed,
MS-analysis of single bands will show, if the proteins belong to a family of proteins,
which all may be labeled at a highly conserved domain. It has been shown that e.g.
proteases or kinases are involved in plant defense and that single probes can label
phosphatases of the same family (van der Hoorn and Jones, 2004).
Alternative methods for target identification
If photoaﬃnity cross-linking and puriﬁcation with modiﬁed versions of the ligand does
not prove to be useful, other methods could be applied to identify a protein target. Such
label-free methods can also be used to verify target binding after successful pulldown
via an independent method.
Binding of ligands may stabilize proteins and make them less prone to degradation as
hypothesized for the interaction of 766 and the luciferase. This fact can be exploited by
applying a probe to protein extracts with subsequent digestion of proteins. Stabilized
proteins will still be detectable in the digested extract. This so called drug aﬃnity
responsive target stability (DARTS) has been successfully applied (Lomenick et al.,
2009; Aghajan et al., 2010). DARTS does not require derivatized compounds for aﬃnity
binding, which has the advantage that the original bioactive compound can be used.
The method is restricted to abundant proteins but due to missing washing steps, as
in classical aﬃnity puriﬁcation, no signal is lost. This increases the chance to identify
lower abundant proteins.
Another very sensitive technique for proving direct interaction is surface plasmon
resonance (SPR). The SPR technology records changes in light refraction on sensor
chip surfaces that occur upon interaction between two (or more) binding partners, one
of which is covalently linked to the sensor chip surface. SPR is the current leading
technology for label-free detection of protein interactions (Hall et al., 2007). Together
with modern imaging techniques surface plasmon resonance imaging (SPRi) forms
a powerful tool for aﬃnity-based biosensors in high throughput screens (Ray et al.,
2010). SPRi has been utilized as SPR-microscopy based protein arrays for analysis of
aﬃnity-tagged proteins during the expression and puriﬁcation process or to improve
drug research or food applications (Ro et al., 2005; Jung et al., 2005; Ro et al., 2006;
Shankaran et al., 2007; Ray et al., 2010). An Arabidopsis protein array using SPR has
been described already but the study was interested in ligands of a single protein, thus
screening 150,000 chemical compounds for interaction with one protein hybridized on
the chip (Yoshitani et al., 2005). Instead of linking only one protein to the sensor chip,
proteins from cDNA libraries could be spotted onto the sensor chip and the ligand
would be injected over the surface to detect the interaction partner. The recent devel-
opment of nanohole arrays increases spatial resolution, facilitating the development of
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protein arrays (De Leebeeck et al., 2007). To my knowledge such a study has not been
performed in Arabidopsis and depends on creating own cDNA libraries or on complete
cDNA collections as from the ORFeome project (Yamada et al., 2003; Gong et al.,
2004). The advantages of SPRi protein arrays are that even natural low abundant pro-
teins are detectable and that it enables kinetic characterization of the protein–ligand
interaction (Rich et al., 2002).
Innovative methods such as DARTS and SPRi protein arrays are two applicable inde-
pendent methods to identify the direct target and do not need derivatized compounds.
Thus, both techniques could be used with either 12 or toyocamycin. However, other
approaches for target identiﬁcation exist. For a survey of such methods see Tóth and
van der Hoorn (2010), Cottier et al. (2011) or Tashiro and Imoto (2012). The identiﬁ-
cation of a direct protein target will provide more insights into the mode of action of
12 or toyocamycin, which in turn may provide another point of view onto JA signaling
or the Arabidopsis hormone signaling network.
4.5 Analysis of toyocamycin and its effect on Arabidopsis
hormone signaling
Potential targets of toyocamycin
Toyocamycin, which was initially isolated as anti-Candida antibiotic from Streptomyces
toyocaensis (Nishimura et al., 1956), modulates auxin signaling potentially via the
SCF-ubiquitination pathway (Hayashi et al., 2009). It would be conceivable that it
may have a general eﬀect on SCF-ubiquitination regulated processes. The Arabidopsis
genome contains more than 600 F-box genes, which suggests that plants make extensive
use of SCF complexes to regulate multiple biological processes (Gagne et al., 2002;
Risseeuw et al., 2003).
Auxin signaling is mediated via the SCFTIR1 complex, that is necessary for ubiqui-
tination of Aux/IAA repressors and their subsequent proteosomal degradation (Gray
et al., 2001; Dharmasiri et al., 2005; Kepinski and Leyser, 2005; Tan et al., 2007). To-
yocamycin was shown to eﬀectively prevent degradation of these Aux/IAA repressors
(Hayashi et al., 2009). This mechanism is similar to the JAZ-degradation in JA-Ile
signaling, that is mediated by SCFCOI1 (Chini et al., 2007; Thines et al., 2007; Yan
et al., 2009; Fonseca et al., 2009b; Sheard et al., 2010). Intriguingly, toyocamycin did
not prevent JAZ1 from degradation. Likewise, the ﬂoral development, which is de-
pendent on SCFUFO (Durfee et al., 2003; Ni et al., 2004; Chae et al., 2008) was not
disturbed after application of toyocamycin. This indicates that toyocamycin does not
target SCF-ubiquitination pathways in general but rather acts speciﬁcally on auxin
and JA signaling or hormonal crosstalk.
Based on the similarity to adenosine it would be conceivable that toyocamycin substi-
tutes adenosine and adenosine nucleotides, thus disturbing energy driven processes in
general. That such a replacement is the cause for toyocamycin’s eﬀect on JA signaling
is rather unlikely, since neither adenosine nor its corresponding nucleotides were able
to outcompete the reporter inhibition. However, it may still act as adenosine analog
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on JA independent processes. The question, in which form toyocamycin is active was
answered by application of a sulfonated form, which mimics a phosphate group, and
a protected form that cannot be phosphorylated. The protected form was inactive,
whereas the sulfonated form exhibited stronger bioactivity concerning LOX2p::LUC
inhibition than toyocamycin. This suggests that phosphorylated toyocamycin is the
bioactive form. In this scenario, toyocamycin ﬁrst has to be phosphorylated, which
may be the reason for the lower bioactivity of toyocamycin. It has been shown that
5’-deoxytoyocamycin retained activity on inhibition of the auxin responsive DR5p::GUS
reporter (Hayashi et al., 2009). This indicates, that unphosphorylated toyocamycin in-
hibits auxin signaling, whereas it has to be phosphorylated for its eﬀect on JA signaling.
Phosphorylation of toyocamycin could be proven by conducting radiolabeling experi-
ments in which radiolabeled ATP serves as donor for phosphorylation of toyocamycin
in vivo with subsequent puriﬁcation and detection of (phosphorylated) toyocamycin.
Such phosphorylation could be catalyzed by a adenosine kinase in planta, which is
bound to and maybe inhibited by toyocamycin, since toyocamycin was shown to in-
hibit human adenosine kinase (Bergstrom et al., 1984; Ugarkar et al., 2000; González
and Moldes, 2004).
Toyocamycin not only inhibits human adenosine kinase, it also was shown to inhibit
phosphatidylinositol-4-kinase (PI4K) of human epithelial cell cultures (Nishioka et al.,
1990). PI4K and phosphatidylinositol-3-kinase (PI3K) both have been shown to be re-
quired for circadian rhythm or white light induced stomatal opening and ABA induced
stomatal closing in Arabidopsis (Jung et al., 2002). Additionally, PI4K is activated
upon SA stimulus in Arabidopsis suspension cells (Krinke et al., 2007). PI3K is re-
quired for auxin induced ROS generation in guard cells, for root gravitropism and for
endosomal traﬃcking (Joo et al., 2005; Jaillais et al., 2006). Wortmannin, an inhibitor
of PI3K, aﬀects auxin distribution, because inhibition of PI3K impairs the polar dis-
tribution of PIN1, an auxin eﬄux carrier (Jaillais et al., 2006). If toyocamycin also
aﬀects the PI3K or PI4K activity, thus interfering with auxin transport remains to be
shown. Indeed, an eﬀect on auxin distribution potentially explains toyocamycin’s eﬀect
on the auxin signaling pathway. Whether toyocamycin impairs PI3K or PI4K activity
can be tested by comparing its eﬀect with the eﬀect of the PI3K and PI4K inhibitors
wortmannin or LY294002 on stomatal movement, ROS generation in guard cells or
endosomal traﬃcking. The latter can be tested by application of FM4-64, which is a
dye for following membrane internalization and transport (Vida, 1995).
Since several possible targets of toyocamycin exist, it would be interesting to iden-
tify its real target(s) in planta. Based on the fact that toyocamycin appears to be
more active as monophosphate, I obtained a sulfonated probe, which mimics the
5’-phosphate and which contains an alkyne tag for ‘click chemistry’ (structure in sup-
plemental Fig. S.4). This probe retained its activity, but preliminary experiments failed
to label any proteins. This may be the result of (1) not fully optimized conditions for
performing such experiments, (2) weak binding to the protein or (3) a low abundant
protein target. Optimal conditions for protein labeling will be established using the
modiﬁed version of compound 12 (65), but those conditions may diﬀer from optimal
conditions for labeling with toyocamycin. Strong (covalent) binding of toyocamycin,
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which is necessary for employing the ‘click-reaction’ without dissociation of protein
and ligand, may occur at the CN-group of the molecule. Tubercidin, the derivative
with no reactive group at C-5 causes similar eﬀects on JA-signaling, as well as no inhi-
bition of ﬂagellin mediated MAPK activation. This fact makes it rather unlikely that
toyocamycin binds covalently via the CN-group. However, toyocamycin and tubercidin
may have diﬀerent targets and a JA-speciﬁc target may not be shared between those
compounds.
How does toyocamycin mediate root growth inhibition?
The eﬀect of toyocamycin on root growth elongation was already described in the early
1970s. Root growth was inhibited in rice, barnyard grass, crab grass, lucerne, tomato
and turnip at rather high concentrations (> 20 µM) (Yamada et al., 1972). This study
aimed just at identiﬁcation of compounds with growth regulating properties and did not
continue with analyzing the eﬀect of toyocamycin. I showed that the root phenotype in
Arabidopsis was less pronounced in aos and jar1-1. Both mutants have in common that
they contain no or only low levels of JA-Ile, because aos does not produce JA and jar1-
1 cannot conjugate JA to Ile. Thus, root growth inhibition by toyocamycin appears
to depend on JA-Ile. Interestingly, the JA-Ile receptor mutant coi1 did fully respond
to treatment with toyocamycin. The mutant jin1, which lacks the transcription factor
MYC2, did behave identical to the wild type. MYC2 is predominantly expressed in the
root and contributes mainly to root growth inhibition by JA (Fernández-Calvo et al.,
2011). Thus, functional JA-Ile signaling is not necessary for root growth inhibition
by toyocamycin. The fact that toyocamycin and MeJA/COR contributed additively
to root growth inhibition indicates that toyocamycin modulates root growth via a
diﬀerent mechanism than via COI1 and MYC2. That JA-Ile is necessary for this
phenotype implies, that toyocamycin may modulate jasmonate levels. If JA-Ile is the
necessary jasmonate it may be perceived via an additionally, yet unknown mechanism.
Another possibility would be that JAR1 forms a novel bioactive jasmonate, which is
not involved in the classical signal transduction JA–COI1–MYC2.
JAR1 belongs to the GH3 gene family of adenylating enzymes, that conjugates amino
acids to IAA, SA or JA (Staswick et al., 2002, 2005). Indeed, it was shown that JAR1
is able to conjugate Ile, Val, Leu, Phe and the ethylene precursor ACC to jasmonic
acid. However, the enzyme has a strong preference for (+)-JA and Ile (Staswick and
Tiryaki, 2004; Guranowski et al., 2007; Suza and Staswick, 2008). Commonly, auxin is
deactivated by conjugation of amino acids to IAA, since it was shown e.g. that IAA-
Trp and also JA-Trp inhibit auxin responses in Arabidopsis roots (Staswick, 2009).
Despite the fact that jar1 is functionally a null allele, this mutant still exhibits very
low amounts of JA-Ile and increased levels of JA-Phe and JA-ACC, inferring that
another enzyme is able to form these derivatives (Staswick and Tiryaki, 2004; Suza and
Staswick, 2008). If such an enzyme is also involved in either activation or inhibition
of JA/auxin signals remains to be shown. The fact that the root phenotype caused by
toyocamycin depends on functional JA synthesis (resistant aos mutant), but does not
need high amounts of JA-Ile, could mean that the signal is a diﬀerent JA-derivative
than JA-Ile as e.g. JA-Phe or JA-ACC.
60
Measurements of jasmonate levels in COR and toyocamycin treated seedlings have
been initiated to verify the hypothesis that toyocamycin modulates jasmonate levels.
However, data on this are not yet available. In addition, I will collect published mutants
for testing their responsiveness to toyocamycin (see supplemental Table S.1). This may
shed light on which known mechanisms are involved in toyocamycin’s root growth in-
hibition. Additionally, a genetic screen for suppressor mutants of toyocamycin induced
root growth inhibition may uncover mutants that are impaired in JA-(amino acid con-
jugate) levels and may even lead to identiﬁcation of the gene, that is responsible for
residual JA-Ile levels in jar1-1.
Understanding toyocamycin’s effect using microarray data?
Since the mode of action of toyocamycin remains unclear, the analysis of global gene
expression could help explaining, how toyocamycin exerts its function on the hormonal
signaling network. Seedlings were pretreated with toyocamycin or DMSO as control.
One half of each pretreatment was then treated with MeJA or DMSO, respectively.
The samples were collected eight hours after chemical treatment and analyzed on the
AGRONOMICS1 microarray.
After toyocamycin treatment roughly 2,800 genes were misregulated compared to the
DMSO control. Around 2,000 genes were misregulated after double treatment together
with MeJA compared to MeJA treatment alone. This conﬁrmed a strong eﬀect of to-
yocamycin. The high numbers of misregulated genes demand careful selection criteria,
if one wants to generate candidate genes, that are involved in JA signaling/crosstalk.
After subjecting the misregulated genes to analysis of GO terms, I observed an en-
richment for genes, of which the encoded products are localized to the chloroplast.
MeJA-induced expression of the chloroplastic enzymes of JA biosynthesis, LOX2, AOS
and AOC2, was inhibited by toyocamycin. AOC1 and AOC4 are also localized to
the chloroplast and showed similar trends in gene expression. The isoforms LOX3,
LOX4 and AOC3 were upregulated by toyocamycin, which may be due to feed-back
regulations of low LOX2 or AOC2 expression. Thus, those two isoforms may in part
compensate for missing expression of the major isoforms. In contrast to the chloroplas-
tic isoforms of JA biosynthesis, the isoforms acting in the peroxisome were transcrip-
tionally regulated diﬀerently. Since these genes were not inhibited by toyocamycin,
this explains the low eﬀect of toyocamycin and also of the other derivatives on the
OPCL1p::GUS reporter (IC50 30 µM). That OPCL1p::GUS expression was inhibited
at these high concentrations may be explained by toxic eﬀects of the nucleoside deriva-
tives.
These observations lead to the question, whether or not toyocamycin modulates JA
levels. Expression of the chloroplast localized part of JA biosynthesis appears to be
impaired. In addition, expression of the JA sulfotransferase (ST2a) shows a similar
pattern as LOX2, AOS or AOC2, while the JA methyltransferase (JMT ) and the JA-
Ile hydroxylase (CYP94B3, see introduction Fig. 1.2) are strongly upregulated by the
double treatment of toyocamycin and MeJA compared to MeJA alone (see Fig. 4.2 A-
C). If this expression is reﬂected on protein level, this may indicate, that the bioactive
jasmonate may be converted to an inactive form, thereby inhibiting JA signaling.
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Nevertheless, this would not explain the induced JAZ expression after toyocamycin
treatment in the microarray. In this case, JAZ expression would be induced via another
mechanism than by bioactive jasmonate.
Expression of JAZ was shown to be linked to degradation of JAZ proteins (Thines
et al., 2007). A similar regulation exists for the Aux/IAA repressors in auxin signal-
ing (Kepinski and Leyser, 2005). JA dependent degradation of JAZ or auxin depen-
dent degradation of Aux/IAA proteins rapidly induces their own expression after hor-
mone stimulus. Whereas toyocamycin prevents the degradation of Aux/IAA proteins
(Hayashi et al., 2009), I showed that toyocamycin does not prevent the degradation
of JAZ1. Intriguingly, the expression of JAZ1, 5, 6, 9 and 10 was induced by to-
yocamycin, which could explain inhibition of JA signaling, if this higher expression
is translated into higher JAZ protein levels. However, the microarray was only per-
formed at a rather late time point, leaving the question unanswered, how JAZ and/or
Aux/IAA are regulated shortly after toyocamycin treatment. Two scenarios are con-
ceivable: (1) Toyocamycin rapidly induces JAZ expression, which in turn would lead
to higher protein levels or (2) toyocamycin induces JAZ expression only at later stages,
which ﬁts better with the observation, that protein levels at early time points do not
change (see JAZ1-GUS degradation in Fig. 3.5). This hypothesis can be veriﬁed by
monitoring protein levels in the JAZ1-GUS overproducing line at later time points and
by analyzing JAZ transcript levels at diﬀerent time points. These experiments could
show, if JAZ1 protein levels are elevated eight hours after toyocamycin treatment or if
JAZ are diﬀerently expressed at early and late time points.
After double treatment with MeJA and toyocamycin, expression of JAZ7 and JAZ8
were more induced than the other JAZ transcripts compared to MeJA treatment. JAZ7
and JAZ8 both lack two arginine residues, which are important for interaction with
COI1 (Chung et al., 2010; Pauwels et al., 2010; Pauwels and Goossens, 2011). Based on
the ﬁndings that the root phenotype was independent of COI1 and that no change in
the COI1-dependent degradation of JAZ1 could be observed, the upregulation of JAZ7
and JAZ8 may indicate their involvement in COI1 independent signaling. To prove
this hypothesis, experiments have been initiated that will analyze if JAZ expression is
inducible in Arabidopsis wild type and the coi1 mutant at diﬀerent time points.
The microarray data yielded more indications that toyocamycin is involved in hor-
monal crosstalk. Not only expression of the JA inactivating enzymes was upregulated,
also two genes belonging to the same family as JAR1, which are involved in auxin
metabolism exhibited an high expression after treatment of toyocamycin and MeJA
(see Fig. 4.2 A-E). IAA-LEUCINE RESISTANT-LIKE 5 (ILL5 ) and GH3.3 belong
to the group of IAA-amino acid conjugating or hydrolyzing enzymes (Davies et al.,
1999; Staswick et al., 2005). Intriguingly, ILL5 was shown to be upregulated during
systemic response to P. syringae in an Arabidopsis auxin transporter mutant (Truman
et al., 2010). This even opens the possibility, that toyocamycin also may be involved
in SA signaling. The transcription factor WRKY70 participates in a convergent node
of SA and JA signaling. Overexpression of WRKY70 activates SA-induced genes and
repression ofWRKY70 induces JA responsive genes (Li et al., 2004). In the microarray
data I observed a strong activation of WRKY70 expression after toyocamycin treat-
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Figure 4.2: Microarray expression of selected genes. 14-day-old Arabidopsis seedlings (Col-
0) were pretreated with DMSO or toyocamycin (10 µM) and JA-specific expression was induced by
application of MeJA (100 µM). Plants were harvested eight hours after MeJA stimulus. Expression of
three independent replicates was analyzed on an AGRONOMICS1 microarray (Rehrauer et al., 2010).
Absolute expression values are shown as average ± standard deviation. A: Expression of the JA
methyltransferase (JMT ) is induced by double treatment of toyocamycin and MeJA. B: Expression
of a sulfotransferase (ST2a) is induced by MeJA, which partially is inhibited by toyocamycin. C:
Expression of JA-Ile hydroxylase (CYP94B3 ) is induced by MeJA, but even stronger induced in
combination with toyocamycin. D: IAA-LEUCINE RESISTANT-LIKE GENE 5 (ILL5 ) is strongly
induced by double treatment of toyocamycin and MeJA. E: GH3.3 is slightly induced by toyocamycin,
but even more by the double treatment with MeJA and toyocamycin. F: WRKY70 is strongly induced
by toyocamycin. MeJA prevents this induction.
ment, which is negatively regulated by addition of MeJA (see Fig. 4.2 F). This (and
also some generated candidate genes, see below) emphasizes that toyocamycin may be
involved in modulating the crosstalk between diﬀerent hormone signaling pathways.
For truly understanding the mode of action of toyocamycin in JA signaling, it is
crucial to either identify a direct protein target or to establish genetic evidence. For the
latter I analyzed the microarray data and generated candidate genes, of which available
mutants will be tested for their response to toyocamycin. Candidates were selected for
genes, that are induced after toyocamycin treatment but not induced after double
treatment of toyocamycin and MeJA. They are also not signiﬁcantly misregulated by
MeJA. These candidates would represent genes, that are negatively regulated by MeJA,
which only can be observed due to the inducing eﬀect of toyocamycin (see supplemental
Fig. S.7 and Table S.2).
Finally, mutants of these respective genes will be obtained and tested for their re-
sponsiveness to toyocamycin but it is worth noting that among these candidates some
genes are, that are already known to be involved in plant defense. These genes include
e.g. AIG1, NIMIN-2, SARD1 or several genes from the WRKY transcription factor
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family (Reuber and Ausubel, 1996; Glocova et al., 2005; Weigel et al., 2005; Wang
et al., 2008; Zhang et al., 2010; Wang et al., 2011). Also unknown genes with proposed
function in plant defense are in this candidate set (AT3G04210 and AT5G48567). If
any of these candidate genes is important in toyocamycin mediated crosstalk remains
to be shown.
4.6 Concluding remarks
I wanted to identify unknown components of the JA signaling pathway, which I tried to
achieve by using a chemical biology approach. Thus, I designed a bidirectional chemical
screen for compounds that are able to modulate JA signaling in Arabidopsis. In this
reporter based screen I identiﬁed several compounds, of which I analyzed three in more
detail. Compound 766 was found by screening a natural compound library of about
1,700 chemicals for activators of LOX2p::LUC reporter expression. This compound
appeared to activate the LUC reporter, but secondary and counter assays indicated
that it may bind directly to or inﬂuence LUC enzyme, thereby presumably stabilizing
the protein. By application of derivatives of this compound to LOX2p::LUC seedlings,
I was able to establish SAR, which indicated that the substituents at C-1 and C-2 are
important for activity. Based on these ﬁndings, 766 could be used as lead structure for
development of new LUC ligands. Such ligands could be either new substrates for the
enzyme itself or could be used as enzyme stabilizing compounds, that increase enzyme
levels in reporter lines with weak promoter activity, by preventing protein degradation.
Screening the natural compound library for inhibitors of MeJA-induced LOX2p::LUC
expression, I identiﬁed 16 compounds that inhibited reporter expression. After vali-
dation in secondary and counter assays, compound 12 was shown to aﬀected only
JA-dependent responses, whereas it did not have any eﬀect on JA-independent read-
outs. Compound 12 not only inhibited downstream markers of JA signaling, it also
prevented degradation of JAZ1 protein. Thus, its mode of action can be integrated
upstream of JAZ into the JA signaling pathway. Establishing SAR showed that a
molecular core of aminocytisine and the substituent biphenylcarboxylic acid both are
important for the bioactivity of 12. A derivatized probe containing a photoreactive
group and an alkyne for ‘click chemistry’ retained bioactivity and was used in prelim-
inary aﬃnity-based target identiﬁcation experiments. These experiments showed that
this probe labels proteins, which could be competed out by 12. The identiﬁcation
of direct protein targets is not completed, but experiments to continue this eﬀort are
underway.
The screen using a small, targeted library of known protein kinase inhibitors iden-
tiﬁed three inhibitors of MeJA-induced LOX2p::LUC expression (staurosporine, 5-
iodotubercidin and tyrphostin AG-879). This indicates the involvement of protein
kinases in the JA signaling pathway. However, I cannot rule out the possibility, that
these inhibitors may target a non-kinase protein, which might be the reason for their
eﬀect on JA signaling. A derivative of 5-iodotubercidin, toyocamycin, was already
described to speciﬁcally inhibit auxin signaling, which is mechanistically similar to JA
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signaling (Hayashi et al., 2009). After testing four derivatives of 5-iodotubercidin for
their eﬀect on JA-speciﬁc reporter expression and JA-independent readouts, toyocamy-
cin appeared to aﬀect JA-signaling most selectively. Based on this ﬁnding and based
on the described eﬀect of toyocamycin on auxin signaling, I focused on the analysis
of this compound. Toyocamycin inhibits not only JA signaling. Microarray data and
published results (Hayashi et al., 2009) showed that it may also aﬀect auxin or SA
signaling. How this compound exerts its function remains unknown, but I showed that
it acts upstream of JAZ expression. Whether modulated JAZ expression is dependent
on COI1 will be shown by expression analysis in the coi1 mutant, but the distinct
expression of JAZ7 and JAZ8 indicate the possibility of a COI1-independent mecha-
nism, since their gene product lacks the functional Jas domain for COI1-interaction.
The fact that JAZ1 degradation was not prevented by toyocamycin indicates that the
compound may act somewhere within the hormonal signaling network, rather than
speciﬁcally modulating COI1-dependent JA signaling or that it has multiple targets.
Additional indications that toyocamycin exerts its function in COI1 independent man-
ner were provided by the fact that the pronounced root growth phenotype caused by
toyocamycin was independent of COI1. Surprisingly, this was dependent on JAR1
and AOS, while the inhibition of LOX2 by toyocamycin was independent of JAR1,
which also suggests the possibility of multiple targets. Identiﬁcation of the direct tar-
get(s) in similar approaches as the protein labeling with 12/65 will be crucial for the
understanding of the mode of action. In addition, genetic evidences by analysis of
Arabidopsis mutants or by genetic screening using the distinct root phenotype may
contribute to understanding the eﬀect of toyocamycin.
The identiﬁcation of compound 12 and toyocamycin as modulators of the JA signal-
ing pathway is only the ﬁrst step to discover new components of the hormone signaling
network. While identiﬁcation of a direct protein target of 12 may already yield a new
component that exerts its function upstream of JAZ, the analysis of the eﬀect of to-
yocamycin may enhance our understanding of how protein kinases are involved in JA
signaling or how JA signaling is integrated into the hormone signaling network.
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5 Materials & methods
5.1 Materials
5.1.1 Plant materials
Arabidopsis ecotype, mutant lines and transgenic lines used in this study are listed in
Table 5.1, 5.2 and 5.3
Table 5.1: Wild type Arabidopsis lines used in this study
Accession Abbreviation Original Source
Columbia Col-0 J. Dangl a
Columbia (gl1-1) Col-5 Nottingham Arabidopsis Stock Centre b
Columbia (gl1-1) Col-6 Nottingham Arabidopsis Stock Centre b
a
University of North Carolina, Chapel Hill, NC, USA
b
Nottingham, UK
Table 5.2: Mutant Arabidopsis lines used in this study
Mutant allele Accession Reference/Source
coi1-16 Col-5 Ellis and Turner (2002)
jar1-1 Col-0 Staswick et al. (1992)
jin1-1 Col-0 Berger et al. (2002)
aos Col-6 Park et al. (2002)
5.1.2 Chemicals
Laboratory grade chemicals and reagents were purchased from Sigma-Aldrich (Deisen-
hofen, Germany), Roth (Karlsruhe, Germany), Merck (Darmstadt, Germany), Invi-
trogen
TM
(Karlsruhe, Germany), Bio-Rad (Hercules, USA), SYNCHEM OHG (Fels-
berg/Altenburg, Germany).
The following chemical libraries were used:
- Natural compound library (1,728 compounds, 10 mM) (AnalytiCon Discovery
GmbH, Potsdam, Germany)
- Kinase inhibitor library (84 compounds, 2 mM) (Biomol GmbH, Hamburg, Ger-
many)
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Table 5.3: Transgenic Arabidopsis lines used in this study
Line Accession Construct Reference/Source
LOX2:GUS/LUC Col-0 LOX2p::GUS/LUC Jensen et al. (2002)
VSP1:GUS Col-5 VSPp::GUS Ellis and Turner (2001)
VSP1:LUC Col-5 VSPp::LUC Ellis and Turner (2001)
OPCL1:GUS Col-0 OPCL1p::GUS Kienow et al. (2008)
35Sp:GUS Col-0 CaMV35Sp::GUS Imre Somssicha
35Sp:LUC Ler CaMV35Sp::LUC Ferenc Nagyb
JAZ1-GUS Col-0 CaMV35Sp::JAZ1-GUS Thines et al. (2007)
WRKY29:GUS Col-0 WRKY29p::GUS Imre Somssicha
a
Max-Planck-Institute for Plant Breeding Research, Cologne, Germany
b
Institute of Plant Biology, Szeged, Hungary
5.1.3 Media
Media were sterilized by autoclaving for 20 min at 121◦C. Before addition of heat labile
compounds the media or solutions were cooled to approx. 60◦C.
Cell culture medium: 1× Murashige and Skoog Basal Salt Mixture (Sigma-Aldrich)
3% (w/v) Sucrose
1% (v/v) 2,4-Dichlorophenoxyacetic acid solution
(stock solution 0.1h (w/v)
2% (v/v) Vitamins solution (1% myo-Inositol,
0.05h nicotinic acid, 0.05h pyridoxin HCl,
0.05h thiamin HCl)
pH 5.7
MS medium: 1/2× Murashige and Skoog Basal Salt Mixture (Sigma-Aldrich)
0.5% (w/v) Sucrose
4 g/L Phytagel (Sigma-Aldrich) for solid medium
pH 5.8
5.1.4 Buffers and solutions
Buﬀers were sterilized by autoclaving for 20 min at 121◦C if needed sterile. Before addi-
tion of heat labile compounds, the media were cooled to approx. 60◦C. Stock solutions
of compounds for plant treatment were dissolved in DMSO at 10 mM concentration,
if not stated otherwise.
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5.2 Methods
5.2.1 Maintenance and cultivation of Arabidopsis plants
Arabidopsis seeds were germinated by directly sowing them on moist compost (Stender
AG, Schermbeck, Germany) or jiﬀy-9 pots (Jiﬀy International AS, Ryomgaard, Den-
mark) supplemented with Wuxal fertilizer (Nitzsch; Kreuztal, Germany). Pots were
transferred to a controlled environment growth chamber, covered with a propagator
lid (10 hour photoperiod, light intensity of approximately 200 µEinsteins/m/sec, 23◦C
day, 22◦C night and 65% humidity). Propagator lids were removed when seeds had
germinated. To allow early bolting and setting of seeds, 4 week old plants were trans-
ferred to long day conditions (16 hour photoperiod). Seeds were collected by enveloping
aerial tissue with a sealed paper bag until siliques were shattered.
5.2.2 Maintenance and cultivation of Arabidopsis cell culture
Arabidopsis cell cultures were maintained shaking (100 rpm) at 25◦C at dark con-
ditions. Inoculum of main cultures was transferred every 7 days to fresh cell culture
medium. Maintenance of Arabidopsis cell cultures was conducted by Lydia Bollenbach.
Experimental cell cultures were taken 5 days after inoculation.
5.2.3 Chemical treatment of Arabidopsis plants
Arabidopsis plants in liquid medium were treated with diﬀerent chemicals as indicated
in microwell plates. Double treatments were performed such as that the compound
of interest was incubated 1 h before stimulus with MeJA, COR or ﬂg22. In adeno-
sine/AMP/ADP/ATP competition assays a mixture of toyocamycin and the respective
competitor was added as ﬁrst treatment 1 h before MeJA stimulus. Adenosine, AMP,
ADP and ATP stock solutions were prepared in potassium phosphate buﬀer (5 mM,
pH 7.0).
Spray application of compounds was conducted in aequous solution supplemented
with 0.05% (v/v) Silwet L-77. Final DMSO concentration was 0.05% (v/v).
Treatment of Arabidopsis cell culture or protein extracts was performed for one
hour in 48-well microplates on ice. For UV-cross-linking, a maximum of 300 µL cul-
ture/extract was added per well. The culture/extract was irradiated from the top with
a hand-held UV lamp at 254 and 366 nm wavelength by placing the lamp directly on
the microplate during chemical treatment.
5.2.4 Biochemical methods
5.2.4.1 Isolation of total protein extract from Arabidopsis
Proteins from 2-4 Arabidopsis seedlings were extracted by grinding frozen material
and subsequent addition of 80 µL protein extraction buﬀer (50 mM Tris-HCl pH 7.5,
150 mM NaCl, 1 mM EDTA, 10mM NaF, 25 mM β-Glycerophosphate, 2 mM Na3VO4,
10% (v/v) Glycerol, 0.1% (v/v) Tween 20, 1 mM DTT (added fresh from 100 mM
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stock solution), 1 mM PMSF (added fresh from 200 mM stock solution in ethanol)).
The lysate was mixed thoroughly and chilled on ice. Cell debris was spun down by
centrifugation at 4◦C for 1 min at 15,000 g. The supernatant was transferred to a fresh
tube. Protein amounts were determined using the method of Bradford (1976) with the
Bio-Rad Protein Assay (Bio-Rad München, Germany) and BSA solutions between 0
and 1.6 mg/mL as internal standard.
Proteins where precipitated using the method of Wessel and Flügge (1984). Brieﬂy,
samples were set to a volume of 200 µL. 250 µL Chloroform:Methanol (1:4) was added,
mixed and spun down for 10 min at 4◦C and 15,000 g. The supernatant was discarded
and the bottom phase was mixed with 200 µL methanol. After a second centrifugation
step the pellet was dried for 30 min and then dissolved in Laemmli Sample Buﬀer
(Bio-Rad, München, Germany) (Laemmli, 1970).
Proteins from Arabidopsis cell culture were extracted in 1× PBS (1.6 mM KH2PO4,
1552 mM NaCl, 30 mM Na2HPO4, pH 7.4) + 1% SDS. For chemical treatment of
protein extracts, the extraction was conducted without SDS. Cells were collected by
short centrifugation and lysated with sonication in PBS. Debris was collected by cen-
trifucation at 4◦C for 15 min at 15,000 g and the supernatant was transferred to fresh
tubes.
5.2.4.2 Denaturing SDS-polyacrylamide gel electrophoresis (SDS-PAGE)
Protein samples boiled for 5 min in Laemmli Sample Buﬀer (Bio-Rad, München, Ger-
many) were subjected to SDS-PAGE on a gel containing 12% polyacrylamide. SDS-
PAGE gels containing ﬂuorescent probe-labeled proteins were washed 3 times with
ddH2O and labeled proteins were visualized by in-gel ﬂuorescence scanning using a
FLA-7000 scanner (Fujiﬁlm, Düsseldorf, Germany) with excitation and emission at 532
and 580 nm, respectively. The whole amount of proteins was visualized by coomassie
blue R250 (Thermo Scientiﬁc, Rockford, USA). Note that samples after ‘click chem-
istry’ contained Cu(I) and β-mercaptoethanol and were not boiled before SDS-PAGE
to avoid chemical protein degradation.
5.2.4.3 Immunublot analysis
On a SDS-PAGE separated proteins were electroblotted onto a Hybond ECL nitrocel-
lulose membrane (Amersham, GE Healthcare) in Towbin buﬀer (25 mM Tris, 195 mM
Glycin, 20% (v/v) methanol). To monitor protein transfer and loading, the membrane
was stained with 0.1% Ponceau S (Sigma-Aldrich) in 5% (v/v) acetic acid, followed
by extensive washes in water. The membrane was blocked for at least 2 hours with
milk powder in TBST (10 mM Tris, 1.5 mM NaCl, pH 7.5, 0.05% (v/v) Tween20). A
commercial antibody (α-Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204), Cell Sig-
naling Technology / New England Biolabs GmbH, Frankfurt am Main, Germany) has
been used already for detection of Arabidopsis MPK3, MPK4 and MPK6 (Ranf et al.,
2011). This antibody was diluted 1:1000 in TBST and hybridized with the membrane
over night at 4◦C. After washing the membrane 3 times in TBST, the second anti-
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body (α-rabbit-HRP, Amersham, GE Healthcare) was hybridized (1:5000 in TBST)
with the membrane. After 1 hour incubation with 3 subsequent washing steps, the
secondary antibody was detected using the Pierce ECL Western Blotting Substrate
(Thermo Scientiﬁc, Rockford, USA) and Kodak biomax light autoradiographic ﬁlm
(Sigma-Aldrich).
5.2.5 Molecular biological methods
5.2.5.1 Isolation of total RNA from Arabidopsis
Total RNA was extracted from 2 week old plant material. Liquid nitrogen frozen
samples (approximately 20 mg) were homogenized using an overhead stirrer (RW-20,
IKA R©Werke GmbH & Co. KG, Staufen, Germany) in 1.5 mL centrifuge tubes. Fur-
ther processing was performed using the RNeasy R©Plant Mini Kit (QIAGEN, Hilden,
Germany) following the manufacturer’s instructions.
To yield micro RNAs ≥ 21 nt the protocol was adapted following the manufacturer’s
instructions. Brieﬂy the tissue was lysed in the provided buﬀer and puriﬁed in the
QIAshredder spin column. The lysate was mixed with 0.75 volumes of ethanol and
bound to the RNeasy spin column. Two times washing was performed with a following
washing step of 80% ethanol. The RNA was eluted with RNase-free water.
5.2.5.2 cDNA synthesis
Synthesis of cDNA was performed using SuperScript
TM
II Reverse Transcriptase (RT)
(Invitrogen) following the suppliers instructions. Brieﬂy, 1 µL Oligo(dT) primers,
500 ng RNA and 1 µL dNTP Mix was incubated for 5 min at 65◦C. 1× Reaction
buﬀer and 10 µM DTT were added. Shortly samples were incubated at 42◦C before
addition of the RT. The synthesis was performed over 60 min with heat inactivation
of the enzyme for 15 min at 70◦C.
5.2.5.3 Reverse-Transcriptase PCR
Reverse-Transcriptase PCR (RT-PCR) was performed using the Superscript R©One-Step
RT-PCR system (Invitrogen, Darmstadt, Germany) following the manufacturers in-
structions. 100 ng RNA template and 1 µL of each primer (10 µM) were used in a
50 µL reaction volume. The PCR program was repeated 30 times.
RT-PCR program:
Step Temperature Time Cycles
cDNA-Synthesis 50◦C 30min
Initial denaturing 94◦C 2min
Denaturing 94◦C 30sec .
.
}
30×Annealing 54◦C 45sec
Elongation 72◦C 90sec
Final elongation 72◦C 10min
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The following primers have been used:
- Actin: Actinfw 5’ CCTTGTACGCCAGTGGTCGTACAACCGGTATTG 3’
- Actin: Actinrw 5’ ATAGTGGTTCCACCACTGAGCACAATGTTACCG 3’
- LOX2: LOX2fw 5’ GTCGAGTCTCCAGACTTTGAACG 3’
- LOX2: LOX2rw 5’ ACTTGTCGGAGAAGAATATCCGC 3’
- LUC: LUCfw 5’ AGAGATACGCCCTGGTTCCT 3’
- LUC: LUCrw 5’ CGTATCCCTGGAAGATGGAA 3’
- VSP1/2: VSPfw 5’ AGCCGAACTCTTAGAGAAAGAGG 3’
- VSP1/2: VSPrw 5’ GCTTAAAAACCCTTCCAGGAGTA 3’
After RT-PCR, samples were subjected to agarose gel electrophoresis for visualiza-
tion of transcripts. Actin served as internal control for equal loading of RNA.
5.2.5.4 Quantitative real-time PCR (qRT-PCR)
Transcript analysis in time course experiments and before microarray hybridization
were performed by qRT-PCR. cDNA corresponding to 500 ng RNA from three biolog-
ical replicates was diluted 1:100 before continuing the protocol. SYBR green assays
were developed using iQ
TM
SYBR R©Green Supermix (Bio-Rad, Hercules, USA) with
gene-speciﬁc primers and an adapted protocol. The reaction set up was adjusted to a
total volume of 25 µL with 12.5 µL iQ SYBR Green Supermix, 1 µL of each primer
(10 µM) and 10 µL diluted cDNA template. PCR was performed on a ‘iQ5 multicolor
real-time PCR detection system’ (Bio-Rad). Expressions were calculated using the
CT method (Schmittgen and Livak, 2008). To simplify data interpretation, expression
levels in DMSO treated control were ﬁxed to 1 and relative values were calculated.
The gene of an expressed protein (At4g26410) served as internal control. This was
previously proposed as reference gene (Czechowski et al., 2005) and RefGenes anal-
ysis (Hruz et al., 2011) revealed this gene to be the most stable expressed gene in
Arabidopsis seedlings.
qRT-PCR program:
Step Temperature Time Cycles
Initial denaturing 95◦C 2min
Denaturing 95◦C 20sec .
.
}
40×Annealing 55◦C 30sec
Elongation 72◦C 25sec
Denaturing 95◦C 1min
Melting curve 55-95◦C 1min temperature increase
0.5◦C each step
The following primers have been used:
- Expr-qRT-fw: 5’ GAGCTGAAGTGGCTTCCATGAC 3’
- Expr-qRT-rw: 5’ GGTCCGACATACCCATGATCC 3’
- LOX2-qRT-fw: 5’ TACTTTCCCAACCGACCAAC 3’
- LOX2-qRT-rw: 5’ CCTGTTTCTGCGATGGGTAT 3’
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5.2.5.5 Microarray hybridization
Arabidopsis seedlings were pretreated for one hour with DMSO, 12 (10 µM) or toyoca-
mycin (10 µM). One half of the samples was then treated with DMSO, the other half
was treated with MeJA (100 µM). RNA was extracted eight hours after treatment.
Analysis of RNA integrity was performed by Dr. Bruno Hüttel (Max Planck Genome
Centre Cologne).
RNA was hybridized with the AGRONOMICS1 microarray as described by Rehrauer
et al. (2010). Microarray hybridization was performed by Bruno Hüttel.
5.2.6 Reporter assays
5.2.6.1 Histochemical GUS staining
For histochemical staining, seedlings were placed in GUS substrate solution (50 mM
sodium phosphate buﬀer, pH 7.0, 0.1% (v/v) Triton X-100, 3 mM K3Fe(CN)6, 1 mM 5-
bromo-4-chloro-3-indolyl-β-D-glucuronide (X-Gluc)), vacuum inﬁltrated and incubated
over night at 37◦C. Stained samples were destained by a series of washes in 80% ethanol
(Jeﬀerson, 1987).
5.2.6.2 Quantitative GUS assay
For quantitative GUS analysis, two to four Arabidopsis seeds were germinated in each
well of a 48-well microplate and grown in MS medium. Chemical treatment was per-
formed at the indicated concentration and incubated for ﬁve to 24 hours as indicated.
Seedling extracts were prepared and ﬂuorimetric GUS activities relative to protein con-
centration were determined as described by Kienow et al. (2008). Brieﬂy, seedlings were
frozen in liquid nitrogen and homogenized in 100 µL Lysis-buﬀer (50 mM Na(PO4),
1 mM EDTA, 0.1% (v/v) Triton X-100, 10 mM β-mercaptoethanol (fresh), pH 7.0).
Debris was spun down at 15,000 g and the supernatant was transferred to a fresh tube.
To 50 µL sample were added 50 µL of MUG-substrate (2 mM 4-methylumbelliferyl-β-
D-glucoronid in lysis buﬀer). These samples were incubated at 37◦C and aliquots were
taken after 0, 30 and 60 minutes. The reaction was stopped by an excess of 0.2 M
Na(CO)3 and ﬂuorescence was measured in a ﬂuorimeter. The GUS activity was cal-
culated in relation to a internal standard and normalized to the protein concentration.
Latter was determined using the method of Bradford (1976) with the Bio-Rad Protein
Assay (Bio-Rad München, Germany) and BSA solutions between 0 and 1.6 mg/mL as
standard.
5.2.6.3 Monitoring JAZ1 degradation
Transgenic Arabidopsis expressing CaMV35Sp::JAZ1-GUS (Thines et al., 2007) were
cultivated in liquid MS medium for 7 days. Degradation of the JAZ-GUS construct
was monitored as in Thines et al. (2007). Brieﬂy, roots of transgenic 35:JAZ1-GUS
were pretreated for 1h as indicated. Degradation of the fusion protein was induced by
addition of 10µM MeJA for 30 min. Histochemical GUS staining using GUS substrate
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solution was performed over night at 37◦C. Results were observed under a optical
microscope.
5.2.6.4 Luciferase assay (in vivo)
Transgenic Arabidopsis plants harboring the LUC reporter were assayed in multiwell
plates (OptiPlate-96, Perkin Elmer, USA) containing 200 µLMS medium. The medium
was supplemented with 0.25 mM Luciferin (5 mM potassium phosphate, pH 7.8, 4 mM
D-luciferin free acid (SYNCHEM OHG, Germany), 0.01% (v/v) Triton X-100). Over
a time of up to 24 h each single well was repeatedly measured for 2 s either using a
TopCount NXT
TM
Microplate Scintillation and Luminescence Counter (Perkin Elmer,
USA) or a Luminometer (Centro LB 960, Berthold Technologies, Germany). Plates
for TopCount readouts were sealed with TopSeal R©-A Microplate Press-On Adhesive
Sealing Film (Perkin Elmer, USA). For allowing transpiration holes were pierced into
the Sealing Film. Values of the time span until the LUC activity decreased to a stable
value (usually 4-6h) were averaged and taken into analysis.
5.2.6.5 Luciferase assay (in vitro)
In vitro LUC assays were performed in black 96-well microplates using recombinant
luciferase (Roche). Chemicals (25 µM) were incubated with 0.1 µM ATP in 100 µL
cold Tris-HCl buﬀer (100 µM, pH 7.8). 100 µL of a cold mixture of luciferase (5 ng/mL)
and luciferin (50 µM) (Luciferase stock: 1 µM in 100 µM Tris-HCl, pH 7.8; Luciferin
stock: 4 mM D-luciferin free acid in 5 mM potassium phosphate, pH 7.8, 0.01% (v/v)
Triton X-100) were injected, and luminescence measurement was initiated after 1 s
delay. Luminescence was detected over 10 s with a luminometer (Centro LB960 XS3,
Berthold Technologies, Bad Wildbad, Germany). Data were collected from at least
ﬁve technical replicates.
5.2.7 Chemical screen
Chemical screens were performed using the transgenic Arabidopsis LOX2p::LUC re-
porter line. Arabidopsis seedlings were grown in hydroponic culture under sterile con-
ditions directly in 96-well microplates. Each well contained two seedlings in 200 µL MS
medium. 12-14 day old seedlings were pretreated with chemicals for 1 h in MS medium
(10 µM: Kinase inhibitory library; 25 µM: Natural compound library). 100µM MeJA
was added to induce reporter expression, DMSO served as negative control. 24 h after
chemical treatment the semiquantitative LUC assay was performed using a TopCount
NXT
TM
Microplate Scintillation and Luminescence Counter (Perkin Elmer, USA), as
described in section 5.2.6.4. A maximum of 288 chemicals was screened at the same
time.
Luminescence of the ﬁrst 4-6 hours was averaged and taken into analysis. One mi-
croplate with 24 uninduced and 24 induced replicates served as control. Values of each
microplate were compared to the control plate. For the activator screen only values
above the average of the negative control were considered as hit. The threshold for the
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inhibitor screen was set to the lower value of the control’s standard deviation. Only
samples with luminescence values below this threshold were considered as hit.
5.2.8 Root growth elongation assay
Root growth assays were performed on square petri dishes containing approximately
35 mL solid MS medium including the respective compounds for testing. Seeds were
sown in 2-3 rows of about 20-30 seeds and plates were kept at 4◦C for two days to
synchronize germination. Plates were transferred to growth cabinets and plants were
grown vertically for 7-10 days. Pictures were taken from the bottom using a conven-
tional image scanner at 600 dpi. Root length was measured using ImageJ software
(Abramoﬀ et al., 2004).
5.2.9 Monitoring the oxidative burst
Oxidative burst analysis in Arabidopsis leaf discs was performed following standard
procedures (Gomez-Gomez et al., 1999). The assay measures active oxygen species
released by leaf tissue by H2O2 dependent luminescence of luminol (Keppler et al.,
1989). Brieﬂy, Arabidopsis leaves were cut into leaf discs (diameter 6 mm) and incu-
bated over night ﬂoating on H2O. Leaf discs were transferred into 96-well microplates
containing 50 µL H2O and respective chemicals for testing. These were incubated for
one hour before triggering the reaction with ﬂg22. This was performed automatically
in a luminometer (Centro LB960, Berthold Technologies, Bad Wildbad, Germany) by
injecting 50 µL of a solution containing ﬂg22 (2 µM), luminol (400 µM) and horseradish
peroxidase (0.1 mg/mL, Sigma-Aldrich, P6782). Luminescence was measured every 2
minutes over a total period of 32 minutes. Each experiment contained 6 biological
replicates.
5.2.10 Probe synthesis and click reaction
Synthesis of molecular probes containing a photoreactive benzophenone and an alkyne
was performed by the group of Prof. Markus Kaiser (ZMB, Universiät Duisburg Es-
sen).
Copper-catalyzed 1,3-dipolar cycloaddition between molecular probes and an azide con-
taining ﬂuorophore (Alexa Fluor R©555, Invitrogen) was performed as described (Speers
et al., 2003; Kaschani et al., 2009). Brieﬂy, cleared protein extracts in 1 × PBS
(1.06 mM KH2PO4, 155.2 mM NaCl, 3 mM Na2HPO4, pH 7.4) were supplemented
with SDS to a ﬁnal concentration of 1% SDS. The reaction was performed in a total
volume of 50 µL. In 4 consecutive steps including mixing of the sample, 1 µL of the
following reagents was added: Alexa Fluor 555 (1mM in DMSO), TBTA (1.7 mM,
fresh in tert-butanol), CuSO4 (50 mM), TCEP (100 mM, fresh). Samples were shaked
for one hour at room temperature before addition of 1× Laemmli Sample Buﬀer (Bio-
Rad, München, Germany) (Laemmli, 1970). Note that protein samples were not boiled
before subjecting them to SDS-PAGE.
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5.2.11 Microarray data analysis
Microarray data processing was performed by Emiel Ver Loren van Themaat (MPI for
Plant Breeding Research, Cologne). Normalization and statistical analysis of the data
was performed as described by Irizarry et al. (2003); Smyth (2004).
Comparison of fold-change expression was performed between the following treatments:
- MeJA vs. DMSO
- 12 vs. DMSO
- Toyocamycin vs. DMSO
- 12 + MeJA vs. MeJA
- Toyocamycin + MeJA vs. MeJA
Two-fold misregulated expression was analyzed using GeneVenn (Pirooznia et al., 2007)
to see coregulated genes.
Gene Ontology analysis was performed using the online tool of The Arabidopsis Infor-
mation Resource (Berardini et al., 2004) and the AmiGO online tool (Ashburner et al.,
2000).
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Supplement
Figure S.1: Structure of in a secondary screen confirmed candidates. The picture depicts
structures of all candidates, whose activity on LOX2p::LUC could be confirmed. Known compounds
are: cycloheximide, 8; diacetoxyscirpenol, 15; neosolaniol, 16; piericidin, 17.
Figure S.2 (following page): Anthraquinone derivatives of 766. The structures of deriva-
tives of 766 are shown (compare table 2.1). 18: Anthraquinone-2-carboxylic acid, 19: 2-
Ethylanthraquinone, 20: 1,4-Dihydroxyanthraquinone, 21: Anthraquinone, 22: 1,3,4-Trihydroxy-
6-methylanthraquinone, 23: 1-Amionanthraquinone, 24: 1,2-Diaminoanthraquinone, 25: 1,8-
Diaminoanthraquinone, 26: 1-Methylamino-anthraquinone, 27: Anthraquinone-2-sulfonic acid,
28: 2-Aminoanthraquinone, 29: 2-Hydroxymethylanthraquinone, 30: 1,4-Diaminoanthraquinone,
31: 1,8-Dinitroanthraquinone, 32: 1,5-Dinitroanthraquinone, 33: 1,5-Diaminoanthraquinone, 34:
2-Chloromethylanthraquinone, 35: 1-Chloroanthraquinone, 36: 1,5-Dichloroanthraquinone, 37:
2-Chloroanthraquinone, 38: 3,6-Diaminoanthraquinone, 39: 1-Amino-4-bromoanthraquinone-2-
carboxylic acid, 40: 1-Aminomethylanthraquinone-2-carboxylic acid, 41: 1-Nitroanthraquinone-
2-carboxylic acid, 42: 1-Amonoanthraquinone-2-methyl ester, 43: Anthraquinone-14-carboxylic
acid, 44: 1-Aminoethylanthraquinone-2-carboxylic acid, 45: 1-Aminophenylanthraquinone-2-
carboxylic acid, 46: 1-Aminoanthraquinone-2-carboxylic acid, 47: 1-(Aminopropyl-3-methyl ester)-
anthraquinone-2-carboxylic acid, 48: 1-(Aminopropyl-3-hydroxy)-anthraquinone-2-carboxylic acid.
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Figure S.3: Structural derivatives of compound 12. The structures of all tested derivatives of
compound 12 are shown. Only 12, 49 and 52 exhibited bioactivity. The modified version 65 contains
a benzophenone photoaffinity group and an alkyne group for click chemistry. Compound 66 exhibits
also a benzophenone and an alkyne but not the part of 12, which was shown to be active.
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Figure S.4: Structure of nucleoside analogs and modified derivatives. The structures of
the four nucleoside analogs toyocamycin, tubercidin, 5-iodotubercidin and sangivamycin are depicted.
Targeted modification of toyocamycin yielded the inactive toyocamycin-BOC and the highly bioactive
toyocamycin-sulfamate (H3SNO3). Toyocamycin-click was active as toyocamycin-sulfamate, contains
and alkyne and may be used in target identification experiments using affinity based labeling methods
in combination with click chemistry.
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Figure S.5: Variation of LUC activities in the screen for inhibitors of the natural com-
pound library. 12-day-old Arabidopsis seedlings harboring the LOX2p::LUC reporter gene were
pretreated for one hour with 1,728 different compounds (each at 25 µM) before addition of MeJA
(100 µM). The overall screen was performed in 13 separate steps with each containing one separate
control plate. The plot presents average LUC activities after application of each compound (n = 2).
The blue line depicts the average of each screening plate. The red line depicts the average of the
respective control plate.
Figure S.6: Microarray expression levels of JAZ, Aux/IAA and DELLA. 14-day-old Ara-
bidopsis seedlings (Col-0) were pretreated with DMSO and JA-specific expression was induced by
application of MeJA (100 µM). Plants were harvested eight hours after MeJA stimulus. Expression of
three independent replicates was analyzed on an AGRONOMICS1 microarray (Rehrauer et al., 2010).
Expression was normalized to the DMSO control and is shown as average ± standard deviation. Only
JAZ are upregulated by MeJA with the exception of JAZ4, JAZ11 and JAZ12.
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Table S.1: Arabidopsis mutants for root growth assays. The table depicts Arabidopsis mutants,
that will be considered for testing their response to toyocamycin and possibly 12. They are selected
based on their known root growth response to hormonal or pathogen stress. This table is not exhaustive
and more mutants may be considered.
Arabidopsis Mutant Reference/Source
aos (Park et al., 2002)
dde2 (von Malek et al., 2002)
opr3 (Stintzi and Browse, 2000)
dde1 (Ishiguro et al., 2001)
jar1-1 (Staswick et al., 1992)
coi1-1 (Feys et al., 1994)
coi1-16 (+pen2) (Ellis and Turner, 2002; Westphal et al., 2008)
pen2 (Lipka et al., 2005)
jin1-1 (Berger et al., 2002)
myc3 (Fernández-Calvo et al., 2011)
myc4 (Fernández-Calvo et al., 2011)
myc2 myc3 myc4 (Fernández-Calvo et al., 2011)
axr1-3 (Hobbie and Estelle, 1995)
tir1-1 (Ruegger et al., 1998)
tir1-1 afb2-3 (Dharmasiri et al., 2005)
tir1-1 afb1-3 afb2-3 (Dharmasiri et al., 2005)
tir1-1 afb2-3 afb3-4 (Dharmasiri et al., 2005)
ein2-1 (Guzmán and Ecker, 1990)
etr1-3 (Guzmán and Ecker, 1990)
aux1-1 (Pickett et al., 1990)
eir1 (Luschnig et al., 1998)
aib1 (Koornneef et al., 1984)
bak1-5 (Schwessinger et al., 2011)
Figure S.7 (following page): Microarray expression of selected genes. 14-day-old Arabidopsis
seedlings (Col-0) were pretreated with DMSO or toyocamycin (10 µM) and JA-specific expression was
induced by application of MeJA (100 µM). Plants were harvested eight hours after MeJA stimulus.
Expression of three independent replicates was analyzed on an AGRONOMICS1 microarray (Rehrauer
et al., 2010). Expression is shown relative to expression after DMSO control treatment. Genes were
selected after following criteria: ≥ 2-fold induction after toyocamycin treatment; < 2-fold misregulation
after MeJA treatment, > 2-fold difference between double treatment toyocamycin + MeJA and single
treatment with MeJA alone; ratio toyocamycin treatment / double treatment with toyocamycin +
MeJA is < 0.7 or > 1.5. Table S.2 shows the same candidates and includes the average expression
values.
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Table S.2: Microarray expression of selected genes. 14-day-old Arabidopsis seedlings (Col-
0) were pretreated with DMSO or toyocamycin (10 µM) and JA-specific expression was induced by
application of MeJA (100 µM). Plants were harvested eight hours after MeJA stimulus. Expression of
three independent replicates was analyzed on an AGRONOMICS1 microarray (Rehrauer et al., 2010).
Genes were selected after following criteria: ≥ 2-fold induction after toyocamycin treatment; < 2-fold
misregulation after MeJA treatment, > 2-fold difference between double treatment toyocamycin +
MeJA and single treatment with MeJA alone; ratio toyocamycin treatment / double treatment with
toyocamycin + MeJA is < 0.7 or > 1.5.
microarray expression values ± standard deviation
Gene number Gene symbol DMSO MeJA Toyocamycin Toyocamycin
+ MeJA
AT2G40880 CYSTATIN A (CYSA) 299.32±73.15 376.32±28.79 993.43±51.75 484.95±44.91
AT5G37770 TOUCH 2 (TCH2) 367.94±31.88 238.36±61.16 765.84±85.03 291.19±67.98
AT2G22470 ARABINOGALACTAN PROTEIN
2 (AGP2)
199.66±4.93 228.11±6.67 544.21±94.45 357.48±115.88
AT4G25900 172.21±15.72 236.81±24.94 455.13±47.4 283.59±32.63
AT1G52200 150.67±7.12 166.79±22.46 416.25±17.81 199.6±13.52
AT1G75860 152.89±24.32 131.3±21.05 414.85±28.03 176.87±36.71
AT4G04620 AUTOPHAGY 8B (ATG8B) 171.12±30.09 202.43±17.47 407.2±63.86 263.08±22.81
AT3G47480 79.14±4.13 61.46±14.43 370.68±60.02 93.86±12.32
AT4G03292 73.74±10.53 81.03±26.52 347.28±36.91 121.06±37.51
AT2G07811 151.3±64.85 215.87±68.31 345.94±112.88 221.18±62.5
AT1G21120 INDOLE GLUCOSINOLATE
O-METHYLTRANSFERASE 2
(IGMT2)
46.84±2.93 42.4±7.48 331.04±55.16 72.32±9.02
AT3G12700 155.39±24.46 84.62±18.13 321.13±89.59 142.9±19.16
AT2G41180 84.04±4.37 93.31±23.8 299.02±15.3 89.2±3.36
AT3G52710 83.09±3.81 90.76±11.3 287.58±25.9 84.01±18.69
AT5G20400 119.98±17.61 121.12±18.25 266.73±24.52 155.71±18.49
AT1G33960 AVRRPT2-INDUCED GENE 1
(AIG1)
81.08±29.73 86.75±11.19 253.39±56.33 123.35±40.42
AT3G25882 NIM1-INTERACTING 2 (NIMIN-
2)
78.28±7.68 67.74±23 242±23.9 65.58±18.36
AT5G66675 103.5±7.15 113±3.74 238.1±21.98 123.49±8.99
AT3G17790 PURPLE ACID PHOSPHATASE
17 (PAP17)
43.21±8.09 74.85±17.87 209.54±24.89 94.83±38.32
AT3G54420 HOMOLOG OF CARROT EP3-3
CHITINASE (EP3)
97.85±31.29 70.35±17.63 204.02±27.67 87.77±30.21
AT5G09530 PRO-GLU-LEU|ILE|VAL-PRO-
LYS 1 (PELPK1)
105.59±58.94 67.87±28.19 199.79±53.84 114.58±22.44
AT1G52340 ABA DEFICIENT 2 (ABA2) 81.53±9.2 82.11±9.61 188.88±13.24 107.17±25.79
AT1G21130 INDOLE GLUCOSINOLATE
O-METHYLTRANSFERASE 4
(IGMT4)
80.42±21.03 49.45±16.66 185.2±30.02 69.56±20.68
AT2G36485 66.07±3.81 75.05±1.12 176.62±11.93 90.28±27.09
AT2G27080 82.71±27.28 58.05±7.64 173.3±25.73 91.24±29.89
AT5G61010 EXOCYST SUBUNIT EXO70
FAMILY PROTEIN E2
(EXO70E2)
31.78±6.16 42.45±12.44 167.73±0.71 54.48±2.64
AT3G52790 74.9±10.49 79.12±3.96 161.13±31.87 82.32±27.02
AT4G37295 35.2±1.38 51.28±25.83 160.46±47.36 88.02±55.09
AT4G22320 79.81±6.31 75.92±10.96 160.27±9.77 94.17±22.65
AT1G51920 21.64±1.55 18.41±3.3 150.3±52.31 33.14±13.71
AT5G20790 27.37±3.32 21.88±6.97 149.34±69.74 38.05±19.42
AT1G32700 64.84±9.73 72.12±12.66 145.4±16.88 93.11±13.94
AT3G01430 66.02±1.57 61.94±4.58 144.72±15.82 73.47±16.32
AT5G36925 32.81±6.97 69.33±29.96 140.86±33.6 92.34±19.6
AT2G38940 PHOSPHATE TRANSPORTER
1;4 (PHT1;4)
62.82±11.1 76.2±12.64 138.15±22.96 71.47±28.58
AT4G12990 64.49±10.11 79.05±11.26 135.54±34.5 64.51±11.53
AT3G50060 MYB DOMAIN PROTEIN 77
(MYB77)
59.66±9.53 64.12±17.02 132.33±48.61 86.42±10.24
AT1G24147 49.31±4.75 49.76±7.25 132.22±54.33 71.32±26.65
AT1G07240 UDP-GLUCOSYL TRANS-
FERASE 71C5 (UGT71C5)
59.23±3.31 72.18±5.49 131.14±31.99 86.84±6.19
AT4G04960 40.38±3.07 33.01±1.27 128.54±14.64 39.71±4.93
AT1G77570 48.67±13.02 52.34±11.07 126.5±9.16 76.08±39.55
AT4G03540 63.51±16.41 51±4.48 124.84±9.45 57.06±6.43
AT2G17740 29.97±4.34 25.9±7.78 123.22±12.29 30.1±12.07
AT5G62570 48.67±4.44 49.42±5.63 123.05±22.89 59.17±5.89
AT1G49150 22.76±4.26 32.72±11.5 120.76±30.39 47.77±12.41
AT1G73805 SAR DEFICIENT 1 (SARD1) 47.46±5.38 37.13±10.9 120.29±24.31 28.57±5.47
AT1G68850 28.38±9.25 26.7±8.75 118.81±32.06 44.14±16.61
AT2G39400 58.82±8.73 53.62±12.91 118.47±12.44 69.31±19.87
AT4G27260 (WES1) 50.78±1.22 28.88±2 117±17.08 46.02±3.33
AT3G10420 SEEDLING PLASTID DEVELOP-
MENT 1 (SPD1)
51.84±4.43 56.37±10.44 116.29±10.74 66.59±10.82
AT4G08330 56.36±3.17 57.34±6 115.64±14.12 62.88±15.12
Continued on next page
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Table S.2 – continued from previous page
microarray expression values ± standard deviation
Gene number Gene symbol DMSO MeJA Toyocamycin Toyocamycin
+ MeJA
AT1G69840 38.81±3.77 43.35±4.53 110.69±15.04 55.12±10.91
AT1G13810 51.36±1.83 51±7.85 109.53±9.36 70.76±12.06
AT1G21550 32.36±6.48 42.36±15.76 108.63±9.78 54.41±4.18
AT2G21320 52.69±5.54 59.68±13.93 108.56±20.4 57.03±11.97
AT4G18430 RAB GTPASE HOMOLOG A1E
(RABA1e)
33.38±3.55 26.78±4.26 108.49±7.29 41.08±7.51
AT2G15220 33.79±3.56 37.08±8.45 105.44±13.98 54.5±22.04
AT1G65481 25.21±6.32 16.97±6.34 98.93±18.51 14.31±3.76
AT1G74250 45.94±0.97 53.38±11.86 98.83±12.87 62.86±7.63
AT5G48175 37.13±6.6 35.58±3.27 95.56±30.8 51.73±11.26
AT4G20000 18.94±1.45 14.97±4.16 89.91±21.21 21.39±2.89
AT1G74590 GLUTATHIONE S-
TRANSFERASE TAU 10
(GSTU10)
15.36±4.36 15.72±2.33 87.9±23.51 27.22±10.81
AT2G40750 WRKY DNA-BINDING PROTEIN
54 (WRKY54)
23.29±2.24 15.53±1.11 85.55±23.11 16.54±3.39
AT5G65790 MYB DOMAIN PROTEIN 68
(MYB68)
21.94±2.9 30.73±5.78 76.39±14.9 42.94±5.4
AT3G27010 TEOSINTE BRANCHED 1, CY-
CLOIDEA, PCF (TCP)-DOMAIN
FAMILY PROTEIN 20 (TCP20)
32.09±2.29 32.53±2.92 68.42±5.2 33.17±9.75
AT4G11521 29.94±3.23 47.62±24.9 68.04±6.23 35.94±4.18
AT3G59700 LECTIN-RECEPTOR KINASE
(HLECRK)
19.1±4.14 22.23±3.51 67.64±5.32 24.13±4.2
AT5G35110 25.24±2.58 25.2±1.74 63.16±13.01 30.96±2.05
AT3G04210 29.88±5.8 29.04±13.13 62.83±4.29 36.47±3.69
AT2G30670 25.42±5.16 32.06±4.1 59.59±26.67 22.92±0.95
AT4G18205 28.91±4.12 26.06±8.81 58.03±4.95 20.99±4.82
ATMG01275 NADH DEHYDROGENASE 1A
(NAD1A)
22.36±4.44 37.12±13.96 57.39±16.35 36.9±4.37
AT4G18250 22.02±1.05 20.33±4.44 54.31±4.24 24.06±1.55
AT2G35658 22.65±2.27 24.92±1.78 54.02±1.43 33.26±7.29
AT1G56320 24.28±4.08 26.66±9.77 53.89±12.99 29.43±5.04
AT1G34180 NAC DOMAIN CONTAINING
PROTEIN 16 (NAC016)
22.73±2.73 23.96±1.64 53.38±8.83 27.66±3.85
AT1G09932 15.9±2.74 17.18±1.44 52.59±6.17 23.87±2.91
AT1G44150 20.57±8.39 23.42±5.4 51.27±15.92 30.69±13.57
AT5G22570 WRKY DNA-BINDING PROTEIN
38 (WRKY38)
9.4±0.19 10.58±1.29 51.2±26.67 25.12±20.07
AT2G26290 ROOT-SPECIFIC KINASE 1
(ARSK1)
18.29±2.57 18.15±3.24 50.81±8.34 23.75±2.18
AT2G32240 20.14±0.27 21.75±3.05 50.78±6.6 26.24±2.49
AT3G11430 GLYCEROL-3-PHOSPHATE
ACYLTRANSFERASE 5 (GPAT5)
24.45±6.4 22.38±5.24 50.28±17.06 27.32±7.32
AT1G49000 19.83±2.66 14.25±1.09 49.87±15.73 14.02±3.11
AT2G43720 20.29±4.16 23.3±2.77 49.41±13.38 20.84±5.48
AT3G21781 9.72±2.18 9.25±1.24 48.25±1.17 14.3±6.62
AT3G21295 23.33±2.25 23.05±2.3 48.1±8.41 28.48±3.64
AT3G26800 16.97±2.15 23.04±10.59 48.01±19.71 25.55±8.08
AT4G29110 21.74±2.94 23.44±1.02 45.21±8.28 29.2±6.63
AT5G49300 GATA TRANSCRIPTION FAC-
TOR 16 (GATA16)
15.6±1.56 15.67±4.95 43.5±6.46 19.59±3.94
AT1G02470 11.37±1.95 17.89±6.89 42.68±10.99 26±2.66
AT3G48640 9.22±1.87 8.42±1.43 41.98±23.74 9.12±0.77
AT4G08040 1-AMINOCYCLOPROPANE-1-
CARBOXYLATE SYNTHASE 11
(ACS11)
17.87±3.05 11.91±3.05 40.98±8.45 12.7±0.7
AT5G57035 18.61±0.73 22.61±0.88 40.28±4.29 24.96±4.01
AT2G31865 POLY(ADP-RIBOSE) GLYCOHY-
DROLASE 2 (PARG2)
16.64±3.76 12.79±0.7 37.31±10.34 17.56±0.68
AT3G01650 RING DOMAIN LIGASE1
(RGLG1)
18.53±0.59 18.3±2.44 37.29±1.61 21.83±1.37
AT4G38560 12.39±0.82 9.35±0.61 35.99±6.64 11.06±2.36
AT5G05300 9.46±2.74 11.45±1.41 35.3±2.18 15.46±5.16
AT2G02220 PHYTOSULFOKIN RECEPTOR
1 (PSKR1)
12.65±0.35 12.82±0.1 34.73±5.06 14.52±2.73
AT1G12420 ACT DOMAIN REPEAT 8
(ACR8)
14.36±1.8 15.36±0.35 34.13±3.8 19.38±1.83
AT4G11000 13.75±3.55 9.87±2.03 33.55±10.69 11.48±0.68
AT1G78355 12.77±5.91 18.12±7 33.08±12.75 21.07±8.67
AT5G37440 12.77±0.39 12.98±1.52 32.43±4.79 13.54±3.86
AT3G21780 UDP-GLUCOSYL TRANS-
FERASE 71B6 (UGT71B6)
14.86±2.49 16.62±2.51 31.82±9.71 15.93±2.41
AT3G28850 12.85±0.11 13.7±1.98 30.87±4.39 14.8±1.02
AT5G09800 13.2±1.25 12.3±2.06 29.68±3.55 13.49±1.11
AT5G54720 10.96±1.4 10.26±1.35 29.53±13.34 12.27±1.61
AT3G55090 ATP-BINDING CASSETTE G16
(ABCG16)
13.05±1.64 13±2.23 29.49±4.97 15.24±1.01
AT4G03113 12.02±7.1 10.6±2.34 28.77±5.08 14.79±1.43
AT1G61415 8.13±1.89 6.51±2.51 28.59±4.33 8.72±1.4
Continued on next page
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Table S.2 – continued from previous page
microarray expression values ± standard deviation
Gene number Gene symbol DMSO MeJA Toyocamycin Toyocamycin
+ MeJA
AT1G11055 11.5±0.91 9.41±3.38 27.94±12.93 15.45±7.18
AT2G21220 8.77±1.75 10.03±1.06 27.62±5.18 14.7±7.68
AT2G36295 13.07±2.79 16.03±2.7 26.83±7.45 14.44±4.3
AT5G48657 10.24±0.74 9.04±1.58 26.59±1.82 11.16±0.57
AT1G67856 9.87±0.73 9.69±0.7 26.51±9.27 13.88±3.1
AT4G12005 10.38±0.95 8.73±2.05 26.44±11.99 13.41±2.55
AT1G30972 10.05±2.06 6.79±3.79 26.29±14.62 11.04±4.37
AT1G32763 12.01±6.13 12±5.4 25.44±12.31 7.32±2.1
AT1G10652 8.75±1.26 7.51±3.2 24.96±18.19 9.63±1.24
AT4G31950 CYTOCHROME P450, FAMILY
82, SUBFAMILY C, POLYPEP-
TIDE 3 (CYP82C3)
8.22±2.52 7.94±0.68 24.93±11.14 12.86±4.86
AT5G16170 11.99±0.18 14.85±1.32 24.63±5.85 14.35±1.01
AT4G19970 10.1±1.25 9.22±1.42 23.38±3.34 11.04±1.1
AT3G22910 9.54±0.47 10.17±0.6 22.77±5.84 13.2±2.06
AT4G26005 7.02±2.05 10.09±3.73 21.99±11.58 10.96±0.4
AT4G25380 STRESS-ASSOCIATED PROTEIN
10 (SAP10)
7.61±0.92 6.89±0.34 21.32±5.93 9.24±1.78
AT2G04495 5.45±1 5.63±0.38 20.33±2.72 5.5±1.53
AT2G25305 8.16±0.76 13.94±9.8 19.82±9.91 10.29±2.06
AT2G38830 6.02±1.08 5.81±0.9 19.58±6.3 7.64±3.02
AT5G46295 7.46±2.26 6.98±1.46 19.52±0.63 10.1±3.53
AT2G23830 5.44±1.5 6.19±1.48 19.43±3.58 8.38±2.22
AT5G57123 8.44±0.79 8.92±1.31 18.91±6.26 9.56±1.67
AT3G16930 8.26±1.38 13.06±5.62 18.9±7.52 11.01±3.78
AT1G18382 6.51±1.48 7.38±4.46 18.7±3.37 9.83±0.62
AT3G28190 5.49±1.19 6.54±1.2 18.3±6.25 8.33±4.56
AT1G51890 8.68±0.87 8.5±0.8 17.54±0.92 9.65±0.69
AT2G17660 5.15±0.87 6.33±2.42 17.42±7.96 7.66±1.69
AT3G57700 7.98±1.07 7.41±2.33 17.39±5.72 8.22±1.22
AT1G05880 ARIADNE 12 (ARI12) 5.9±0.54 6.71±1.78 16.84±5.54 7.76±1.58
AT3G50200 7.72±0.82 8.78±1.59 16.25±5.59 8.63±0.82
AT5G39100 GERMIN-LIKE PROTEIN 6
(GLP6)
6.13±1.46 8.91±1.27 16.21±4.55 8.28±1.24
AT5G64790 7.18±0.42 7.02±0.79 15.57±2.52 7.5±0.59
AT1G13310 6.16±0.43 6.31±0.6 15.15±9.68 7.76±1.11
AT1G41798 6.68±1.54 4.81±0.81 15.03±9.16 5.27±0.77
AT1G80590 WRKY DNA-BINDING PROTEIN
66 (WRKY66)
5.43±0.92 6.08±1.23 14.63±10.04 8.73±2.92
AT5G09876 6.29±1.96 5.38±1.81 14.52±7.12 6.03±1.19
AT4G04155 6.06±0.96 8.71±5.37 14.29±3.89 6.01±0.4
AT5G35407 MICRORNA396B (MIR396B) 4.71±0.55 5.97±0.48 14.27±8.38 6±1.56
AT5G39130 5.51±1.73 5.35±0.07 14.15±1.77 8.3±3.08
AT2G14350 5.57±0.55 6.45±2.41 13.67±7.15 5.7±0.81
AT5G11140 6.11±0.31 5.93±0.79 12.83±3.99 7.67±0.93
AT5G35688 4.34±0.23 5.03±1.82 12.77±2.91 8.19±3.27
AT1G02230 NAC DOMAIN CONTAINING
PROTEIN 4 (NAC004)
5.69±0.58 5.21±0.48 12.2±3.71 5.99±0.07
AT2G34123 5.84±2.26 8.87±1.12 11.92±3.03 7.68±2.16
AT2G06750 5.28±0.77 7.01±0.79 11.65±1.23 6.49±1.45
AT3G28510 5.56±0.24 6.02±0.62 11.46±1.53 6.96±0.93
AT2G43371 4.92±0.31 5.58±0.43 11.01±6.36 5.11±0.31
AT3G42480 4.73±0.96 5.57±2.04 10.84±3.69 7.15±4.64
AT4G10767 SCR-LIKE 21 (SCRL21) 4.65±0.53 4.91±0.64 10.72±4.36 6.31±0.91
AT1G69797 MICRORNA395F (MIR395F) 4.33±0.56 5.18±0.47 10.57±5.02 6.03±2.25
AT1G29430 3.73±1.03 6.42±1.1 9.52±3.12 4.61±0.56
AT1G37063 4.05±0.98 6.88±3.07 8.47±1.65 5.04±1.52
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